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Colorectal cancer (CRC) is the third leading cause of cancer, and the second leading cause of 
cancer death in the United States (US). Recent evidence links consumption of a diet high in 
animal protein and fat as an environmental risk factor for CRC development, and the intestinal 
microbiota modulates the tumor promoting or protective effects of diet. Hydrogen sulfide (H2S), 
produced by resident sulfidogenic bacteria, triggers hyper-proliferation and pro-inflammatory 
pathways, and is genotoxic. In the US, there is a higher incidence of CRC in African Americans 
(AAs) compared to non-Hispanic whites (NHWs). We hypothesized that sulfidogenic bacterial 
abundance in colonic mucosa may be an environmental CRC risk factor that distinguishes AAs 
and NHWs, and may be correlated with differences in dietary composition. Colonic biopsies 
from uninvolved or healthy mucosa from CRC cases and controls were collected from five 
medical centers through the Chicago Colorectal Cancer Consortium. Using quantitative PCR, 
sulfidogenic bacterial abundance was measured in uninvolved colonic mucosa of 97 AA and 56 
NHW CRC cases, and 100 AA and 76 NHW controls. In addition, 16S rRNA sequencing was 
performed in AA cases and AA controls. A Block Brief 2000 Food Frequency Questionnaire was 
collected from a subset of subjects of 50 AA and 31 NHW CRC cases and 30 AA and 24 NHW 
controls. Differences were examined among bacterial targets, race, disease status, and dietary 
intake. African Americans harbored a greater abundance (p<0.001) of sulfidogenic bacteria 
compared to NHWs regardless of disease status, including the functional gene for H2S 
production in sulfate-reducing bacteria (SRB), dissimilatory sulfate reductase (pan-dsrA), 
Bilophila wadsworthia-specific dsrA, and 16S rRNA genes for Desulfobacter spp., Desulfovibrio 
spp., and Desulfotomaculum spp.. Bilophila wadsworthia-specific dsrA was more abundant in 
AA cases compared to AA controls (p<0.001). Linear discriminant analysis of 16S rRNA gene 
sequences highlighted the sulfidogenic Bilophila, Lactococcus, Odoribacter, Porphyromonas 
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and Pyramidobacter genera as features that characterize AA CRC. Fat intake and daily servings 
of meat were higher (p<0.01) in AAs compared with NHWs, and dietary fat intake correlated 
positively with pan-dsrA abundance (p=0.011). Additionally, dairy and calcium intake were 
lower (p<0.001) in AA, and servings of dairy correlated negatively with pan-dsrA abundance 
(p=0.007). Together, these results implicate sulfidogenic bacteria as an environmental risk factor 
contributing to CRC development in AAs. 
 Sulfidogenic bacteria metabolize organic and inorganic sulfur in order to produce H2S. We 
observed that microbes that metabolize organic sulfur distinguished AA CRC from NHW CRC 
subjects and AA controls. We hypothesize that SRB, (inorganic sulfur metabolizers), may impart 
beneficial functions, such as hydrogen disposal and barrier protection through antimicrobial 
effects of sulfide. Increased abundance of bacteria that utilize organic sources of sulfur may 
increase sulfide concentrations to levels that are proinflammatory and genotoxic. Bilophila 
wadsworthia produces H2S through metabolism of taurine, a sulfur amino acid available in the 
colon by diet and taurine conjugated bile acids. While studies have demonstrated preference for 
taurine as a terminal electron acceptor by B. wadworthia in vitro, none have determined the in 
vivo metobolic ‘lifestyle’ in a defined mixed community. Thus, as it was one of the most 
significant markers distinguishing AA CRC, we aimed to observe the baseline metabolic activity 
of this bacterium in vivo in mice fed a standard chow diet. Six gnotobiotic mice were colonized 
with a synthetic microbial community previously validated to be capable of metabolizing the 
taurine conjugated bile acid taurocholate (TCA), and were housed at the Mayo Clinic 
Gnotobiotic Facility for 30 days. A transcriptome analysis of cecal content revealed 4099 
transcripts expressed by B. wadsworthia. Transcripts were observed for all three enzymes 
involved in taurine metabolism: taurine:pyruvate aminotransferase (tpa), sulfoacetaldehyde 
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sulfolyase, and dissimilatory sulfite reductase A (dsrA). Taurine metabolism was the most 
abundant metabolic pathway expressed by the microbe, and dsrA an upstream enzyme to tpa 
were among the most abundant genes transcribed. Community analysis revealed expression of 
genes involved in liberating taurine from the bile acid taurocholate. Additionally, genes for D-
cysteine and nitrogen metabolism were highly expressed, indicating that alternate forms of 
metabolism may be important for pathogenesis and microbial fitness. These results indicate that 
B. wadsworthia is likely producing H2S in the colonic environment from taurine and D-cysteine 
metabolism, and that taurine from TCA metabolism is an available substrate for this microbe.  
In addition to B. wadsworthia, our recent study revealed Odoribacter spp. as a feature that 
distinguished AA CRC. Therefore, we aimed to verify that members of this genus do produce 
sulfide, and to determine the mechanism of their sulfur metabolism. The microbial species 
Odoribacter splanchnicus served as a surrogate for this analysis. Culture of O. splanchnicus in 
Sulfide Indole and Motility Medium revealed the microbe does indeed produce H2S. A genome 
search revealed a bifunctional tryptophanase/cysteine desulfhydrase (tnaA). The gene tnaA from 
O. splanchnicus was amplified by PCR, ligated into the expression vector pET-28a, transformed 
into Eschericia coli strain BL21, and overexpressed at 16°C for 16 hours. Functional analysis of 
the recombinant enzyme revealed positive cysteine desulfhydrase and tryptophanase activity. 
Cysteine desulfhydrase activity resulted in the consumption of cysteine and production of H2S 
and pyruvate. This implicates tnaA as an important functional enzyme in future analyses of the 
microbiome in CRC.  
Given that our analyses revealed microbial organic sulfur metabolism as a significant 
indicator of CRC, and identified two additional sulfidogenic enzymes to be considered in 
evaluations of sulfur metabolism in the human gut, an examination of the sulfidogenic capacity 
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of the human microbiome was performed. A survey of genomes published from the Human 
Microbiome Project (HMP) revealed that over a third of microbial species harbored genes for 
sulfur metabolism. Genes for cysteine metabolism were the most abundant sulfidogenic genes, 
revealing that it may be a more important driver of sulfidogenesis than inorganic sulfate 
metabolism in the human gut. In addition, a retroactive analysis revealed several species that 
were significantly correlated with CRC harbored genes for sulfur metabolism. These findings 
suggest that sulfur metabolism is more wide-spread in the human gut than previously understood, 
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Colorectal cancer is the third leading cause of cancer death in the US with an estimated 140,250 
new cases and 50,630 new cancer deaths in 2018.1 While increases in CRC screening have 
significantly lowered the abundance of incidence over the years, it is evident that CRC still has a 
tremendous impact and warrants further study. The majority of CRCs are sporadic and are 
thought to be the result of an environmental trigger acting on a predisposing multigenic 
background leading to chromosomal instability, suppression of tumor suppressor genes, and 
triggering of oncogenic pathways.2,3 It is commonly postulated that this environmental trigger 
may be diet and microbial metabolites. 
Hydrogen sulfide is a microbial metabolite commonly produced by microbial sulfur 
metabolism.4 Through a series of in vitro experiments, the Gaskins lab has highlighted the 
potential role of H2S in cancer progression. At mM concentrations, H2S inhibits cytochrome 
oxidase resulting in decreased oxidative phosphorylation and ATP synthesis causing reductive 
stress. Direct exposure to sulfide results in DNA damage and cell cycle arrest, which is driven by 
oxidative stress. Sulfide also modulates expression of inflammatory, cell cycle, and DNA repair 
genes, and is genotoxic at concentrations normally found in the colon.5-8 These data provide 
compelling evidence that sulfide is a genotoxic and proinflammatory agent that may trigger 
cancer progression. 
The Gaskins lab has also shown in a series of publications that the human mucosa is 
persistently colonized by SRB.9 As hydrogenotrophic microbes, SRB are vital contributors to the 
hydrogen (H2) economy of the human colon, disposing of H2 produced as a byproduct of 
microbial fermentation.10 In addition to SRB, which utilize inorganic sulfur, there are bacteria 
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which utilize organic sources of sulfur like taurine and cysteine to make proinflammatory and 
genotoxic H2S.
4  
The sulfur amino acids taurine and cysteine are abundant in diets high in animal fat and 
protein.12 There is compelling epidemiological evidence that a high meat and high fat “western” 
type diet is associated with increased CRC incidence. Seventh Day Adventists who consume a 
vegetarian diet have a lower incidence of CRC, and CRC risk of Japanese immigrants to Hawaii 
was increased within two generations upon switching to a “western” diet.12-14 Consistent with 
this, Native Africans (NAs) who consume a diet low in animal fat and protein have a negligible 
risk of CRC compared to AAs who consume a western type diet, and microbes who produce H2S 
as a consequence of organic sulfur metabolism are positively correlated with consumption of a 
“western” diet in these cohorts. 
Thus, we hypothesized that microbial sulfur metabolism is widespread in the human gut and 
is an important contributor to CRC. To evaluate this hypothesis, several aims were completed to 
evaluate the abundance of sulfidogenic bacteria in subjects with CRC, and to further our 
understanding of microbial sulfur metabolism in the human gut. These aims are presented in 
Chapters 2-6. The second chapter of this dissertation reviews what is currently known about 
colorectal carcinogenesis, defines factors and demographics currently associated with CRC, 
evaluates associations between CRC and a “western diet”, summarizes the carcinogenic features 
of H2S, and describes the current understanding of microbial sulfur metabolism in the human gut.  
The third chapter describes a study that determined the relationship between sulfidogenic 
microbes and CRC. In an attempt to explain the disparity of CRC observed in AAs, this study 
evaluated the abundance of sulfidogenic bacteria between 97 AA and 56 NHW CRC cases, and 
100 AA and 76 NHW controls. In addition to quantifying specific microbial targets, sequencing 
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analysis was performed to examine additional differences in the microbial community between 
AA CRC cases and controls. Comparisons between bacterial sulfidogenic targets and diet were 
also evaluated.  
The fourth and fifth chapters of this dissertation aim to increase our understanding of 
specific sulfidogenic bacteria. In the fourth chapter, a transcriptomic analysis of the taurine 
respiring B. wadsworthia was performed to elucidate its microbial “lifestyle” in vivo. The fifth 
chapter characterizes a sulfide producing enzyme harbored by the sulfidogenic bacterium O. 
splanchnicus.  
 The sixth chapter evaluates the sulfidogenic capacity of the human gut microbiome. To 
achieve this, a survey of genomes from the HMP was conducted using sequences from known 
human gut sulfidogenic genes. The seventh chapter evaluates significant findings from the 
collection of studies presented, and examines their combined implications. Future work, which 
may build on the findings on these studies, is also described.  
My studies also included projects that focused on microbial H2 metabolism in the colon. The 
appendices include summaries of that work (appendix A-C) as well as summaries of additional 
projects I contributed to that also focused on sulfidogenic bacteria, diet and human disease 
(appendix D-G). Together, these studies provide foundational evidence substantiating the 
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REVIEW OF LITERATURE 
CRC INCIDENCE, RISK FACTORS, AND DISPARITIES 
Colorectal cancer is the third leading cause of cancer, and the second leading cause of cancer 
death among men and women in the US.1 In 2012, 1.2 million Americans were reported to have 
a history of CRC, and in 2016, it was estimated that CRC incidence was to increase by 134,490 
people. The risk of CRC varies among age groups and genders, and is influenced by a variety of 
risk factors. Age appears to be one of the greatest determinants of risk, as it is estimated that over 
90% of new cases and CRC related deaths will occur to individuals over the age of 50.2 
Colorectal cancer incidence is 30-40% lower in women, and women have a higher rate of 
proximal cancers.3 
Personal and family health history is highly correlated to CRC risk. Hereditary CRC 
syndromes comprise 5% of total CRC cases, and include Lynch syndrome (also known as 
hereditary non-polyposis CRC (HNPCC)) and familial adenomatous polyposis. Individuals with 
a personal history of adenomatous polyps or CRC are more likely to develop CRC in the future, 
and those with a first degree relative with a history of CRC have a two to three times greater risk. 
4,5 Inflammatory bowel disease (IBD), like Crohn’s disease or ulcerative colitis, increases the 
risk of CRC, and those with a 30-year personal history of IBD are over twice as likely to develop 
CRC in their lifetime compared to those with average risk.6 Additionally, individuals with 
diabetes have a greater risk of CRC, even after adjusting for modifiable risk factors.7-9 
Modifiable risk factors for CRC include smoking, alcohol, non-steroidal anti-inflammatory 
drugs (NSAIDs), obesity, physical activity, and diet.4 In 2009, it was reported that there was 
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sufficient evidence to determine that smoking tobacco products is a cause of CRC.10 Moderate to 
heavy alcohol use results in a 23% greater CRC risk to individuals compared to those who 
consume less than one alcoholic beverage a day.11 As a cyclooxygenase inhibitor, long-term use 
of low dose NSAIDs may protect from CRC, though intake holds substantial risk of gastric 
bleeding.12-15 Increased body mass index (BMI), waist circumference, and waist to hip ratio are 
all associated with increased colon cancer risk,16-18 while physical activity is associated with 
lower risk as well as better patient outcomes.19 Additionally, there are well-established dietary 
intake patterns that are associated with increased or decreased cancer incidence, which will be 
covered later in this review.  
In addition to the aforementioned risk factors, race has been consistently observed to be a 
substantial indicator of CRC risk and outcomes. African Americans have the highest risk of 
CRC, with incidence rates 25% higher than NHWs. Hispanics have a lower incidence than 
NHWs, followed by Asian Pacific Islanders whose risk is 50% lower than AAs. Mortality rates 
reveal even larger disproportions for AAs whose risk of death is 50% higher than NHWs, and 
twice that of Asian Pacific Islanders.20 These disparities likely reflect a combination of genetic 
and environmental differences between AAs and other races. Before the 1980s, CRC incidence 
in AAs was slightly less than that of NHWs.21 Following President Reagan’s CRC diagnosis in 
1985, increased national attention led to greater CRC screening and diagnosis.22 This, combined 
with increased use of low dose NSAIDs for cardiovascular disease prevention, as well as 
population wide decreases in tobacco use, has led to a steady decline in CRC incidence rates 
among NHWs.1 Conversely, decreases in AA CRC incidence has been attenuated leading to a 
widening separation in CRC incidence and mortality rates in AAs compared to NHWs.22  
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Much of this difference reflects disparities in access for regular CRC screenings and high 
quality treatment in lower income communities.23 Indeed, compared to those who are uninsured, 
privately insured AAs are 46% more likely to survive five years after diagnosis,24 and AAs who 
receive similar chemotherapy treatment as NHWs have similar mortality outcomes with fewer 
negative side effects.25,26 Additionally, NHWs are more likely to be diagnosed with smaller 
polyps at a localized stage of carcinogenesis― factors which likely reflect early screening access 
and are associated with better survival rates.27 However, despite documented disproportions in 
CRC screening,28-32 compared with NHWs, AAs have a greater number of proximal tumors,33 
have lower stage specific survival rates,23 and are diagnosed at earlier ages.22 This points to 
genetic or environmental factors, which in addition to socioeconomic inequalities, appear to 
influence the disparity in CRC incidence and mortality in AAs compared with other races.  
COLORECTAL CANCER CARCINOGENESIS  
Colorectal cancer typically develops from non-cancerous lesions of the colon or rectal mucosa 
over the course of one or two decades.35 These growths, called polyps, are classified based on 
their shape, structure, size, and malignancy. Polyps can be tubular, villous, or serrated in shape, 
and sessile, subpendunculated, pendunculated, or flat in structure. Polyp sizes range from 1 mm 
to >10 mm and are characterized as hyperplastic or adenomatous. Hyperplastic polyps are 
predominately found in the distal colon, are usually less than 5 mm of size, and are generally 
considered to be non-malignant. 36-39 Adenomatous polyps, which arise from glandular cells of 
the colonic epithelium, have malignant potential.39 This potential increases with polyp size, 
presence of serration, and percentage of villous structures.37 
Most cancers of the colon or rectum originate from conventional adenomatous polyps or 
adenomas, and are known as adenocarcinomas.40 Adults in the US have a 25% chance of 
8 
 
acquiring an adenoma by age 50,41 and a 5% chance of developing adenocarcinoma in their 
lifetime.42 While approximately 15-30% of adenomas have a genetic component, as established 
by a family history of CRC, 44,45 the majority of adenocarcinomas are sporadic in nature─ the 
consequence of multiple genetic mutations resulting in chromosomal instability (CIN), 
microsatellite instability (MSI), and CpD island methylation (CIMP).46,47 These molecular 
pathways, common to both sporadic and hereditary CRC syndromes, often occur in tandem 
during a progression referred to as the adenoma-to-carcinoma sequence.48  
Occurring in approximately 65-75% of sporadic tumors, CIN is the most common of these 
pathways, and is characterized by chromosomal insertions and deletions, aneuploidy, and loss of 
heterozygosity (LOH). Events leading to aneuploidy and LOH include chromosomal segregation 
defects, disruptions in DNA damage repair, mutations in tumor suppressor and oncogenes, and 
excess telomere breakage.49 Loss of heterozygosity is observed in approximately 85% of CRC 
tumors, and occurs in many different loci, most notably 5q, 17p, and 18q.46  
Mutations or LOH in the 5q locus may cause inactivation of the tumor suppressor gene 
(TSG) adenomatous polyposis coli (APC).50 Inactivation of APC is observed in 75% of 
adenomas and adenocarcinomas and is hypothesized to be an initiating event of the adenoma-to-
carcinoma sequence.47, 50 Accounting for less than 1% of CRCs, familial adenomatous polyposis 
(FAP) is a hereditary CRC syndrome distinguished by germline APC mutations.51,52 Persons with 
FAP develop hundreds to thousands of colorectal polyps and reach a 100% risk of CRC by the 
age of 40.53  
Adenomatous polyposis coli serves as a regulator of β-catenin in the Wnt signaling pathway, 
in the absence of Wnt ligand signaling. Inactivation of APC through mutation or LOH results in 
a cytoplasmic accumulation of β-catenin which, once translocated to the nucleus, acts as a 
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transcriptional coactivator, initiating the expression of proto-oncogenes, as well as membrane 
and growth factors.54,55 In the “classical” CIN pathway, APC inactivation is followed by 
mutational activation of the oncogene KRAS.50 It is hypothesized that mutations of this gene are 
not initiating events of CRC carcinogenesis, as 60-90% of hyperplastic polyps contain this 
mutation. Rather, KRAS activation appears to be important for tumor progression when in 
coordination with APC mutations.56, 57 Accordingly, KRAS mutations occur 4 to 5 times more 
frequently in polyps greater than 1 cm compared to those less than 1 cm in size.58  
Observed in 70% of adenocarcinomas, 50 LOH of the 18q locus may result in mutation of the 
TSGs, SMAD2 and SMAD4.59, 60 As part of the transforming growth factor β (TGF-β) signaling 
pathway, the SMAD protein complex acts as a transcription factor to activate TGF-β mitigated 
growth inhibition. This pathway activates the mitogen-activated protein kinase 8 pathway, 
triggering apoptosis. Additionally, TGF-β stimulates synthesis of proteins, which inhibit cell 
cycle progression at the G1 stage of growth, and approximately 25% of CRCs have inactivating 
mutations of the TGF-β type II receptor (TGFβIIR) gene. Thus, inhibition of the TGF-β response 
through mutation or LOH prevents apoptosis and results in impeded growth inhibition.61  
Loss of heterozygosity in the 17p locus is observed in 70% of CRCs and often leads to 
mutation of the tumor suppressor transcription factor 53 (p53) gene. 50, 58 Inactivation of p53 
occurs in the majority of human tumors and is considered a key step in the transition from 
adenoma to adenocarcinoma in CRC.62 The p53 protein acts as a transcription factor to activate 
cell cycle inhibitors and pro-apoptotic pathways and to restrict angiogenesis in times of cellular 
stress.63 Consequently, mutation of p53 may lead to increased invasiveness and uninhibited 
tumor growth.  
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Microsatellite instability is the consequence of genetic alteration or hypermethylation of 
mismatch repair (MMR) genes resulting in inactivation of genes containing repetitive elements 
known as microsatellites.64 High frequency MSI (MSI-H) is found in 15% of CRC tumors, and is 
a hallmark of the most frequently occurring hereditary CRC syndrome, HNPCC.66 Characterized 
by a germline MMR mutation, followed by a second MMR inactivation by mutation or 
epigenetic inactivation, HNPCC or Lynch Syndrome occurs in 3-5% of CRC.67, 68 Both sporadic 
and HNPCC MSI may cause mutational inactivation of genes involved in cell cycle inhibition 
pathways (TGFβIIR) or apoptosis (BAX).61, 69 Similarly, in the CIMP pathway, hypermethylation 
of MMR genes, particularly MLH1, leads to MSI and is highly correlated with the mutation of 
the proto-oncogene BRAF.70-72 Intriguingly, in one analysis of 509 CRC cases, subjects with 
MSI-H tumors had more proximal CRC and the highest five-year survival rate, while those with 
CIMP and BRAF mutations had the poorest survival.73  
For the majority of CRC cases, the adenoma-to-carcinoma sequence takes place sporadically 
over the course of many years. During this time, concurrent triggering of CIN, MSI, and CIMP 
pathways, as well as localized somatic mutations, result in TSG regulation and activation of 
oncogenes. It is estimated that microsatellite stable tumors accumulate a median of 60 mutations, 
while MSI-H tumors may acquire as many as 700.48 The knowledge that the colonic environment 
is highly dynamic, and that the majority of these mutations are somatic, provides intriguing 
rational to explore potential environmental triggers, like diet and microbial metabolites, as 





DIET AND CRC RISK 
As mentioned previously, specific modifiable dietary elements have been identified which may 
protect or contribute to CRC risk. Dietary elements that are associated with reduced risk of CRC 
include fiber, dairy, and fruit and vegetable intake. A 10% reduction in CRC risk has been 
observed for every 10 g of fiber consumed.27, 74 In agreement with this finding, NAs who have a 
very low CRC risk (<1:100,000) consume a diet made up almost entirely of maize porridge, 
which is high in resistant starch.75, 76 Proposed mechanisms for reduction of CRC risk from fiber  
includes increased beneficial metabolites produced by resident gut microbes, increased stool 
bulking, and decreased transit time.74, 77-79 Dairy and calcium intake also appear to decrease the 
risk of CRC.80 Proposed mechanisms of this observation include inert bile salt formation by 
calcium and toxic secondary bile acids, and associations with lowered risk and blood vitamin D 
levels.80-82 Additionally, intracellular calcium inhibits cell proliferation, and supplemental 
calcium has been observed to reduce risk of CRC development by 20%.83,84 Finally, moderate 
daily fruit and vegetable intake is associated with reduced CRC risk, which may be associated 
with a recent analysis that confirmed an inverse association between CRC and total dietary 
folate.85, 86  
In 2011, a meta-analysis of prospective studies revealed increased CRC incidence among 
subjects who consumed a diet high in red and processed meat. This analysis reported increases in 
CRC risk by 29% for every 100 grams of red meat consumed per day and 21% for every 50 
grams per day of increased processed meat intake.87 N-nitroso compounds and N-nitroso 
promoting heme have both been independently associated with increased CRC risk.88-90 
Additionally blackened and charbroiled meats contain high levels of heterocyclic amines, which 
are mutagenic.91, 92 As central components of the “western” diet, animal protein and fat have long 
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been implicated in increased CRC risk. Early epidemiological data from the 1970s correlated 
populations consuming a high fat diet with increased CRC rates.93 Similarly, a study of Seventh 
Day Adventists who consume a vegetarian diet have a lower incidence of CRC than age-matched 
socioeconomically similar cohorts consuming a “western” diet.94 It was observed that Japanese 
CRC risk increased within two generations upon switching to a “western” diet after immigration 
to America.95, 96 Consistent with this, NAs who consume a diet low in animal fat and protein 
have a negligible risk of CRC compared to AAs who consume a “western” diet.75, 76 From these 
observations it is clear that exploring the contributions of a diet high in animal fat and protein to 
increased CRC risk warrants further study.  
MICROBIAL SULFUR METABOLISM AS AN ENVIRONMENTAL TRIGGER OF 
CRC 
A number of studies have linked differences in fecal and colonic microbial composition with 
CRC risk, but mechanisms underlying these observations are a source of ongoing study.97-106 Of 
recent interest is the metabolic capacity of the colonic microbiome and the release of nutritive or 
pro-inflammatory microbial metabolites resulting in either colonic health or damage. There is 
evidence that diet has a dynamic impact on gut microbiome composition. Indeed, an 
investigation of microbiome response to short-term macronutrient changes observed a significant 
change to microbiome structure on an animal-based diet, only one day after the diet had reached 
the colon.107 In concordance with this, a diet exchange between low CRC risk NA subjects who 
eat a diet low in fat and animal protein, and high risk AA subjects who eat a high fat and animal 
protein “western” diet, observed reciprocal changes in microbial target abundance and fecal 
metabolome composition.108 Given these connections between diet and microbial composition, 
and parallels observed between a “western” diet and increased CRC risk, it is possible that a 
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“western” diet associated microbiome structure results in the accumulation of pro-inflammatory 
microbial metabolites which act as environmental triggers of colorectal carcinogenesis.  
 Hydrogen sulfide is a metabolite predominately produced as a by-product of microbial 
sulfur metabolism. Once produced, exogenous H2S exists in the volatile undissociated form, 
which is highly toxic. An estimated 95% of H2S is absorbed through the colon, owing to a 
natural diffusion gradient between colonic lumen (mM) and blood (μM), while the rest passes as 
flatus.109 Once absorbed, H2S creates a state of energy deficiency leading to the significant 
reduction of cell function. At μM concentrations, H2S is oxidized by the mitochondrial electron 
transport chain by H2S:quinone oxidoreductase, thus increasing ATP synthesis, and resulting in a 
mix of oxidized metabolites including S2O3
2-, HSO3
-, SO4
2-. In contrast, at mM concentrations, 
H2S inhibits cytochrome oxidase, decreasing the electrochemical potential, and inhibiting basic 
cellular physiology.110,111 In addition to reduced ATP synthesis, H2S is thought to inhibit the β-
oxidation of butyrate, the preferred substrate of colonocytes, through the formation of 
persulfide.112-114 Persulfide-CoA inhibits acyl-CoA dehydrogenase by complexing with its FAD 
prosthetic group, which results in the competitive inhibition of butyryl-coA ligandation.115 
Truncated butyrate oxidation results in reduced protective mucus formation, cellular 
detoxification, and ion absorption.116 
In addition to colonocyte energy deficiency, the Gaskins’ lab has demonstrated that H2S 
induces proliferative and inflammatory pathways, and provided unequivocal evidence that 
sulfide is genotoxic at concentrations less than those measured previously in human colon, 
leading to cell-cycle arrest and DNA damage, which is produced by oxidative stress.117-120 In 
non-transformed human intestinal epithelial FHs 74 Int cells, H2S generated single-stranded 
DNA breaks at concentrations as low as 250 µM. In naked nuclei from Chinese Hampster Ovary 
14 
 
cells, sulfide damaged directly at concentrations as low as 1 µM. Co-treatment with the free 
radical scavenger butyl-hydroxyanisole or incubation with the DNA repair enzyme [fapy]- DNA 
glycosylase resulted in decreased sulfide induced DNA damage demonstrating that H2S 
treatment can result in oxidative DNA damage.117 More recently, the Gaskins lab demonstrated 
in non-transformed human intestine epithelial cells that H2S was genotoxic but not cytotoxic at 
concentrations (250 to 2000μM) similar to that found in the large intestine.119 Sulfide exposure 
for 30 minutes or 4 hours led to increased expression of DNA repair pathways. A 30-minute 
exposure to H2S modulated cytokine and TNF signaling pathways, and a 4-hour exposure 
upregulated expression of pro-inflammatory genes including IL8 and COX-2 as well as genes 
involved in cell cycle progression and apoptosis.118 Overall, these data provide rationale-
implicating sulfide as an environmental trigger leading to CRC carcinogenesis (Figure 2.1).  
Resident sulfidogenic bacteria are active participants of the H2 economy of the human colon, 
in which H2 is produced by microbial carbohydrate metabolism. Hydrogen consumption is 
thermodynamically essential in the H2 rich environment of the colon, which is persistently 
colonized by hydrogenotrophic microbes including acetogens, methogens, and sulfidogenic 
bacteria.121,122 The most widely studied sulfidogenic bacteria of the human colon are the SRB, 
which utilize H2 to reduce inorganic sulfate to produce H2S. In addition to the SRB, the colon is 
colonized by bacteria that metabolize organic sources of sulfur including sulfur amino acids.123  
 There is abundant evidence linking sulfidogenic bacteria, CRC risk, and a “western” type 
diet high in animal fat and protein. The sulfidogenic species, Fusobacterium nucleatum has been 
repeatedly observed to be more abundant in subjects with CRC, but little attention has been 
given to the ability of this bacterium to produce H2S as a mechanism for carcinogenesis.
124-127 As 
mentioned previously, a diet exchange between high CRC risk AA subjects and low CRC risk 
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NA subjects observed reciprocal changes in abundance of F. nucleatum and the sulfidogenic 
bacteria B. wadsworthia.108 Several studies have observed higher abundance of sulfidogenic 
bacteria in mice fed a diet high in animal fat.128-130 Consistent with this, one study observed an 
increase in sulfidogenic bacteria abundance in subjects consuming an animal-based versus a 
plant-based diet.107  
 A “western” diet abundant in protein, animal fat, and processed foods is rich in sulfur 
sources for microbial sulfur metabolism. The sulfur amino acids cysteine, cystine, methionine, 
and taurine are abundant in dietary protein, and fecal sulfide concentrations are significantly 
correlated with meat intake.123, 131,132 Inorganic sulfates and L-cysteine are commonly used as 
dough conditioners and strengtheners in commercial breads.128,132 In addition, L-cysteine is 
regularly added to canned foods to prevent enzymatic browning, and may be used as a flavor 
additive to produce meaty-like flavor compounds.133 Sulfites are commonly added as a 
preservative in processed fruit, vegetables, and meats. Finally, taurine and calcium are added as a 
supplement to energy drinks and to lower pH in fermented beverages respectively.123,132 
Although dietary inorganic sulfate naturally occurs in higher abundance in grapes, nuts, shellfish, 
and Brassica vegetables, the widespread use of sulfur compounds in processed food production, 
along with the abundance of sulfur amino acid content in animal protein, have the potential to be 
substantial contributors of dietary sulfur in the “western” diet.132  
 In addition to dietary sulfur, endogenous sulfur may be an important contributor to microbial 
sulfur metabolism. Sulfomucins, sulfated glycoprotein components of the colonic mucus layer, 
may be degraded by microbial glycosulfatases resulting in the release of inorganic sulfate. 
Similarly, sulfate may be liberated from sulfated bile acids by microbial arylsulfatases.134  
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 The taurine conjugated primary bile acid TCA may be a key component linking diet, 
microbial sulfur metabolism, and CRC risk.123 In the 1970s, an examination of epidemiological 
data revealed that patients with CRC or adenomas had higher fecal bile acids, and that this was 
correlated with a diet high in animal fat and protein.135,136 Two studies observed increased 
primary and secondary bile acid concentrations in subjects consuming an animal protein rich 
diet. 107,108 Taurine for bile acid conjugation is supplied by the diet or synthesized in hepatocytes 
from methionine and cysteine.108, 137 Humans are unable to metabolize taurine, and excess taurine 
is excreted through the bile or urine.138,139 Consequently, a diet high in taurine shifts conjugation 
of primary bile acids to tauro-conjugation resulting in an increased taurocholic acid:glycocholic 
acid ratio,140 and providing an ideal niche for TCA metabolizing microbes.123  
SULFIDOGENIC PATHWAYS RELEVANT TO THE HUMAN MICROBIOME 
Sulfate reduction 
The SRB are the most well studied of the human colonic sulfidogenic bacteria. These bacteria 
are capable of gaining energy for growth through the eight-electron reduction of inorganic 
sulfate (SO4
-2) supplied exogenously by diet or endogenously by degradation of sulfated bile 
acids and mucin by arylsulfatases and glycosulfatases, respectively.131,141-144 Unlike the 
assimilatory sulfate reduction pathway which does not result in sulfide release aside from 
putrefaction, the dissimilatory sulfate reduction pathway results in a net production of H2S.
141 
Dissimilatory sulfate reduction begins with the ion-gradient driven transport of SO4
-2 into the 
SRB cytoplasm. All enzymatic steps of dissimilatory sulfate reduction take place exclusively in 
association with the inner cytoplasmic membrane or the cytoplasm of the bacteria, and as such 
genes for sulfate transport are highly conserved among SRB. 145-150 Dissimilatory sulfate 
reduction then takes place through three enzymatic steps (Figure 2.2). In the first step, due to its 
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low redox potential, SO4
-2 is activated by ATP sulfurylase (sat) resulting in adenosine-5’-
phosphosulfate (APS).151-153 Adenosine-5’-phoshosulfate is reduced to sulfite (SO3
-2) or bisulfite 
(HSO3
-) and AMP by APS reductase (aprAB). While the mechanism has not been unequivocally 
elucidated, it has been proposed that electron transfer for APS reduction comes from the 
Quinone-interacting membrane-bound oxidoreductase complex (QmoABC). 150, 154 
The final step of dissimilatory sulfate reduction, SO3
2− reduction, is carried out by the multi-
subunit enzyme known as dissimilatory-sulfite reductase (dsr), which catalyzes the six-electron 
reduction of SO3
2− to H2S.
155 Desulfoviridin type dsrs, were originally thought to be comprised 
of α, β, and γ subunits designated as dsrA, dsrB, and dsrC respectively. Subsequent evidence 
revealed that dsrC was not only expressed at a separate locus, but is a separate protein, which 
interacts with the dsrAB complex with a cysteine, containing C-terminal residue. It has been 
proposed that SO3
2− reduction takes place as a series of two electron transfers to dsrAB from the 
dsrMKJOP complex via dsrC.155 dsrAB type dissimilatory (bi)sulfite reductases are highly 
conserved and abundant in many bacteria and archaea due to lateral gene transfer, and as such 
have been used to characterize phylogenetic diversity of microbes with sulfate reducing 
capability. Additionally, degenerate functional gene primers have been successfully used to 
quantify the abundance or SRBs in a variety of environments.156  
Reducing equivalents are needed for the latter two steps of sulfate reduction, and are 
generally produced through H2 or formate oxidation, hydrogen cycling, and electron transfer to 
the membrane-associated menaquinone pool. The large variety of SRB, accounts for the diversity 
of protein composition involved in reducing equivalent production pathways.155 Though SRB 
have been isolated without hydrogenases, the majority of SRB harbor periplasmic [NiFe] uptake 
hydrogenases which transfer electrons liberated by hydrogen oxidation to multiheme 
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cytochromes c.157 Similarly, most SRB contain periplasmic formate dehydrogenases which 
transfer electrons obtained by formate oxidation to cytochromes c.155 In hydrogen cycling 
reducing equivalents from lactate or pyruvate are used by cytoplasmic hydrogenases to evolve 
hydrogen, which then diffuses into the periplasm to create reducing equivalents by the 
aforementioned hydrogen oxidation pathway.158 Formate and carbon monoxide have also been 
proposed as substrates for hydrogen cycling.159 Reducing equivalents from lactate and putatively 
pyruvate oxidation are also transferred through the membrane associated menaquinone pool. The 
final step of these pathways involves the transfer of electrons from cytochromes c, the membrane 
associated menaquinone pool, or other proposed electron transfer proteins through membrane-
bound electron- transfer complexes to provide reducing equivalents for sulfate reduction.150 
Sulfide production was first recognized in aquatic habitats, 160, 161 and sulfate reduction was 
first demonstrated in anaerobic enrichment cultures of mud in the 1800s.162 In 1895 the first 
SRB, Spirillum desulfuricans (later Desulfovibrio desulfuricans), was isolated.163 Since that time 
researchers have found SRBs to be ubiquitous throughout nature, and sulfate reduction to be 
conserved among four bacterial and two archaeal phyla.156 Although highly abundant, the 
diversity of SRBs in the human colon is low. At this time, the human gut microbial community 
consist of only four known SRB species including members of the δ-Proteobacteria 
Desulfovibrio, Desulfobacter, and Desulfobulbous, as well as the gram positive Firmicute, 
Desulfotomaculum.164 Consisting of 64-81% of the SRB community, Desulfovibrio spp. is by far 
the most abundant,164 the most common species being Desulfovibrio piger.165 Sulfate reducing 
bacteria have been isolated in a number of human samples including the blood, urine, and 
abdominal and brain abscesses.166-171 These bacteria have been associated with periodontitis 
severity and have been implicated in the etiology of IBD.165,172,173 Patients with ulcerative colitis 
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(UC) have been observed to have a greater abundance of SRB in their colon, as well as a 
significantly elevated abundance of fecal sulfide.174-177 It has been proposed that UC is the result 
of colonic energy deficiency caused by the inhibition of butyrate oxidation by SRB derived 
H2S.
111-113 As mentioned previously, butyrate is the primary energy source for colonocytes, and 
indeed clinical symptoms of UC have been effectively reduced by butyrate enemas.178 As IBD is 
a risk factor for CRC, an elevated risk of IBD by increased SRB abundance may translate into 
increased cancer risk.6 
Taurine respiration 
Sulfonates are organic sulfur compounds with a SO3
- moiety, which are abundant in marine 
sediments and detergents, and play an important role in the environmental sulfur cycle.179 While 
less is known about the role of sulfonates in the human intestine, there is evidence that sulfonate 
metabolism is performed by resident gut microbes. Desulfitobacterium spp. and strains of 
Desulfovibrio spp. have been observed to metabolize the sulfonates cysteate and isethionate, 180 
and cysteate and taurine are respired by the bacteria B. wadsworthia.181 Bilophila wadsworthia 
respires taurine in three enzymatic steps, resulting in the release of ammonia, acetate, carbon 
dioxide, and H2S (Figure 2.2). In the first enzymatic step, taurine, provided by the diet or by 
taurine conjugated bile acids, is transanimated from pyruvate using the enzyme tpa to produce 
alanine and sulfoacetaldehyde. Sulfoacetaldehyde is then sulfonated with water by 
sulfoacetaldehyde sulfolyase (Xsc) to produce acetate and sulfite. Using the same final 
enzymatic step as SRB, SO3
2− reduction is achieved using formate, lactate, pyruvate, or the 
taurine carbon as electron donors, but is most efficient when utilizing hydrogen.160 Sequencing 
analysis groups B. wadsworthia’s dsrAB in the Deltaproteobacteria supercluster, and similar to 
other Desulfoviridin type dsr harboring microbes, B. wadsworthia’s dsr contains a single dsrAB 
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transcriptional unit that is coordinately expressed. Usually, Desulfoviridin type dsrs contain an 
additional dsrD gene with unknown purpose at the terminal end of the dsrAB operon, but B. 
wadsworthia is unique in that it does not have a separate dsrD gene, but rather has a merged 
dsrBD unit.182 The dsrA gene has been a useful marker for quantification of SRB, and B. 
wadsworthia specific dsrA primers have proven to be most suitable for quantification of this 
bacterium in intestinal and mucosal samples.156 
Bilophila wadsworthia was first identified in 1988 during a study characterizing the 
microbiome of gangrenous appendicitis. The microbe is a common anaerobic isolate in 
infections, including ear, biliary tract and liver abscess, and is the third most common isolate 
detected in appendicitis, with abundance correlating with severity of disease.183 Similarly, 
increased abundance of B. wadsworthia was observed in mice fed a high milk fat die in a dextran 
sodium sulfate induced model of colitis.128 As a β-lactamase producer, B. wadsworthia is 
resistant to most antibiotics, with metronidazole being the only effective agent against all tested 
strains.183-185 The bacterium has endotoxic activity, and has been observed to produce intra-
abdominal abscesses in mice when injected directly into the peritoneal cavity.186, 187 Evolutionary 
analysis of 16S rRNA genes place B. wadsworthia within the Desulfovibrionaceae family, and 
intriguingly Desulfovibrio spp. has also been identified in pathogenic roles.188 Bilophila 
wadsworthia is asaccharolytic, and while it is able to ferment pyruvate and reduce nitrate, it 
grows most efficiently in the presence of taurine,181 making it uniquely suited to thrive in the 
taurine and hydrogen rich environment of the colon.  
Cysteine fermentation 
Cysteine is a conditionally essential amino acid, which is provided to the intestine directly by 
diet or the decomposition of methionine.189 For most cysteine fermenting bacteria, catabolism is 
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achieved by the enzyme L-cysteine desulfhydrase (cdl), resulting in the release of H2S. The cdl 
enzyme is observed in a variety of resident colonic genera including Clostridium, Desulfovibrio, 
Enterobacter, and Klebsiella, as well as known human pathogens such as Helicobacter pylori, 
Mycobacterium turberculosis, Escherichia coli and Salmonella typhimurium.135 In addition to 
cdl, orthologs of the mammalian sulfidogenic enzymes, cystathionine-β-synthase (CBS), 
cystathionine-γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3MST) are wide spread 
in bacterial genomes.189 The production of H2S through cysteine degradation has been most 
extensively studied in the oral microbiome where volatile sulfur compounds like H2S are 
implicated as a source of oral abscess, breath malodor, and delayed wound healing. Some of 
these oral cavity residents are also found in the human colon, and include such genera as 
Prevotella, Streptococcus, and Fusobacterium. Of particular interest is the bacterium F. 
nucleatum as it has been observed to create the largest amounts of sulfide in vitro among other 
oral bacteria and can form aggregates with periodontal disease causing bacteria.190-192 In addition, 
Fusobacterium spp. have been consistently associated with the CRC dysbiosis.124-127 Two studies 
have demonstrated association between F. nucleatum and the tumor surface in a subset of 
CRC,123, 125 F. nucleatum DNA in CRC tumors correlate with reduced survival,193,194 and two 
subspecies of F. nucleatum (vincentii and animalis) have been proposed as part of a microbial 
signature for fecal CRC classification.127  
Fusobacterium nucleatum degrades cysteine using four known enzymatic pathways resulting 
in the formation of H2S and additional by-products (Figure 2.2). The most abundant enzyme is 
F. nucleatum’s cdl homologue (FN1220), which achieves cysteine catabolism through β-
replacement resulting in the condensation of two cysteine molecules and the release of 
lanthionine and H2S.
195, 196 The second pathway described in F. nucleatum is an additional 
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homologue (lcd or FN0625), which ferments L-cysteine through α,β-elimination resulting in 
pyruvate, ammonia, and H2S.
191 The third pathway, cystathionine-β-synthase (FN1055), releases 
L-Serine and H2S through β-elimination, and has been observed to have the highest affinity for 
L-cysteine of the four pathways.196 Similar to lcd, the final known pathway, L-methionine-γ-
lyase (FN1419), produces pyruvate, ammonia, and H2S through α,β-elimination. As the name 
implies, L-methionine-γ-lyase was first reported to catalyze the α,γ-elimination of L-methionine. 
As the enzyme’s affinity for L-methionine is greater than that of L-cysteine in F. nucleatum, it is 
unlikely that this enzyme contributes greatly to sulfide production.197 Indeed, an experiment 
measuring mRNA expression of these four sulfidogenic genes ranked their respective H2S 
contribution as follows: FN1220 > FN1055 > FN1419 > FN0625. Consequently, the cdl of F. 
nucleatum appears to be the most important enzyme for H2S production.
197 More research is 
needed to identify the total contribution of H2S by cdl and sulfidogenic human orthologues from 














Figure 2.1. Genotoxic and inflammatory mechanisms of H2S. Sulfide is genotoxic at concentrations normally found in the colon. 
At mM concentrations sulfide inhibits cytochrome oxidase resulting in decreased oxidative phosphorylation and ATP synthesis 
resulting in reductive stress. Direct exposure to sulfide results in DNA damage and cell cycle arrest which is driven by oxidative 


































Figure 2.2. Known pathways of microbial sulfur metabolism in the human gut. a. Inorganic sulfate reduction by sulfate 
reducing bacteria. Dissimilatory sulfate reduction is achieved via three enzymatic steps and results in the successive reduction of 
inorganic SO4
-2 to H2S. b. Taurine reduction by Bilophila wadsworthia. Taurine reduction is achieved via deanimation of taurine 
and successive reduction of sulfite using the same terminal enzyme conserved in sulfate reducing bacteria. c. Cysteine reducing 
pathways of Fusobacterium nucleatum. Cysteine is fermented by F. nucleatum using 4 similar mechanistic pathways resulting in the 
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RACE-DEPENDENT ASSOCIATION OF SULFIDOGENIC BACTERIA  
WITH COLORECTAL CANCER 
 
ABSTRACT 
Colorectal cancer incidence is higher in AAs compared to NHWs. The intestinal microbiota is 
postulated to modulate the effects of diet in promoting or preventing CRC. Hydrogen sulfide, 
produced by autochthonous sulfidogenic bacteria, triggers pro-inflammatory pathways and 
hyper-proliferation, and is genotoxic. We hypothesized that sulfidogenic bacterial abundance in 
colonic mucosa may be an environmental CRC risk factor that distinguishes AA and NHW. 
Colonic biopsies from uninvolved or healthy mucosa from CRC cases and tumor-free controls 
were collected prospectively from five medical centers in Chicago for association studies. 
Sulfidogenic bacterial abundance in uninvolved colonic mucosa of AA and NHW CRC cases 
was compared to normal mucosa of AA and NHW controls. In addition, 16S rDNA sequencing 
was performed in AA cases and controls. Correlations were examined among bacterial targets, 
race, disease status, and dietary intake. AAs harbored a greater abundance of sulfidogenic 
bacteria compared to NHWs regardless of disease status. Bilophila wadsworthia-specific dsrA 
was more abundant in AA cases than controls. Linear discriminant analysis of 16S rRNA gene 
sequences revealed five sulfidogenic genera that were more abundant in AA cases. These results 
implicate sulfidogenic bacteria as a potential environmental risk factor contributing to CRC 
development in AAs. 
______________________________________________________________________________ 
1 Reprinted with permission from Yazici C, Wolf PG, Kim H, Cross TL, Vermillion K, Carroll T, Augustus GJ, 
Mutlu E, Tussing-Humphreys L, Braunschweig C, Xicola RM, Jung B, Llor X, Ellis NA, Gaskins HR. Race-
dependent association of sulfidogenic bacteria with colorectal cancer. Gut. 2017;66(11):1983-1994. © (2017). BMJ. 
All rights reserved. 





Colorectal cancer is the third most frequent cancer in the United States with an estimated 
134,490 new cases and 49,190 deaths in 2016. African Americans have a CRC incidence 10-
30% higher than other races and ethnicities, and even greater disparities in mortality rates.1 
African Americans are diagnosed at earlier ages and have more proximal CRC compared to 
NHWs.2 Although some types of CRC are influenced by genetic risk factors or disease, the 
majority occur sporadically as a consequence of environmental exposures that promote 
colonocyte hyperproliferation, loss of apoptotic control and epithelial barrier integrity, and 
excess production of pro-inflammatory immunomodulatory factors.3 
Significant differences in fecal and colonic microbial composition in healthy subjects and 
cancer patients have been identified, 4-13 but the impact remains uncertain. Compared with tumor-
free controls, CRC subjects have higher levels of stool hydrogen sulfide (H₂S).14 Higher levels 
of fecal H2S have been detected in patients with colitis, who have an increased susceptibility of 
CRC.15-18 Exogenous H₂S is genotoxic at levels commonly found in the colon. This bacterial-
derived gas induces proliferative and pro-inflammatory pathways and inhibits β-oxidation of 
butyrate—an anti-carcinogenic metabolite and favored substrate of colonocytes.19-22 Multiple 
bacterial species produce H₂S, including taurine-respiring B. wadsworthia, cysteine-utilizing 
Fusobacterium nucleatum, and sulfate-reducing bacteria (SRB) such as Desulfovibrio spp. 23-25 
Additionally, higher levels of fecal bile acids have been observed in CRC cases than controls,14 
which could be associated with increased abundance of taurocholate-utilizing B. wadsworthia.  
Because exposure to H2S could promote CRC development, we hypothesized that 
sulfidogenic bacteria contribute to a microenvironment conducive to colorectal carcinogenesis 
through production of H2S. Accordingly, we examined sulfidogenic bacterial abundance in 
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uninvolved mucosa of subjects with CRC compared to tumor-free controls. Of particular interest 
was whether differences in sulfidogenic bacteria between AAs and NHWs might contribute to 
racial differences in CRC incidence rates.  
MATERIALS AND METHODS 
Human Subjects 
The Chicago Colorectal Cancer Consortium prospectively ascertained incident CRC cases from 
surgery and endoscopy units and tumor-free controls undergoing routine screening colonoscopy 
from five Chicago medical centers, including University of Illinois Hospital and Health Sciences 
System, Jesse Brown Veterans Administration, John H. Stroger Hospital of Cook County, 
University of Chicago Medicine, and Rush University Medical Center, over a two-year period 
(2011-2012), as previously described.26 The parent study received approval for human subjects 
research from the institutional review boards (IRBs) of each participating medical center; the 
parent protocol was administered by the IRB at University of Illinois Hospital and Health 
Sciences System (2010-0168). Colonic tissue biopsies from uninvolved or healthy mucosa were 
studied from 329 subjects after routine bowel preparation. The cases were persons with 
adenocarcinoma of the colon or rectum detected during patient workup due to gastrointestinal 
symptoms or collected at the time of surgical resection. Control subjects were persons 
undergoing colonoscopy in whom tumors were not identified. In CRC cases, biopsies were 
collected approximately 10 cm away from the tumor location. Samples were taken either with 
endoscopic biopsy or surgical forceps. Included were 97 AA and 56 NHW CRC cases, and 100 
AA and 76 NHW controls. Persons with a personal history of cancer, inflammatory bowel 
disease, adenomatous or benign polyps, polyposis, or tumors with microsatellite instability were 
excluded.26 Clinical data were extracted from medical records, and epidemiologic and 
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demographic information were obtained using subject questionnaires as previously described.26 
Factors analyzed included age, sex, race; tumor or biopsy site, tumor stage; body weight, body 
mass index; education and income level; usage of tobacco products and alcohol; and usage of 
omega-3 fatty acids and non-steroidal anti-inflammatory drugs (NSAIDs) (Table 3.1, 
Supplementary Table 3.1). Significantly different factors were used as covariates for potential 
confounder adjustment. 
Quantitative Polymerase Chain Reaction (qPCR) Analysis 
Mucosal biopsies were placed into RNAlater and stored at 4° C overnight, after which they were 
stored at -80° C until extraction. DNA was isolated from mucosal biopsies using commercial 
DNA extraction kits (Promega, Madison, WI; Mobio, Carlsbad, CA), quantified, and diluted to 5 
ng/μL. Examination of bacterial target abundances of NHW cases prepared with the two kits 
yielded similar results, indicating that DNA extraction method did not introduce bias. 
Sulfidogenic bacteria abundance was quantified in triplicate with a 7900HT Fast Real-Time PCR 
System (Applied Biosystems, Foster City, CA). Small subunit rRNA genes of SRBs including 
Desulfobacter spp. (DSB), Desulfobulbus spp. (DBB), Desulfotomaculum spp. (DFM), and 
Desulfovibrio spp. (DSV) were targeted and validated as previously described.27 In addition, 
functional genes from the H2S production pathway, pan-dsrA
28 harbored by all SRB29 and B. 
wadsworthia-specific dsrA (dsrA-BW)22 were quantified. 
Statistical Analysis 
To test differences between groups, Wilcoxon Rank Sum test or t-test, for continuous variables, 
and chi-square or Fisher exact test for dichotomous variables were used. Because bacterial 
targets were not normally distributed, data was log-transformed. For binary outcome analyses 
(AA vs. NHW and case vs. control), logistic regression models were used adjusting for selected 
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covariates. In all models, age, sex, and biopsy location were included. For sulfidogenic bacterial 
analysis in AAs, BMI, education level, and annual income level were included. In NHWs, BMI, 
education level, and NSAID use were included. Spearman correlation analysis was used to test 
associations between sulfidogenic bacteria. Statistical tests were conducted using SAS 9.3 (SAS 
Inc., Cary, NC).  
16S rDNA Sequence Analysis and Bioinformatics 
Mucosal DNA samples were processed using Zymo Research DNA Clean and Concentrator, 
quantified using a Qubit fluorimeter (Life Technologies, Carlsbad, CA), and the V4 region of 
16S rDNA was amplified according to Fluidigm protocols. Products were subjected to a second 
round of amplification with Illumina linkers and barcodes. Final products were quantified, 
quality tested with a Fragment Analyzer (Advanced Analytics, Ames, IA), and size selected 
using a 2% agarose E-gel (Life Technologies Carlsbad, CA). Quality of cleaned and extracted 
product was verified using an Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA) and 
sequencing was carried out using an Illumina MiSeq (Illumina, San Diego, CA).  
Sequencing of the V4 region resulted in 4,885,578 raw reads, which were demultiplexed, 
quality filtered to remove low abundant operational taxonomic units (OTUs) and singletons, and 
clustered using a 97% similarity threshold through QIIME 1.8.0 using the Greengenes 13_8 
reference database as previously described.30-32 Quality filtering and rarefaction to 5571 (Max= 
67,359) sequences per sample resulted in 2,689,301 reads from 155 samples (61 AA CRC cases 
and 94 AA controls) with a sample mean of 17,350 sequences and an average base pair length of 
252. Alpha- and beta-diversity was assessed using the core_diversity_analysis.py workflow in 
QIIME 1.8.0. To confirm core diversity findings were not an artifact of sequence rarefaction and 
obtain an estimate of robustness, comparably-sized jack-knifed sample datasets were created, 
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and beta diversity was re-analyzed in QIIME 1.9.1.31 
Linear discriminant analysis (LDA) effect size was calculated with the LEfSe algorithm to 
identify biomarkers for the differences between CRC cases and controls.33 A secondary analysis 
was performed to examine differences between subjects based on tumor location, comparing left-
sided cases (n=33) and left-sided controls (n=52) and comparing right-sided cases (n=27) and 
right-sided controls (n=42); and based on age, comparing cases <50 (n=11) and controls <50 
(n=20) and comparing cases <50 (n=11) and cases ≥50 (n=48). No further adjustments for 
multiple testing were required. 33 
Analysis of Dietary Intake  
Dietary intake was obtained using the Block Brief 2000 Food Frequency Questionnaire (BBFFQ) 
from a subset of subjects, including 50 AA and 31 NHW CRC cases and 30 AA and 24 NHW 
controls.34 The questionnaires were administered within three weeks of the diagnostic procedure 
to reduce recall bias. NutritionQuest (Berkeley, CA) processed completed BBFFQs. The Diet 
and Behavior Shared Resource of the University of Illinois-Chicago Cancer Center prepared a 
dataset for statistical analysis.  
Dietary intake data from outliers were excluded [<600 kcals (n = 11) or >3500 kcals (n = 1)]. 
Because energy intake is highly correlated with macro and micronutrient intake,35 nutrient or 
food group was adjusted per 1000 calories. Density variables were created for total fat (g), 
saturated fat (g), monounsaturated fat (g), polyunsaturated fat (g), protein (g), total carbohydrate 
(g), total fiber (g), cysteine (mg), calcium (mg), iron (mg), alcohol (g), omega-6 fatty acids (g), 
and daily food group servings of meat, vegetables, fruit, total grains, and dairy. Percent kcals 
from fat, protein, and carbohydrate were also examined.  
Differences in intake of nutritional variables between AAs and NHWs were assessed using 
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the Wilcoxon Signed Rank test or t-test, as appropriate. To analyze the relationship between 
selected dietary intake variables (cysteine, total fat, and daily servings of dairy) and sulfidogenic 
bacterial abundance, linear regression models were created using R version 3.3.1 and adjusted 
for age, sex, race, disease status, and BMI. 36-38 Due to the high degree of co-linearity between 
these variables and other dietary factors of interest, it was necessary to isolate the independent 
effect of these intake variables. Consequently, we residualized each variable by obtaining the 
residuals for a model fit with all correlated variables > 0.50 as explanatory and used these 
residuals in our final model.  
RESULTS 
Race-Specific Differences in Mucosal Sulfidogenic Bacteria 
Comparison of sulfidogenic bacterial targets between races revealed pan-dsrA, a measure of SRB 
abundance across a range of species, to be 10-times higher in AAs compared to NHWs 
(p<0.001) irrespective of disease status (Figure 3.1A). Abundance of individual SRB genera 
were higher in AAs compared to NHWs for all species except DBB; DBB levels were mostly 
undetectable in AAs. Similarly, the abundance of B. wadsworthia was 2.5-times higher in AAs 
compared to NHWs irrespective of disease status (p<0.001). These differences in abundance 
remained statistically significant after adjustment for clinical and epidemiological variables that 
were different between races (Supplementary Table 3.1). 
Comparison of sulfidogenic bacterial targets between CRC cases and controls within each 
racial group revealed the mean abundance of pan-dsrA to be 1.8-times higher in AA controls 
than AA CRC cases (p<0.001) (Figure 3.1B). By contrast, this target was 2.9-times higher in 
NHW CRC cases than NHW controls (p<0.001). These racial differences remained significant 
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after adjusting for age, sex, biopsy site, BMI, education, income level, and NSAID use (Table 
3.1).  
The taurine-respiring sulfidogenic bacterium B. wadsworthia was 1.9-times more abundant in 
AA CRC cases than AA controls (p<0.001), and remained significant after adjusting for 
demographic factors mentioned previously. On the other hand, abundance of B. wadsworthia did 
not differ between NHW cases and controls. 
Consistent with the pan-dsrA results, the abundance of DSB (p<0.001) and DFM (p<0.001) 
was higher in AA controls than AA CRC cases. On the other hand, abundance of DSB (p=0.018) 
and DBB (p<0.001) was higher in NHW CRC cases than NHW controls. These data demonstrate 
that AA and NHW cases and controls display reciprocal differences in SRB abundance, which 
remained after adjusting for tumor stage. Additionally, Spearman’s correlation analysis revealed 
that SRBs correlated positively with B. wadsworthia in NHWs, but not in AAs (Supplementary 
Table 3.2). 
16S rDNA Sequencing Analysis in African Americans 
Due to the disparity in CRC risk in the AA compared to the NHW population, a 16S rRNA gene 
sequence analysis was conducted to validate sulfidogenic abundance trends observed by our 
qPCR analysis and to compare case versus control differences in taxa not tested by qPCR 
analysis. The overall microbial population was represented by 10 phyla, 70 families, and 137 
genera (Supplementary Figure 3.1). Relative abundance differences in phyla between AA CRC 
cases and AA controls were not statistically significant, and measures of alpha diversity were not 
different. Analysis of UniFrac distance matrices using Monte Carlo permutations (n=999) 
revealed significant differences in beta diversity between AA CRC cases and AA controls for 
both unweighted (p=0.01) and weighted (p=0.01) Unifrac distances. (Supplementary Figures 
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3.2A and 3.2B.) To ensure results were not due to sequence rarefraction, this analysis was 
further validated using jackknifed estimates, and similar results were obtained (Supplementary 
Figure 3.3). Overall, these data indicate that AA CRC cases displayed differences in taxon 
composition for both highly abundant and rare taxa compared to AA controls. 
To determine which bacterial taxa were primary drivers of microbiome differences between 
AA CRC cases and AA controls, LDA was used to calculate effect size of different bacterial taxa 
(Figure 3.2A). LDA analysis revealed the genera Faecalibacterium, Pseudomonas, and an 
unknown genus of Peptostreptococcaceae were strongly associated with AA controls; and the 
genera Alistipes, Delftia, Erysipelotrichaceae, Micrococcus, Pyramidobacter, Ruminococcus, 
and unidentified genera associated with the Bacteroidales, Christensenellaceae, and 
Mogibacteriaceae families were associated with AA CRC cases. The mean abundance of genera 
identified by LDA in AA CRC cases and controls is shown in Figure 3.2B. We note that many of 
the subjects had undetected levels for the bacteria identified by this analysis. 
Analysis of genera-specific differences of sulfidogenic bacteria revealed increased relative 
abundance of Bilophila and Desulfovibrio in AA CRC cases compared to AA controls, although 
these differences were not significant after adjusting for false discovery rate (Figure 3.2C). 
OTUs for DSB, DFM, and DBB were not identified. Fusobacterium was the most abundant 
sulfidogenic bacterium identified in the analysis, but the relative abundance of Fusobacterium 
was similar between cases and controls. Apparent differences in relative abundance of 
Desulfovibrio as estimated by 16S rDNA sequencing likely reflects the greater number of null 
reads in control subjects.  
Linear discriminant analysis was used to identify differences in bacterial genera relative 
abundance for right and left-sided colonic biopsies (Figure 3.3A and 3.3B). Effect size scores 
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identified Pyramidobacter, Weissella, and unknown genera of the Bacteroidales, 
Mogibacteriaceae and Pseudomonadaceae families as being significantly associated with right-
sided AA CRC cases. The genera Faecalibacterium, Erwinia, Klebsiella, Variovorax, 
Caulobacteraceae and Delftia were associated with right-sided AA controls. Coprobacillus, 
Alistipes, Christensenellaceae, Cc 115 Erysipelotrichaceae, Porphyromonas, Ruminococcus, 
Odoribacter, and unknown genera belonging to YS2 were significantly associated with left-sided 
AA CRC cases. The genera Oxalobacteraceae, Erwinia, and unknown genera of 
Peptostreptococcaceae were associated with left sided AA controls. 
Additionally, LDA was used to identify differences in relative abundance of bacterial species 
comparing CRC cases and controls less than 50 years of age (Figure 3.3C). The genera 
Bilophila, Parabacteroides, Odoribacter, and an unknown genus of the Barnesiellaceae family 
were associated with early-onset CRC and the genus Acidaminococcus was associated with 
controls less than 50. We also compared CRC cases below 50 and CRC cases 50 and older, 
revealing two genera (unknown genera of the families Barnesiellaceae and Pseudomonadaceae) 
associated with cases above the age of 50, and 11 genera (Staphylococcus, Coprobaccilus, 
Lactococcus, Corynebacterium, Cetobacterium, Megamonas, Anaerococcus, Sneathiia, 
Odoribacter, and unknown genera of the Methylobacteriaceae and Mogibacteriaceae families) 
associated with cases under age 50 (Figure 3.3D).  
Associations between Diet and Sulfidogenic Bacteria 
To examine whether diet differed between AAs and NHWs, dietary intake was analyzed with the 
BBFFQ, focusing on nutrient and dietary factors associated with the typical mixed Western-style 
diet, namely intake of total fat, animal fat, and protein. Overall, dietary fat and protein intake per 
1000 kcals was significantly greater in AA compared to NHW subjects; on the other hand, 
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calcium intake and servings of dairy per 1000 kcals were lower (Supplementary Table 3.3). To 
examine the effect of dietary intake on sulfidogenic target abundance, these dietary variables 
were examined using linear regression models (Figure 3.4; Supplementary Figure 3.4; 
Supplementary Table 3.4). As observed in the larger dataset (Figure 3.1), the three major 
sulfidogenic bacteria tested (pan-dsrA, B. wadsworthia, and DSV) strongly associated with race - 
the main variable that explained differences between AAs and NHWs (Figure 3.4). In the 
models, pan-dsrA abundance also associated with residuals for cysteine (p=0.016), total fat 
(p=0.011), and daily servings of dairy (p=0.007), as well as male sex (p=0.0032). DSV 
abundance was not significantly associated with dietary variables, but trends were observed with 
cysteine and male sex. Similarly, B. wadsworthia abundance was not significantly associated 
with dietary variables, but there was a strong association with age (Figure 3.4; p=0.001).  
 
DISCUSSION 
The present results demonstrate that the microbiome of uninvolved mucosa in CRC cases is 
distinct from tumor-free controls and implicate sulfidogenic bacteria as potential contributors to 
CRC development. One of the more striking observations was the greater abundance of SRBs 
and B. wadsworthia in AAs compared to NHWs irrespective of disease status. Pan-dsrA was 10-
fold and B. wadsworthia dsrA 2.5-fold more abundant in AA colonic mucosa, and overall, 
analysis of individual sulfidogenic bacterial species confirmed this difference. Secondly, 
reciprocal differences in sulfidogenic bacterial abundance were observed in both AA and NHW 
CRC cases compared to controls. Notably, similar reciprocal differences were observed during 
diet exchange between rural South African blacks and AAs living in Pittsburgh.14  
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We demonstrated previously that human colonic mucosa is persistently colonized by 
sulfidogenic bacteria.39Constitutive bacterial-derived sulfide may have a protective anti-
microbial effect, based on the susceptibility of resident microbes to H2S.
40 Sulfide production 
may become deleterious when the provision of organic sources of sulfur promotes growth of 
taurine and cysteine utilizing bacteria, increasing sulfide to pro-inflammatory and genotoxic 
concentrations. Taurine provided by bacterial deconjugation of taurocholic acid acts as a 
substrate for anaerobic respiration by B. wadsworthia, generating genotoxic H2S.
41 Once 
deconjugated, free primary bile acids are further metabolized by colonic bacteria to genotoxic 
and pro-inflammatory secondary bile acids. Specifically, the secondary bile acid, deoxycholic 
acid, acts as a tumor promoter, causing membrane perturbations leading to arachidonic acid 
release. Arachadonic acid is converted by COX-2 and lipooxygenase to pro-inflammatory and 
pro-angiogenic prostaglandins and reactive oxygen species, damaging DNA and inhibiting DNA 
repair enzymes.41 Accordingly, these data support the hypothesis that differences in sulfidogenic 
bacteria between AAs and NHWs may contribute to variations in CRC incidence between these 
two populations.  
Examination of microbial abundance in uninvolved mucosa from AA CRC cases and 
controls using 16S rDNA analysis underscored a number of prevailing taxonomic trends 
associated previously with cancer development in NHWs.4-13 For example, in agreement with 
previous analyses,8,9,10,12 relative abundance of Mogibacteriaceae, Leptotrichia, Porphyromonas, 
Erysipelotrichaceae, and Ruminococcus were significantly higher in AA CRC cases. Similar to 
F. nucleatum, Mogibacteriaceae was first isolated from the human oral cavity and associated 
with oral and extraoral abscesses.42 Likewise, species of the genera Sneathia,43 formally known 
as Leptotrichia sanguinegens,44 and Porphyromonas are prevalent in periodontal disease,45 and 
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recently members of the oral microbial community have been associated with CRC.46 Bacteria 
from the family Erysipelotrichacea, have been linked with inflammatory bowel disease, are 
consistently positively associated with high-fat diets and dyslipidemia, and may be modulated by 
changes in host cholesterol metabolites.47 While some species of the genus Ruminococcus appear 
to be protective,48,49 a greater abundance of Ruminococcus obeum was observed in the feces of 
rats with 1,2-dimethyl hydrazine induced precancerous lesions.50 
Several reports note increased abundance of sulfidogenic microbes in CRC related-dysbiosis, 
but few have connected the production of H2S with CRC development.
5-13 Our study is the first 
to look at differences in sulfidogenic bacteria, specifically in uninvolved mucosa of individuals 
with CRC compared to controls. LDA revealed several genera associated with sulfur metabolism 
as significant indicators of disease, including Mogibacteriacea, an bacteria observed previously 
to co-occur with volatile sulfur compound-producing microbes like F. nucleatum,42 and the 
sulfidogenic genera Lactococcus, Porphyromonas, Odoribacter, Bilophila, and 
Pyramidobacter.23, 51-54 Similar to F. nucleatum, species of Lactococcus and Poryphyromonas 
generate sulfide from cysteine metabolism.51,52 The growth of Odoribacter splanchnicus, another 
species from the Porphyromonadaceae family, is enhanced with addition of bile, and this 
bacterium produces an abundance of sulfide.53 While one other study observed higher abundance 
of Pyramidobacter in proximal colon cancer tissue, the authors did not make the association with 
sulfide.6 Our study also corroborates previous evidence that microbial composition of proximal 
and distal cancers differ and that Pyramidobacter is enriched in proximal cancers.6 Thus, 
Pyramidobacter spp. could contribute to the propensity for proximal tumors in AAs.2 The 
present report is the first to demonstrate that B. wadsworthia is associated with CRC. 
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A meta-analysis of prospective cohorts revealed increased CRC incidence among persons 
who consume a diet high in red and processed meat.55 Consistently, the present study observed a 
higher intake of dietary fat and protein in AAs, who are at higher risk of CRC development 
compared with NHWs. A Western diet is thought to be a major contributor to CRC incidence 
variance in different countries. For example, rural South African blacks, who consume a diet low 
in fat and animal protein have a negligible risk of CRC compared to AAs and American NHWs, 
who on average consume a diet high in animal products.21 A recent comparison of AA and rural 
South African blacks showed significantly higher levels of both primary and secondary bile acids 
in AAs, as well as reciprocal changes in secondary bile acids and colonic microbiota after diet 
exchange.21 Additionally, a recent study revealed rapid changes in “bile-tolerant” microbes upon 
consumption of a diet rich in fat and animal protein, including two genera abundant in this study, 
namely, Alistipes and Bilophila.56 Notably species of Cetobacterium, a taxon observed to be 
significant in AA CRC, are also bile tolerant.57 Similarly, B. wadsworthia was significantly more 
abundant in mice fed a high milk fat diet and increased severity of symptoms in DSS induced 
colitis.58 A high fat diet, rich in the sulfur-containing amino acids cysteine and taurine increases 
bile secretion, and shifts the taurine:glycine bile acid ratio towards taurine conjugation.59  
A key advantage of the present study is that recruited subjects represent an urban American 
population of average to low-income persons with predominantly high school or some college 
education, enabling a more generalizable examination of health and dietary disparities than 
performed previously.12, 57, 60, 61Additionally epithelial cell function is affected to a greater extent 
by mucosally-associated microbes62-64 as measured herein, functional differences have been 
observed between mucosal and luminal microbiota,65 and mucosal but not fecal microbiota may 
discriminate between disease status and health.63  
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Our study is limited by use of the BBFFQ to measure habitual dietary intake of subjects. It is 
well established that diet assessment methods which rely on self-report are prone to 
underreporting of nutrient intake due to socially-desirable responses and recall bias. 66,67The 
BBFFQ has a reduced food list (only 70 foods/beverages) and thus inherently will result in 
energy and macronutrient estimates lower than actual intake. With this in mind, nutrient density 
(per 1000 kcals) variables were created for dietary components of interest and have been 
suggested to more closely correlate with “true” intake versus estimates of absolute intake.67 
Given the limitations of self-report diet assessment methods, to best understand the impact of 
diet composition in the manipulation of bile acid ratios and microbial metabolites, controlled 
feeding studies are warranted. Additional limitations include lack of information on probiotic 
and antibiotic use by subjects. Use of LEfSe to identify significant genera in the 16S analysis 
may bias against identification of rare OTUs; however, it is one of the most commonly utilized 
analytical methods for biodiscovery. Metabolites and histologic biomarkers were not examined 
in the present study; these variables should be evaluated in future studies.  
Our analysis revealed that race was the strongest variable associated with differences in 
sulfidogenic bacteria in AA compared to NHWs, and that diet differences had relatively small 
effects; consequently, we propose some other latent variable explains this difference. Identifying 
that latent variable is an important future direction. In the meantime, it is clear a greater 
understanding of sulfidogenic bacteria associated with the colonic mucosa and development of 
novel CRC prediction models using key sulfidogenic bacteria may provide substantial 
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FIGURES AND TABLE 
Table 3.1. Clinical and demographic characteristics of African American and non-Hispanic White subjects  
 African Americans (n=197) non-Hispanic Whites (n=132) 
Clinical variable Controls N Cases N p-value Controls N Cases N p-value 
Age, mean in years ± SD 55.5 ± 9.6 100 59.8 ± 10.8 97 0.003 55 ± 12.91 76 59.6 ± 10.1 56 0.047 
Biopsy, left/right large bowel1 55/45 100 55/42 97 0.886 50/25 75 42/13 55 0.248 
Gender, F/M  46/54 100 40/57 97 0.566 32/44 76 18/38 56 0.28 





 ± SD 30.4 ± 6.1 100 28.3 ± 6.5 97 0.043 27.5 ± 6.5 76 28.4 ± 5.9 56 0.046 
College education, percent2 59.6 99 35.5 97 < 0.001 69.7 76 52.7 55 0.047 
Annual income, percent  100  96 0.032  75  55 0.384 
<25,000 60 60 75 72  36 27 47.3 26  
25,000-75,000 29 29 21.9 21  36 27 32.7 18  
≥75,0000 11 11 3.1 3  28 21 20 11  
Omega-3, percent users3 27.6 87 14.6 41 0.174  50 50 27.3 22 0.07 
Alcohol, percent current users 31.3 99 24.2 91 0.33 48.7 76 32.1 53 0.06 
Smoking, mean pack years 6.1 ± 10.7 46 7.6 ± 14.8 70 0.73 12 ± 21.8 39 14.9 ± 26.3 44 0.92 
NSAID use in years4 4.9 ± 6.8 93 3.03 ± 7.8 95 0.084 7.6 ± 9.2 75 3.1 ± 7  51 < 0.001 









    14 (28%) 
16 (32%) 
12 (24%) 
  8 (16%)   
  
Statistical comparisons between cases and controls within each ethnic group were performed using Wilcoxon rank sum or t-test for continuous  
variables and chi square or Fisher exact test for dichotomous variables. Annual income in US dollars; body mass index, 
BMI; non-steroidal anti-inflammatory drug, NSAID; standard deviation, SD; tumor-node-metastasis classification of malignant tumors,  
TNM stage. The N is the number of subject from whom information was available. 
1The right side of the large bowel includes the cecum and appendix, ascending colon, hepatic flexure, and transverse colon. The left side includes 
the splenic flexure, descending colon, sigmoid colon, and rectum. 
2Percent of subjects who graduated from a four-year undergraduate scholastic program.  
3Percent of subjects who reported dietary supplementation with omega-3 fatty acids in the last five years. 
4NSAID used included [Ibuprofen, Advil or Motrin].  
5The p value for the comparison of stages between AA CRCs and NHW CRCs was 0.89. 
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Figure 3.1. Differences in mean gene copy numbers of sulfidogenic bacteria comparing colorectal cancer cases and controls in 
African Americans and non-Hispanic Whites. a. Scatterplot representations of mean gene copy numbers per nanogram of DNA of 
sulfidogenic bacterial targets in African Americans compared to non-Hispanic Whites with median and upper and lower quartiles 
indicated. African Americans are represented in green and non-Hispanic Whites are represented in purple. All comparisons had a 
p<0.001. b. Scatterplot representations of mean gene copy numbers per nanogram of DNA of sulfidogenic bacterial targets in cases 
and controls in each racial group. African Americans cases are represented in light green and controls in dark green. Non-Hispanic 














Figure 3.2a. Analysis of bacterial 16S rDNA data identifies differences in bacterial abundances comparing African American 
colorectal cancer cases and controls. Differences identified by linear discriminant analysis. Effect sizes were calculated by the 
LEfSe algorithm and genera associated with effect size differences ≤-log2 and ≥log2 are shown. Genera associated with control 
















Figure 3.2b. Analysis of bacterial 16S rDNA data identifies differences in bacterial abundances comparing African American 
colorectal cancer cases and controls. Scatterplot representations of the bacterial genera identified by LEfSe analysis in cases and 
controls. Each point is the logarithm of the proportion of each indicated bacterial genera with median and upper and lower quartiles 
indicated. The null measurements are not indicated on the plot. The numbers of nulls for each subject (case/control) by genera is 
Faecalibacterium 1 case/1 control, Pseudomonas 22/31, Peptostreptococcaceae 58/64, Alistipes 61/94, Delftia 62/79, 
Mogibacteriaceae 62/94, Micrococcus 62/94, Pyramidobacter 58/92, Christensenellaseae 54/92, Cc_115 Erysipelotrichaceae 60/93, 










Figure 3.2c. Analysis of bacterial 16S rDNA data identifies differences in bacterial abundances comparing African American 
colorectal cancer cases and controls. Scatterplot representations of abundances of three selected sulfidogenic bacteria— 
Fusobacterium, Desulfovibrio and Bilophila—shown as in B. The numbers of nulls for each subject (case/control) by genera is 












Figure 3.3. Linear discriminant analysis identifies differences between colorectal cancer cases and controls. Effect size 
calculated by the LEfSe algorithm identifies genera strongly associated with differences between colorectal cancer cases and controls 
in right-sided colonic biopsies (a) and in left-sided colonic biopsies (b), as well as differences based on age, comparing cases <50 and 
controls <50 (c) and comparing cases <50 and cases ≥50 (d). Genera associated with control samples are in green and genera 









Figure 3.4a Comparison of selected factors that explain differences in sulfidogenic bacteria 
in African American and non-Hispanic Whites. Scatter plot representations of residuals of 
linear models for selected bacterial targets, namely, pan-dsrA, Desulfovibrio spp., and B. 
wadsworthia. African Americans are represented in green, non-Hispanic whites are represented 
in purple. Cases are represented as open circles and controls as closed circles. B. Forest plots of 
effect size estimates from the linear models. Outcome variables were log transformed gene copy 
abundances of pan-dsrA, Desulfovibrio spp., and B. wadsworthia. Points and lines on each plot 
represent the point estimate and 95% confidence interval, respectively, for each covariate in the 
model. Estimates reflect predicted change in variable for one-unit change in outcome. Positive 
associations are in blue, negative associations are in red. P-value for each covariate is 
represented on the right, and statistically significant values after Bonferroni correction are in 
bold. The wide confidence interval seen in the BMI, underweight class is explained by the small 





















Figure 3.4b. Comparison of selected factors that explain differences in sulfidogenic bacteria 
in African American and non-Hispanic Whites. Forest plots of effect size estimates from the 
linear models. Outcome variables were log transformed gene copy abundances of pan-dsrA, 
Desulfovibrio spp., and B. wadsworthia. Points and lines on each plot represent the point 
estimate and 95% confidence interval, respectively, for each covariate in the model. Estimates 
reflect predicted change in variable for one-unit change in outcome. Positive associations are in 
blue, negative associations are in red. P-value for each covariate is represented on the right, and 
statistically significant values after Bonferroni correction are in bold.  
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SUPPLEMENTARY FIGURES AND TABLES 
 
Supplementary Table 3.1. Clinical and demographic characteristics of African American and non-Hispanic White subjects  
 African Americans (n=197) non-Hispanic Whites (n=132) p values 
Age, mean in years ± SD 57.7 ± 10.4 197 56.9 ± 11.9 132 0.824 
Biopsy, left/right large bowel1 110/87 197 92/38 130 0.007 
Gender, F/M  86/117 197 50/82 132 0.307 
Weight, mean in lbs. ± SD 188.6 ± 43.9 197 182.3 ± 40.9 132 0.305 
BMI, kg/m
2
 ± SD 29.4 ± 6.4 197 27.9 ± 6.2 132 0.033 
College education, percent2 47.4 196 62.6 131 0.009 
Annual income, percent  196  130 <0.001 
<25,000 67.3 132 40.8  53  
25,000-75,000 22.5  50 34.6  45  
≥75,0000 7.1  14 24.6  32  
Omega-3, percent users3 23.4 128 43.1  72 0.004 
Alcohol, percent current users 27.9 190 41.9 129 0.011 
Smoking, mean pack yrs 7 ± 13.2 116 13.5 ± 24.1  83 0.226 
NSAID use in yr4 3.9 ± 7.3 188 5.7 ± 8.6 126 0.163 
Statistical comparisons between cases and controls within each ethnic group were performed using Wilcoxon rank sum 
or t-test for continuous variables and chi square or Fisher exact test for dichotomous variables. Annual income in  
US dollars; body mass index, BMI; non-steroidal anti-inflammatory drug, NSAID; standard deviation, SD. The N is the  
number of subjects from whom information was available. 
1The right side of the large bowel includes the cecum and appendix, ascending colon, hepatic flexure, and transverse  
colon. The left side includes the splenic flexure, descending colon, sigmoid colon, and rectum. 
2Percent of subjects who graduated from a four-year undergraduate scholastic program.  
3Percent of subjects who reported dietary supplementation with omega-3 fatty acids in the last five years. 
4NSAID [Ibuprofen, Advil or Motrin]. 
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Supplementary Table 3.2. Pair-wise comparisons of sulfidogenic bacteria in African Americans 
and in non-Hispanic Whites tested by Spearman correlation analysis. 
 Log pan-dsrA Log DSV Log DSB Log DBB Log DFM Log B. wads 
 African Americans 
Log pan-dsrA 1 (190) 
 
     
Log DSV 0.260 (179) 
<0.001 
1 (185)     




1 (190)    






1 (193)   








1 (193)  











 Non-Hispanic Whites 
Log pan-dsrA 1 (114) 
 
     
Log DSV 0.528 (91) 
<0.001 
1 (97)     




1 (131)    






1 (129)   








1 (126)  











The Spearman rho value is the upper value in each cell with the total n is in parenthesis. The p-value of the 
comparison is the lower value in each cell. Bilophila wadsworthia, B. wads; Desulfobacter spp., DSB; 
Desulfobulbus spp., DBB; Desulfotomaculum spp., DSM; Desulfovibio spp., DSV; Dissimilatory sulfite 








Supplementary Table 3.3. Comparisons of key dietary nutrients in African Americans and non-
Hispanic Whites. 





Total kilocalories  1269.2 ± 521.3 1400.9 ± 555.5 0.183 
Total protein (g) 38.9 ± 6.9 39 ± 7 0.946 
Daily servings of meat  1.44 ± 0.49 1.18 ± 0.51 0.006 
Cysteine (mg) 565.6 ± 104.9 515.5 ± 94.3 0.008 
Total iron (mg) 13.9 ± 14.8 12 ± 11.9 0.456 
Daily servings of dairy  0.55 ± 0.43 0.97 ± 0.85 <0.001 
Calcium (mg)  341.8 ± 130.5 450.8 ± 206.8 <0.001 
Daily servings of vegetables 
Daily servings of grains 
Daily servings of fruits 
1.9 ± 1.7 
2.29 ± 0.93 
1.08 ± 0.93 
2 ± 1.4 
2.11 ± 0.91 




Total fiber (g) 9.4 ± 4.8 9.6 ± 4.7 0.833 
Total fat (g)  44.3 ± 8.1 40.7 ± 10.3 0.033 
% of kilocalories from fat 35.9 ± 14.2 29 ± 10.4 0.004 
Saturated fat (g)  14.3 ± 3.3 13.7 ± 4.3 0.371 
Monounsaturated fat (g)  16.9 ± 3.8 15.8 ± 4.6 0.155 
Trans fats (g) 1.6 ± 0.7 1.2 ± 0.5 <0.001 
Polyunsaturated fat (g)  9.5 ± 2.8 7.8 ± 2.3 <0.001 
Dietary PUFA (~N-6) 18:2 (g)  8.2 ± 1.8 6.8 ± 1.8 <0.001 
Dietary PUFA (~N-6) 18:3 (g)  0.93 ± 0.33 0.78 ± 0.27 0.007 
Dietary PUFA (~N-6) 20:5 (g)  0.017 ± 0.013 0.015 ± 0.014 0.259 
Omega-6 FA (g) 8.3 ± 1.8 6.9 ± 1.8 <0.001 
Omega-3 FA (g) 0.99 ± 0.34 0.82 ± 0.27 0.003 
Total alcohol (g) 3.4 ± 8.2 5.6 ± 12.3 0.248 
 Nutrient intakes are reported in either gram (g), milligram (mg), daily servings or percent (%) 
kilocalories (kcal), adjusted for total calorie intake. Mean intake ± standard deviations are per 
1000 calorie intake except the total kilocalories variable. To adjust for multiple testing, a 
significance threshold (p<0.0063) was set based on comparing the eight major food groups, 
herein shown as protein, dairy, vegetables, grains, fruits, fiber, fat, and alcohol; the significant 










Supplementary Table 3.4. Statistics of linear regression models for the selected sulfidogenic bacteria.  
Variable Estimate Std. Error t value Pr(>|t|) 
Pan-dsrA 
Residual for cysteine 0.0021 0.00087 2.46 0.016 
Residual for total fat 0.25 0.099 2.57 0.011 
Residual for dairy servings -0.51 0.18 -2.76 0.0070 
Age -0.0014 0.0043 -0.33 0.74 
African American race 0.88 0.095 9.25 3.8 x 10-15 
Male sex 0.29 0.097 3.02 0.0032 
Disease status, case 0.056 0.092 0.61 0.55 
BMI, under weight 0.61 0.48 1.27 0.21 
BMI, over-weight 0.13 0.11 1.19 0.24 
BMI, obese -0.089 0.11 -0.81 0.42 
(Intercept) 0.97 0.26 3.74 0.00031 
Desulfovibrio spp. 
Residual for cysteine 0.0014 0.00058 2.41 0.018* 
Residual for total fat 0.049 0.072 0.69 0.49 
Residual for dairy servings -0.052 0.12 -0.43 0.67 
Age -0.0024 0.003 -0.79 0.43 
African American race 0.21 0.066 3.2 0.0017 
Male sex 0.12 0.068 1.77 0.080* 
Disease status, case 0.059 0.064 0.92 0.36 
BMI, under weight -0.081 0.33 -0.25 0.81 
BMI, over-weight -0.021 0.079 -0.26 0.79 
BMI, obese -0.096 0.078 -1.22 0.23 
(Intercept) 2.26 0.18 12.53 3.9 x 10-22 
Bilophila wadsworthia 
Residual for cysteine 7.93e-05 0.00071 0.11 0.91 
Residual for total fat 0.038 0.083 0.45 0.65 
Residual for dairy servings 0.18 0.14 1.24 0.22 
Age 0.013 0.0037 3.38 0.0010 
African American race 0.28 0.080 3.47 0.00076 
Male sex -0.056 0.082 -0.67 0.50 
Disease status, case 0.078 0.079 0.99 0.32 
BMI, under weight -0.062 0.41 -0.15 0.88 
BMI, over-weight -0.025 0.095 -0.25 0.79 
BMI, obese -0.17 0.094 -1.77 0.079* 
(Intercept) 0.68 0.22 3.05 0.0029 
The estimate provides the increase (or decrease) in bacterial abundance per each unit of variable; the unit of 
abundance is the log-transformed value of the mean gene copy number. Significant associations are bolded and 
trends are marked by an asterisk. 53% of the variance in the abundance of pan-dsrA is explained by variable in the 
present model; 14% of the abundance of Desulfovibrio; and, 20% of the abundance of Bilophila wadsworthia, as 
shown in the sub-table below. 
Bacterial target Observations Residual Std. Error 𝑅2 Adjusted 𝑅2 
Pan-dsrA 113 0.4558 0.5707 0.53 
Desulfovibrio spp. 110 0.3118 0.2201 0.14 















Supplementary Figure 3.1. Phyla composition shown as percent relative abundance in 
African American colorectal cancer cases and controls. Phyla for the microbial population 
was determined using core_diversity_analysis.py workflow in QIIME 1.8.0, and represented by 
the following 8 phyla: Firmicutes (38.9%), Bacteroidetes (38.1%), Proteobacteria (18.8%), 
Fusobacteria (2.0%), Actinobacteria (1.1%), Verrucomicrobia (1.0%), Synergistetes (0.1%), and 
Cyanobacteria (0.1%). Overall, the colorectal cancer cases displayed a greater abundance of 
Cyanobacteria (0.1% vs. 0.0%), Firmicutes (38.9% vs. 38.8%), Fusobacteria (2.6% vs. 1.4%), 
Proteobacteria (20.4% vs. 17.1%), Synergistetes (0.1% vs. 0%) and Verrucomicrobia (1.4% vs. 
0.6%) compared to AA controls, though not statistically significant. Of less abundance were 












Supplementary Figure 3.2. Principal coordinates analysis of Unifrac differences between African American colorectal cancer 
cases and African American controls based on 16S rDNA sequence analysis. Weighted (a) and unweighted (b) analyses show a 
difference between cases and controls. Colorectal cancer samples are shown in blue and control samples are shown in red. 
 
 












Supplementary Figure 3.3. Principal coordinates analysis of Unifrac differences between African American colorectal cancer 
cases and African American controls based on jackknifed estimates of bacterial genera. Weighted (a) and unweighted (b) 
analyses show a difference between colorectal cancer cases and controls. Colorectal cancer samples are shown in blue and control 
samples are shown in red. The jackknifed estimates are represented by the confidence ellipsoids around each sample point, 
representing the degree of variation from one replicate to the next. Due to minimal variation in weighted analysis, ellipsoids are not 
apparent in a. 



















Supplementary Figure 3.4. Linear regression models showing effect of selected factors in 
African American and non-Hispanic Whites. Scatterplots representing model residuals of 
selected variables. In each panel, symbols are shaded to indicate the residual of the variable 
indicated. African Americans are represented by triangles and non-Hispanic Whites by circles. 
The intensity of the color represents the variable as shown in the inset. The indicated variables 
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TRANSCRIPTOMIC ANALYSIS OF BILOPHILA WADSWORTHIA 
 
ABSTRACT 
Bilophila wadsworthia, a common resident of the human gut, produces genotoxic H2S as a 
consequence of taurine metabolism. Over the past few years, B. wadsworthia has gained 
substantial attention as a microbial risk factor associated with the development of colitis and 
CRC. While several studies have established the metabolic capacity of this microbe in vitro, 
much remains unknown about the “lifestyle” of B. wadsworthia in the dynamic gut environment. 
Thus, a detailed transcriptomic analysis was performed on B. wadsworthia from a gnotobiotic 
synthetic microbial community capable taurine conjugated bile acid metabolism. Transcriptomic 
analysis confirmed that taurine metabolism was the most abundant metabolic pathway expressed 
by B. wadsworthia, and community analysis revealed taurocholate metabolism as a likely 
contributor of substrate in vivo. Expression analysis of electron transporters and proteins 
involved in substrate oxidation clarified upstream mechanisms of taurine metabolism. In 
addition, expression analysis of pathogenic and alternate metabolic proteins revealed nitrogen 
metabolism as a putative strategy to combat oxidative stress, and metabolism of D-cysteine as a 








Bilophila wadsworthia, a resident microbe of the human gut, is an anaerobic gram negative 
bacteria commonly isolated in clinical infections.1,2 As of late, the bacterium has gained 
considerable interest after the publication of several high impact studies highlighting the 
potential role of B. wadsworthia in colonic disease.3-6 In an Il10-/- mouse model of colitis, B. 
wadsworthia stimulated T-helper type 1 immune response and abundance of the bacterium 
correlated with colitis severity.3 Similarly, B. wadsworthia is isolated in roughly half of 
appendicitis specimens, and presence of the bacterium is positively associated with severity of 
disease.7,8 Two publications observed increased abundance of B. wadsworthia with intake of a 
diet positively associated with increased CRC risk.4,5 Finally, a recently published study which 
investigated gut microbial differences between AA and NHW CRC cases and controls revealed 
B. wadsworthia to be a significant marker which distinguished CRC in AAs.6 It was postulated 
that genotoxic H2S released as a byproduct of anaerobic respiration by B. wadsworthia acts as an 
environmental trigger which stimulates CRC intiation and/or progression.  
Taken together, these studies implicate B. wadsworthia as a microbial risk factor for colonic 
disease and carcinogenesis. However, whether the bacterium contributes to disease progression 
or is present purely as a consequence of the diseased microenvironment remains to be elucidated. 
While the metabolic capability of B. wadsworthia has been well characterized in vitro, little is 
known about the ‘lifestyle’ of this bacterium in the dynamic gut environment.7,8 In culture, B. 
wadsworthia is urease positive and resistant to β-lactam antibiotics.7,8 But, whether these and 
other genes related to pathogenesis and microbial fiteness are expressed by the bacterium in the 
gut environment remains unknown. Additionally, B. wadsworthia preferentially respires the 
sulfur amino acid taurine as a component of energy metabolism in vivo.8 However, whether this 
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remains the case in a mixed microbial community with diverse substrate supplied by normal 
chow remains to be determined.  
Substrate for microbial taurine metabolism in the colon may be derived from diet and taurine 
conjugated bile acids.9-11 Stimulation of B. wadsworthia growth has been demonstrated both in 
vivo and in vitro with addition of the taurine conjugated bile acid TCA.3 In the colon, TCA 
metabolism takes place over a series of metabolic steps performed by multiple members of the 
gut community. Taurine and cholic acid (CA) are liberated from TCA by bacteria containing a 
bile salt hydrolase.12,13 Taurine is then available as a metabolic substrate by B. wadsworthia, 
resulting in release of the genotoxic by-product, H2S. Liberated CA may also then be 7α-
dehydroxylated by resulting in the pro-inflammatory and tumor promoting secondary bile acid, 
deoxycholic acid (DCA).9 Through a series of in vitro and in vivo experiments, a previous study 
established a minimal microbial consortium capable of TCA metabolism using bacteria isolated 
from human feces. Successful colonization of bacteria capable of bile acid deconjugation and 7α-
dehydroxylation was observed in several minimal communities, however complete conversion of 
CA to DCA appeared to be contingent on the presence of B. wadsworthia. While formation of 
proinflammatory DCA on a commercial chow diet was confirmed in this study, formation of H2S 
via taurine respiration by B. wadsworthia was not determined in this community.14 Thus, a 
transcriptomic analysis of TCA metabolism was performed in vivo using this defined microbial 
consortium capable of TCA metabolism. Given the particular interest in B. wadsworthia, a 
deeper investigation into the transcriptome of the bacterium was performed in an attempt to gain 





MATERIALS AND METHODS 
Gnotobiotic mice 
Six C57BL/6J germ-free mice, bred and maintained in the germ free facility at the Mayo Clinic 
(Rochester, MN), were colonized with a synthetic microbial community capable of TCA 
metabolism (Figure 4.1). Specifically, mice were gavaged with 108 colony-forming units of 
Bacteroides vulgatus, Bacteroides uniformis, Parabacteroides distasonis, B. wadsworthia, 
Clostridium hylemonae, and Clostridium hiranonis on days 1 and 3 of the experiment. For the 
remainder of the experiment, mice received a daily oral gavage of sterile saline, were fed sterile 
chow, and were housed in sterile cages under a 12 h light/dark cycle at 23 °C. Mice were 
sacrificed at day 30 by CO2 asphyxiation followed by cervical dislocation. Serum, cecal tissue, 
and cecal digesta were collected and stored at -80°C.  
Quantitative Polymerase Chain Reaction (qPCR) Analysis 
DNA was isolated from cecal mucosa using a Mobio Powersoil DNA extraction kit (Mobio, 
Carlsbad, CA), quantified with a Nanodrop 2000c Spectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE), and diluted to 5 ng/μL. Abundance of B. wadsworthia was quantified in 
triplicate with a 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA), 
using the functional gene dsrA-BW.6  
Cecal RNA isolation and construction of stranded RNAseq libraries 
Cecal tissue was homogenized with a FastPrep-24 5G bead-beating device (MP Biomedicals) at 6 
m/s for 40 sec. Total cecal RNA was extracted on an EZ1 automated extraction instrument using 
the EZ1 RNA tissue kit (Qiagen, Germantown, MD), and subject to an additional DNase treatment 
using the RNeasy Mini Kit (Qiagen). Stranded RNASeq libraries were constructed and sequenced 
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at the DNA Services laboratory of the Roy J. Carver Biotechnology Center at the University of 
Illinois at Urbana-Champaign using the TruSeq Stranded RNA Sample Preparation Kit (Illumina 
San Diego, CA). Briefly, total RNA was quantified by Qubit (Life Technologies, Grand Island, 
NY) and checked for integrity on a 2% eGel (Life Technologies). Ribosomal RNA was removed 
from total RNA using the Ribo-Zero™ Magnetic Bacteria kit (Illumina, San Diego, CA). First-
strand synthesis was achieved with SuperScript II (Life Technologies) and a random hexamer. 
Double stranded DNA was blunt-ended, 3'-end A-tailed, and ligated to unique dual-indexed 
adaptors. The adaptor-ligated double-stranded cDNA was amplified by PCR for 8 cycles with the 
Kapa HiFi polymerase (Kapa Biosystems, Wilmington, MA). The final libraries were pooled 
evenly and cleaned using AxyPrep Mag PCR Cleanup beads (Axygen, Inc. Union City, CA) to 
ensure removal of primer and adaptor dimers, quantified by Qubit, and evaluated on AATI 
Fragment Analyzer (Advanced Analytics, Ames, IA). The final pool was diluted to 5nM and 
further quantified by qPCR on a BioRad CFX Connect Real-Time System (Bio-Rad Laboratories, 
Inc. CA). 
Sequencing on an Illumina HiSeq4000 and analysis 
The final pool containing 12 libraries was loaded and sequenced on an Illumina HiSeq4000 with 
SBS sequencing reagents (v1) for a total read length of 100 nt per end. Final quality control and 
RNA-seq output was prepared by the Ridlon lab. Fastq read files were generated and 
demultiplexed with bcl2fastq v2.20 Conversion Software (Illumina), evaluated with the FastQC 
v0.11.5., and quality and adapter-trimmed using Trimmomatic v0.33. Raw reads were aligned with 
Ribosomal RNA sequences prepared from genome of B. wadsworthia using bowtie2 (v2.3.3.1). 
Unaligned files were saved and realigned with the genome of B. wadsworthia using the same tool. 
Output sam files were converted to the bam format using Samtools (v0.1.6) and were name-sorted 
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prior to input into HTSeq (v0.9.1). HTSeq counting was performed in union mode against a Gene 
Feature Format (GFF) annotation of B. wadsworthia, and reads were counted against coding DNA 
sequences of the bacteria and expressed as transcripts per million (TPM). Hypothetical protein 
reads were analyzed using the Protein Basic Local Alignment Search Tool (BLASTv2.8.1+), and 
the closest functional match with at least 60% identity was retained. Genes were searched against 
the Kyoto Encyclopedia of Genes and Genomes (KEGG) and binned according to known 
functional pathway or hierarchy. Genes for each bin were summed and transcript averages were 
calculated to create summary graphs in Excel. Gene clusters of interest were identified by aligning 
known gene clusters of Desulfovibrio vulgaris Hildenborough to highly expressed gene regions of 
B. wadsworthia via BLAST.  
RESULTS 
RNA-seq analysis of B. wadsworthia from cecal mucosa 
Six germ-free C57BL/6J mice were inoculated with a synthetic microbial community capable of 
TCA metabolism. Quantification of the functional gene dsrA-BW revealed successful colonization 
of B. wadsworthia in all mice with an average of 235.08 ± 82.67 gene copies per ng of DNA. 
RNA-seq of cecum mucosa resulted in 24 million filtered RNA reads per sample that were mapped 
to the six genomes. Of these reads, 1,000,000 transcripts per sample were mapped to the B. 
wadsworthia genome. Transcriptomic analysis resulted in 4099 transcribed genes, 1370 of which 
mapped to hypothetical proteins or domains of unknown function. Alignment searches of 
hypothetical proteins revealed functional matches for 864 reads resulting in 3235 transcribed genes 
which were binned by function and homology into categories for metabolism (39%); genetic 
information processing (30%); environmental processing and transport (19%); and cellular 
processes, antimicrobial resistance, and stress response (8%). The most abundant transcripts 
81 
 
represented included genes for taurine and hypotaurine metabolism (62416.6 ± 7822.23 TPM) and 
glycolysis (42509.64 ± 7226.39 TPM); antibiotic resistance (17939.12 ± 4796.94 TPM) and stress 
response (15607 ± 3644.89 TPM); ribosomal proteins (108919 ± 21004 TPM); and ABC 
transporters (72881.93 TPM) and two-component systems (30506.43 ± 1608.65 TPM) (Figure 
4.2).  
Expression of taurine reduction pathway 
Taurine metabolism was the most abundant metabolic pathway, comprising ~7% of all enzymes, 
and the third most abundant functional pathway expressed (Figure 4.2). The enzymes alanine 
dehydrogenase, dsrA, and taurine-pyruvate aminotransferase (tpa) of the taurine reduction 
pathway were among the most abundant genes transcribed (Table 4.1; Figure 4.3a). While there 
was no apparent transcription of sulfoacetaldehyde sulfo-lyase, the protein which putatively 
performs the second enzymatic step of taurine reduction, 8 a highly expressed NAD-dependent 
alcohol dehydrogenase is located within the alanine dehydrogenase:tpa operon suggesting 
involvement (Figure 4.3b). The dsrAB sub-units for the third enzymatic step of taurine respiration, 
while located at an operon separate from the earlier enzymatic steps, were both highly expressed 
(Table 4.1; Figure 4.3c). A comparative analysis of transcriptomes within our synthetic 
consortium revealed coordinate expression of bile salt hydrolase (bsh), which liberates taurine 
from TCA (Figure 4.4).10,11 Together, these results indicate that taurine metabolism is the 
predominate metabolic pathway of B. wadsworthia, and that taurine liberated from TCA by bsh 
harboring bacteria is available to serve as substrate for this pathway within our model.  
Expression of genes involved in electron transfer for sulfite reduction 
Expression of genes encoding proteins which function to liberate electrons for sulfite reduction 
included hydrogenases, formate dehydrogenases, alcohol dehydrogenases, and 
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pyruvate:ferrodoxin oxidoreductases (Table 4.1). Cytochromes C3, heterodisulfide reductases, and 
the dsrC protein which perform periplasmic and cytoplasmic electron transfer, were expressed 
(Table 2).15 The expression of four gene clusters which encode components of the membrane 
redox complexes DsrMKJOP, Tmc, Rnf, and Nqr were identified (Table 4.3). All complexes 
displayed similar levels of expression with the exception of Rnf, suggesting that this membrane 
component does not play a role in taurine reduction.  
Expression of autotrophic pathways and NADH recycling 
All proteins of the citric acid cycle appear to be highly expressed with the exception of alpha-
ketoglutarate dehydrogenase. The gluconeogenic enzyme pyruvate carboxylase (357.47 ± 72.73) 
was expressed, as was a gene cluster which suggests the successive carboxylation of acetate to 
pyruvate via acetate kinase (604.15 ± 152.67), phosphate acetyltransferase (833.36 ± 274.96), and 
pyruvate: ferredoxin oxidoreductase (1780.08 ± 587.10). All enzymes of the Wood–ljungdahl 
pathway of carbon fixation were expressed.16 Enzymes of the glyoxylate cycle were not expressed 
(Table 4.4).17  
Expression of alternate metabolic pathways 
A D-cysteine desulfhydrase (5650.99 ± 3387.18) was highly expressed in a gene cluster near a 
dicarboxylate/amino acid: cation symporter (2545.39 ± 1097.08). As mentioned previously, 
components of gluconeogenesis and the reductive citric acid cycle were expressed suggesting 
pyruvate fermentation to succinate, and the gene encoding the lactate utilization protein (771.70 ± 
337.0) was expressed. Multiple copies of the gene encoding alcohol dehydrogenase were highly 
expressed indicating that ethanol metabolism plays a significant role in energy metabolism or 
growth of B. wadsworthia. In addition, both nitrate reductase and nitrite reductase were highly 
expressed, demonstrating that the microbe is capable of nitrogen metabolism (Table 4.5).  
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Expression of genes involved in virulence, antimicrobial resistance, and stress response 
The transcriptome included expressed genes for β-lactamase resistance and a gene cluster 
suggestive of urease activity. Genes expressed which support persistence of the microbe in the gut 
environment included genes for quorum sensing and biofilm formation. In addition, the gene 
catalase, a cluster for cytochrome bd activity, and multiple copies of universal stress proteins were 
expressed (Table 4.6).  
DISCUSSION 
This study is the first in depth investigation into the in vivo transcriptome of B. wadsworthia from 
mice consuming a normal chow diet. While the in vitro metabolic capability of B. wadsworthia 
has been well-described,7,8 given the potential importance of the microbe in colonic disease, a 
baseline examination of the ‘lifestyle’ of the bacterium within the host was warranted. 
Transcriptomic analysis revealed that taurine metabolism was indeed the most abundant metabolic 
pathway expressed by B. wadsworthia, and that the gene bsh which liberates taurine from TCA 
was expressed by B. uniformis and B. vulgatus in our synthetic consortium. This suggests that 
taurine, liberated from the taurine conjugated bile acid TCA, is used as a substrate by B. 
wadsworthia, and that genotoxic H2S is regularly released as a by-product of this metabolism.  
 The coordinated activity of many enzymes is necessary to liberate electrons for taurine 
reduction and to create a proton motive force for ATP synthesis. Formate and H2 are oxidized by 
periplasmic formate dehydrogenase (fdhABC) and hydrogenase, resulting in the release of CO2, 
H+, and free electrons.18-20 Electrons are then transferred via non-membrane bound cytochromes 
C3
21
, to the membrane bound redox complexes DsrMKJOP and Tmc.
22 These electrons are then 
used to reduce the oxidized cytoplasmic transfer protein DsrC. Cytoplasmic oxidation of formate 
and pyruvate may also provide electrons for DsrC reduction,15 via electron transfer to the 
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heterodisulfide reductase complex (hdrABC) from the reduced formate dehydrogenase or pyruvate 
oxidoreductase.22,23 Protons released as a result of formate/pyruvate oxidation are likely pumped 
to the periplasmic space via sodium:proton antiporters. Reduced DsrC then interacts with the 
dsrAB protein complex to provide electrons to achieve the final step of taurine metabolism— 
dissimilatory sulfite reduction.15 Protons released from both cytoplasmic and periplasmic steps 
then create a proton motive force that drives ATP production via ATP synthase.15  
 The first enzymatic step of taurine metabolism, the deamination of taurine via taurine: 
pyruvate aminotransferase, results in an abundance of NADH.9 Recycling of NADH appears to be 
achieved by way of a reductive citric acid cycle, with carbon contributors deriving from ethanol, 
formate, fumarate, lactate, malate, and succinate. In addition, NADH may be recycled via electron 
donation to the membrane redox complex Nqr, which functions similarly to complex I of the 
oxidative electron transport chain.24 Both the reductive citric acid cycle and the Wood–Ljungdahl 
pathway may be used for carbon fixation, and lactate and ethanol may be used for anaplerosis of 
glycolytic intermediates. The expression of genes in these pathways are consistent with in vitro 
studies which observed growth on these electron/carbon components with the subsequent 
production of acetate.8 
 Unrelated to taurine metabolism, highly expressed enzymes in the B. wadsworthia 
transcriptome were related to D-cysteine and nitrogen metabolism. The enzyme D-cysteine 
desulfhydrase was one of the most highly expressed enzymes in our analysis. This enzyme is often 
overlooked, as L-cysteine is the more commonly occurring enantiomer of the amino acid in 
foods.25 That being said, abundant evidence indicates that the conditions administered to create 
processed foods results in racemization of L-cysteine to D-cysteine.26,27 Given that chow for this 
study was heat sterilized in order to maintain the constrained microbial conditions of our 
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experiment, it is possible that naturally occurring L-cysteine was racemized, providing substrate 
for an alternate sulfidogenic metabolic pathway of B. wadsworthia. This provides a potential 
additional substrate to be evaluated in future studies linking a “western” type diet with CRC.  
As reported previously, B. wadsworthia is capable of nitrogen metabolism.8 Indeed, enzymes 
for nitrate and nitrite metabolism were both highly expressed in this study, though expression 
remained lower than that of enzymes for taurine metabolism. This observation seems 
counterintuitive given that nitrate reduction is more thermodynamically favorable. It is possible 
that expression of these metabolic genes does not directly relate to abundance of protein. An 
additional potential explanation is that the cecal RNA collected describes bacteria which are in a 
transitional state due to substrate limitation. Perhaps available nitrate was used as the primary 
terminal electron acceptor for anaerobic respiration, and the bacterium was transitioning to taurine 
metabolism given limited substrate availability. An alternative explanation may be that taurine 
availability is so high that it drives taurine metabolism, and that coordinate metabolism of nitrogen 
may take place to increase microbial fitness in the gut environment. Cytochrome bd, a gene 
complex highly expressed in this analysis, is an electron transporter which can use O2, NO3, and 
H2O2 and electron acceptors.
28,29 In Salmonella spp., expression of cytochrome bd in anoxic 
conditions results in oxidation of toxic nitric oxide to nitrite, which increases metabolic activity 
and combats nitrosative stress.30 In the SRB Alishewanella strain WH16-1, expression of 
cytochrome bd led to H2O2 detoxification and increased resistance to H2S.
31 Taken together, this 
describes a scenario in which coordinate metabolism of nitrogen and taurine could provide a 
competitive advantage B. wadsworthia, allowing resistance to host and microbial derived toxins.  
 Additional enzymes expressed by B. wadsworthia which aid in competitive fitness and 
virulence include catalase, components of the β-lactam resistance pathway, and a gene cluster 
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encoding for a urease complex. Similar to cytochrome bd, catalase functions to combat reductive 
stress via the reduction of H2O2.
32 Enzymes of the β-lactam resistance pathway confer resistance 
to β-lactam antibiotics, which perhaps accounts for B. wadsworthia’s prevalence in clinical 
infections.1,2,33 Urease, which hydrolyzes urea, is predominate in pathogenic microbes like 
Helicobacter pylori. Activity of urease is thought to aid in virulence by multiple mechanisms 
including pH neutralization of extreme microenvironments, alkalization of moderate environments 
to prevent phagosome maturation, and making available nitrogen in nitrogen poor environments.34  
 Taken together, this transcriptomic analysis provides insight into the predominant pathways 
expressed by B. wadsworthia in vivo. The study confirmed that taurine metabolism was the 
predominant metabolic pathway expressed, and that electrons were donated by pyruvate, formate, 
lactate, ethanol, and hydrogen. In addition, this study confirmed that B. wadsworthia expresses 
proteins to aid in microbial fitness and virulence like urease, β-lactamase, cytochrome bd and 
catalase in vivo. More importantly, this analysis revealed details into mechanisms of electron 
transport as well as an additional diet derived sulfidogenic substrate which may be utilized for 
future dietary and pharmaceutical interventions. Development of genetic system for B. 
wadsworthia will be necessary to confirm the proposed pathway of electron transport. In addition, 
future studies which observe the transcriptomic profile of B. wadsworthia in vivo in varying 
colonic locations and with varying substrates (high vs. low TCA), as well as in vitro with varying 











Table 4.1. Expression of taurine metabolic proteins and electron donors 




  T370_RS0108870 NZ_JNJP01000017.1 MULTISPECIES: alanine dehydrogenase 24569.53 6057.06 
  T370_RS0108875 NZ_JNJP01000017.1 MULTISPECIES: taurine--pyruvate 
aminotransferase 
7381.06 2225.02 
  T370_RS0109480 NZ_JNJP01000022.1 MULTISPECIES: dissimilatory-type sulfite 
reductase subunit alpha 
12217.81 1762.70 
  T370_RS0109485 NZ_JNJP01000022.1 dissimilatory-type sulfite reductase subunit 
beta 
2131.63 516.84 






T370_RS0101115 NZ_JNJP01000001.1 pyruvate ferredoxin oxidoreductase 46.25 72.63 
T370_RS0101705 NZ_JNJP01000002.1 pyruvate:ferredoxin (flavodoxin) 
oxidoreductase 
54.65 47.69 
T370_RS0103465 NZ_JNJP01000004.1 pyruvate ferredoxin oxidoreductase 14.71 25.56 
T370_RS0103475 NZ_JNJP01000004.1 MULTISPECIES: pyruvate ferredoxin 
oxidoreductase 
24.00 41.31 
T370_RS0103950 NZ_JNJP01000005.1 pyruvate ferredoxin oxidoreductase 5.94 9.55 
T370_RS0104695 NZ_JNJP01000006.1 pyruvate:ferredoxin (flavodoxin) 
oxidoreductase 
1780.08 587.10 








T370_RS0103145 NZ_JNJP01000004.1 formate dehydrogenase subunit beta 66.14 82.46 
T370_RS0103150 NZ_JNJP01000004.1 formate dehydrogenase-N subunit alpha 38.30 35.36 
T370_RS0107640 NZ_JNJP01000014.1 formate dehydrogenase 1.82 4.47 
T370_RS0109585 NZ_JNJP01000022.1 formate dehydrogenase H subunit alpha 11.15 16.40 
T370_RS0111260 NZ_JNJP01000029.1 formate dehydrogenase 264.39 186.01 


























T370_RS0100320 NZ_JNJP01000001.1 iron hydrogenase 9.87 10.82 
T370_RS0108905 NZ_JNJP01000017.1 MULTISPECIES: hydrogenase 275.26 168.40 
T370_RS0109945 NZ_JNJP01000024.1 hydrogenase 190.16 76.10 
T370_RS0109950 NZ_JNJP01000024.1 hydrogenase 65.47 53.49 
T370_RS0112660 NZ_JNJP01000035.1 MULTISPECIES: iron hydrogenase 29.67 23.03 
T370_RS0112665 NZ_JNJP01000035.1 iron hydrogenase 38.03 37.72 
T370_RS0113165 NZ_JNJP01000038.1 hydrogenase 539.02 165.85 
T370_RS0113170 NZ_JNJP01000038.1 hydrogenase 318.11 190.69 
T370_RS0113175 NZ_JNJP01000038.1 hydrogenase 623.53 99.66 
T370_RS0113175 NZ_JNJP01000038.1 hydrogenase 623.53 99.66 
T370_RS0114890 NZ_JNJP01000049.1 nickel-dependent hydrogenase large subunit 94.02 59.19 
T370_RS0119690 NZ_JNJP01000109.1 hydrogenase 86.69 109.11 
T370_RS0119690 NZ_JNJP01000109.1 hydrogenase 86.69 109.11 
T370_RS0119760 NZ_JNJP01000111.1 iron hydrogenase 436.76 128.18 
T370_RS0119765 NZ_JNJP01000111.1 nickel-dependent hydrogenase large subunit 207.80 62.92 
Formate 
Dehydrogenase ABC 
T370_RS0103830 NZ_JNJP01000005.1 cytochrome c 175.93 138.99 
T370_RS0103835 NZ_JNJP01000005.1 formate dehydrogenase 272.08 164.64 
T370_RS0103840 NZ_JNJP01000005.1 formate dehydrogenase-N subunit alpha 312.90 87.90 
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Table 4.2. Expression of proteins involved in electron and proton transfer for taurine reduction and ATP synthesis 






T370_RS0113150 NZ_JNJP01000038.1 MULTISPECIES: heterodisulfide reductase subunit C 1812.50 381.36 
T370_RS0113155 NZ_JNJP01000038.1 MULTISPECIES: heterodisulfide reductase subunit B 799.58 269.32  
T370_RS0113160 NZ_JNJP01000038.1 disulfide reductase 2301.42 823.17 
Cytochrome C T370_RS0101025 NZ_JNJP01000001.1 cytochrome c 1490.45 316.28 
  T370_RS0103230 NZ_JNJP01000004.1 cytochrome c 18.73 32.79 
  T370_RS0103240 NZ_JNJP01000004.1 MULTISPECIES: cytochrome c 273.73 340.71 
  T370_RS0110450 NZ_JNJP01000026.1 split-Soret cytochrome C 4341.81 1404.64 





T370_RS0104485 NZ_JNJP01000006.1 sodium:proton antiporter 77.68 74.35 
T370_RS0104980 NZ_JNJP01000007.1 Na+/H+ antiporter NhaC 79.55 26.57 
T370_RS0113265 NZ_JNJP01000039.1 sodium/hydrogen exchanger 258.41 23.35 
T370_RS0115850 NZ_JNJP01000057.1 sodium:proton antiporter 9.62 12.61 
  T370_RS0115935 NZ_JNJP01000058.1 sodium:proton antiporter 16.06 17.39 
  T370_RS0118030 NZ_JNJP01000081.1 Na+/H+ antiporter NhaC 39.46 72.02 
  T370_RS0118440 NZ_JNJP01000087.1 sodium:proton antiporter 1380.32 342.09 
  T370_RS22645 NZ_JNJP01000006.1 Na+/H+ antiporter NhaC 605.79 158.98 
ATP synthase T370_RS0103250 NZ_JNJP01000004.1 MULTISPECIES: ATP synthase subunit alpha 4.01 8.93 
  T370_RS0113275 NZ_JNJP01000039.1 F0F1 ATP synthase subunit epsilon 807.73 213.87 
  T370_RS0113280 NZ_JNJP01000039.1 F0F1 ATP synthase subunit beta 1731.19 382.28 
  T370_RS0113285 NZ_JNJP01000039.1 ATP F0F1 synthase subunit gamma 3565.78 1583.66 
  T370_RS0113290 NZ_JNJP01000039.1 F0F1 ATP synthase subunit alpha 1006.64 334.76 
  T370_RS0113295 NZ_JNJP01000039.1 F0F1 ATP synthase subunit delta 641.76 234.68 
  T370_RS0113300 NZ_JNJP01000039.1 MULTISPECIES: hypothetical protein 478.81 188.02 
  T370_RS0113305 NZ_JNJP01000039.1 MULTISPECIES: V-type ATP synthase subunit F 477.93 247.30 
  T370_RS0116555 NZ_JNJP01000064.1 MULTISPECIES: ATP synthase subunit 10.40 20.79 
  T370_RS0116560 NZ_JNJP01000064.1 hypothetical protein 73.30 45.02 
  T370_RS0116565 NZ_JNJP01000064.1 MULTISPECIES: ATP synthase F0 subunit A 795.74 203.62 





Table 4.3. Expression of membrane redox complexes involved in taurine reduction and NADH recycling 







T370_RS0118675 NZ_JNJP01000091.1 molybdopterin oxidoreductase 881.47 193.97 
T370_RS0118680 NZ_JNJP01000091.1 MULTISPECIES: molybdopterin oxidoreductase 1324.53 350.23 
T370_RS0118685 NZ_JNJP01000091.1 molybdopterin oxidoreductase 298.78 132.33 





T370_RS0109270 NZ_JNJP01000021.1 MULTISPECIES: 4Fe-4S dicluster domain-containing protein 615.48 370.56 
T370_RS0109275 NZ_JNJP01000021.1 MULTISPECIES: NADH dehydrogenase 4804.55 1795.66 
T370_RS0109280 NZ_JNJP01000021.1 MULTISPECIES: hypothetical protein 2608.02 1246.49 
T370_RS0109285 NZ_JNJP01000021.1 MULTISPECIES: NADH ubiquinone oxidoreductase 968.97 447.45 
  T370_RS0109290 NZ_JNJP01000021.1 MULTISPECIES: NADH dehydrogenase subunit 1 332.34 221.97 




T370_RS0117135 NZ_JNJP01000072.1 menaquinol oxidoreductase 1094.15 386.22 
T370_RS0117140 NZ_JNJP01000072.1 MULTISPECIES: (Fe-S)-binding protein 617.25 148.43 
T370_RS0117145 NZ_JNJP01000072.1 MULTISPECIES: hypothetical protein 549.46 262.19 
  T370_RS0117150 NZ_JNJP01000072.1 4Fe-4S ferredoxin 627.10 279.12 




T370_RS0100330 NZ_JNJP01000001.1 electron transporter RnfC, partial 31.69 44.10 
T370_RS0100335 NZ_JNJP01000001.1 electron transporter RnfD 6.33 7.49 
T370_RS0100340 NZ_JNJP01000001.1 FMN-binding protein 11.36 19.94 
  T370_RS0100345 NZ_JNJP01000001.1 electron transport complex subunit RsxE 41.75 49.13 
  T370_RS0100350 NZ_JNJP01000001.1 electron transport complex subunit RsxA 4.41 9.56 
  T370_RS0100355 NZ_JNJP01000001.1 ferredoxin 8.39 11.31 
  T370_RS0100360 NZ_JNJP01000001.1 FAD:protein FMN transferase 34.70 32.00 
Complex 2 
  
T370_RS0113105 NZ_JNJP01000038.1 MULTISPECIES: succinate dehydrogenase/fumarate reductase 
iron-sulfur subunit 
136.53 229.05 
T370_RS0113110 NZ_JNJP01000038.1 MULTISPECIES: fumarate reductase flavoprotein subunit 125.35 106.94 
  T370_RS0113115 NZ_JNJP01000038.1 MULTISPECIES: succinate dehydrogenase/fumarate reductase 
cytochrome b subunit 
201.94 247.24 
  T370_RS0113125 NZ_JNJP01000038.1 MULTISPECIES: desulfoferrodoxin 3333.16 857.95 
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Table 4.4. Expression of autotrophic pathways and NADH recylcing in B. wadsworthia 












T370_RS0100240 NZ_JNJP01000001.1 dihydrolipoyl dehydrogenase 72.69 108.10 
T370_RS0100790 NZ_JNJP01000001.1 malate dehydrogenase 215.08 274.33 
T370_RS0100800 NZ_JNJP01000001.1 succinyl-CoA synthetase subunit alpha 440.03 622.42 
T370_RS0100810 NZ_JNJP01000001.1 succinyl-CoA synthetase subunit beta 885.73 957.92 
T370_RS0100940 NZ_JNJP01000001.1 pyruvate carboxylase 357.47 66.39 
T370_RS0100945 NZ_JNJP01000001.1 phosphoenolpyruvate synthase 410.72 176.67 
T370_RS0101270 NZ_JNJP01000002.1 dihydrolipoyl dehydrogenase 252.18 128.85 
T370_RS0103955 NZ_JNJP01000005.1 ADP-forming succinate--CoA ligase subunit beta 12.45 27.08 
  T370_RS0103960 NZ_JNJP01000005.1 succinate--CoA ligase subunit alpha 26.54 35.81 
  T370_RS0105790 NZ_JNJP01000009.1 dihydrolipoyl dehydrogenase 30.73 26.68 
  T370_RS0106430 NZ_JNJP01000010.1 MULTISPECIES: fumarate hydratase 27.71 20.59 
  T370_RS0106435 NZ_JNJP01000010.1 MULTISPECIES: fumarate hydratase 123.99 61.85 
  T370_RS0107920 NZ_JNJP01000014.1 dihydrolipoyl dehydrogenase 167.87 176.35 
  T370_RS0108955 NZ_JNJP01000017.1 NADP-dependent isocitrate dehydrogenase 178.10 74.83 
  T370_RS0109330 NZ_JNJP01000021.1 succinate--CoA ligase subunit alpha 78.93 56.23 
  T370_RS0109335 NZ_JNJP01000021.1 succinate--CoA ligase 120.46 110.70 
  T370_RS0111820 NZ_JNJP01000032.1 malate dehydrogenase 354.40 124.00 
  T370_RS0113100 NZ_JNJP01000038.1 malate dehydrogenase 22.46 48.83 
  T370_RS0113105 NZ_JNJP01000038.1 MULTISPECIES: succinate dehydrogenase/fumarate 
reductase iron-sulfur subunit 
136.53 209.09 
  T370_RS0113110 NZ_JNJP01000038.1 MULTISPECIES: fumarate reductase flavoprotein subunit 125.35 97.62 
  T370_RS0113115 NZ_JNJP01000038.1 MULTISPECIES: succinate dehydrogenase/fumarate 
reductase cytochrome b subunit 
201.94 225.70 
  T370_RS0116130 NZ_JNJP01000060.1 aconitate hydratase 232.52 55.67 
      
      
      
      

















T370_RS0101640 NZ_JNJP01000002.1 4-hydroxybutyryl-CoA dehydratase 35.32 22.85 
T370_RS0115780 NZ_JNJP01000057.1 methylenetetrahydrofolate reductase 173.89 86.53 




T370_RS0119660 NZ_JNJP01000108.1 formate--tetrahydrofolate ligase 150.64 74.71 





T370_RS0104695 NZ_JNJP01000006.1 pyruvate:ferredoxin (flavodoxin) oxidoreductase 1780.08 587.10 
T370_RS0104700 NZ_JNJP01000006.1 phosphate acetyltransferase 833.36 274.96 
T370_RS0104705 NZ_JNJP01000006.1 acetate kinase 604.15 152.67 
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Table 4.5. Expression of alternate metabolic pathways in B. wadsworthia  






T370_RS0100760 NZ_JNJP01000001.1 alcohol dehydrogenase 77.19 53.10 
T370_RS0102105 NZ_JNJP01000003.1 alcohol dehydrogenase 6857.34 3299.07 
  T370_RS0105100 NZ_JNJP01000007.1 alcohol dehydrogenase 560.04 141.61 
  T370_RS0108880 NZ_JNJP01000017.1 NAD-dependent alcohol dehydrogenase 19719.74 6535.27 
  T370_RS0108995 NZ_JNJP01000020.1 alcohol dehydrogenase 727.36 719.99 
  T370_RS0110250 NZ_JNJP01000025.1 alcohol dehydrogenase [Clostridium sp. KLE 1755] 65.07 90.52 
  T370_RS0110745 NZ_JNJP01000027.1 alcohol dehydrogenase 8.31 8.62 
  T370_RS0111020 NZ_JNJP01000028.1 alcohol dehydrogenase 101.26 45.67 
  T370_RS0113505 NZ_JNJP01000040.1 alcohol dehydrogenase 1035.70 348.62 
  T370_RS0119110 NZ_JNJP01000097.1 alcohol dehydrogenase 65.45 17.08 
  T370_RS0117355 NZ_JNJP01000074.1 ethanolamine utilization microcompartment protein EutM 1915.55 387.44 
  T370_RS0117360 NZ_JNJP01000074.1 MULTISPECIES: ethanolamine utilization protein EutN 1301.88 1208.32 
  T370_RS0117365 NZ_JNJP01000074.1 MULTISPECIES: aldehyde dehydrogenase EutE 1904.51 891.17 
Lactate 
metabolism 
T370_RS0114000 NZ_JNJP01000044.1 lactate utilization protein 771.70 337.00 
D-cysteine 
metabolism 
T370_RS0108090 NZ_JNJP01000015.1 D-cysteine desulfhydrase family protein 21.57 43.45 






T370_RS0101235 NZ_JNJP01000001.1 nitroreductase 74.37 78.88 
T370_RS0101240 NZ_JNJP01000002.1 nitrate reductase subunit alpha 23.21 19.99 
T370_RS0108890 NZ_JNJP01000017.1 nitroreductase 27.84 43.49 
T370_RS0112910 NZ_JNJP01000037.1 nitroreductase 163.85 103.78 
T370_RS0115230 NZ_JNJP01000052.1 MULTISPECIES: nitroreductase 978.12 351.22 
  T370_RS0115535 NZ_JNJP01000054.1 nitroreductase 34.63 53.04 
  T370_RS0116640 NZ_JNJP01000065.1 nitrate reductase 1308.33 175.66 
  T370_RS0118095 NZ_JNJP01000083.1 nitrate reductase subunit beta 28.60 63.02 
  T370_RS0118105 NZ_JNJP01000083.1 respiratory nitrate reductase subunit gamma 16.06 30.95 
  T370_RS0119505 NZ_JNJP01000105.1 nitroreductase family protein 509.67 317.20 
  T370_RS0121140 NZ_JNJP01000144.1 nitroreductase 648.3 648.39 
  T370_RS0122165 NZ_KL370817.1 ammonia-forming cytochrome c nitrite reductase subunit c552 1267.53 392.44 
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Table 4.6. Expression of genes related to microbial fitness and pathogenesis 









T370_RS0109055 NZ_JNJP01000020.1 MULTISPECIES: desulfoferrodoxin 1477.25 757.48 
T370_RS0109060 NZ_JNJP01000020.1 MULTISPECIES: rubredoxin 1108.33 868.54 
T370_RS0109065 NZ_JNJP01000020.1 MBL fold metallo-hydrolase 1995.10 995.98 
T370_RS0109075 NZ_JNJP01000020.1 MULTISPECIES: cytochrome ubiquinol oxidase subunit I 2228.38 1049.87 
T370_RS0109080 NZ_JNJP01000020.1 cytochrome d ubiquinol oxidase subunit II 1820.32 680.63 
Urease T370_RS0104370 NZ_JNJP01000006.1 ammonium transporter 17.50 12.24 
  T370_RS0104375 NZ_JNJP01000006.1 urea transporter 28.73 16.17 
  T370_RS0104380 NZ_JNJP01000006.1 urease accessory protein UreD 21.53 13.41 
  T370_RS0104385 NZ_JNJP01000006.1 MULTISPECIES: urease accessory protein UreG 11.57 18.59 
  T370_RS0104390 NZ_JNJP01000006.1 urease accessory protein UreF 21.10 27.07 
  T370_RS0104395 NZ_JNJP01000006.1 urease accessory protein UreE 33.83 49.44 
  T370_RS0104400 NZ_JNJP01000006.1 urease subunit alpha 76.82 31.02 
  T370_RS0104405 NZ_JNJP01000006.1 MULTISPECIES: urease subunit beta 164.77 242.68 
  T370_RS0104410 NZ_JNJP01000006.1 MULTISPECIES: urease subunit gamma 405.61 324.21 








T370_RS0114855 NZ_JNJP01000049.1 MULTISPECIES: universal stress protein 2807.17 603.85 
T370_RS0119075 NZ_JNJP01000097.1 MULTISPECIES: universal stress protein 103.22 70.23 
T370_RS0100995 NZ_JNJP01000001.1 universal stress protein 114.73 207.92 
T370_RS0106800 NZ_JNJP01000011.1 MULTISPECIES: universal stress protein 2181.26 993.90 
T370_RS0109440 NZ_JNJP01000022.1 universal stress protein 2752.64 1205.40 





Figure 4.1. TCA metabolism by a defined microbial consortium in germ freem mice. Germ-free C57BL/6 mice were gavaged 
with a defined microbial community capable of TCA metabolism. Taurine is liberated from taurocholate by bacteria containing a bile 
salt hydrolase (Bacteroides vulgatus, Bacteroides uniformis, Parabacteroides distasonas. Taurine is then utilized by Bilophila 
wadsworthia to produce genotoxic H2S. Resulting cholic acid may then be utilized by 7α-dehydroxylating bacteria to produce tumor 












Figure 4.2. RNA-seq analysis of B. wadsworthia from cecal mucosa. Transcriptomic annotations from RNA-seq analysis were binned 
by function and homology into five major categories (metabolism; genetic information processing; environmental information 
processing and transport; cellular processes, antimicrobial resistance, and stress response; and miscellaneous proteins). Sub-categories 












Figure 4.3. Expression of taurine metabolic genes in B. wadsworthia. A. Bar graph of the 20 
most highly expressed genes of the B. wadsworthia, as represented by transcripts per million. B. 
Gene organization of the alanine dehydrogenase:tpa and dsrAB operons. Axis represents base pair 
location in representative scaffolds.  
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Figure 4.4. Coordinate expression of TCA metabolizing genes in the synthetic microbial 
community. a. RNA sequencing coverage of bsh, the enzyme which liberates taurine from TCA, 
in B. uniformis and B. vulgatus. b. RNA sequencing of the taurine metabolizing genes tca and dsrA 








 Figure 4.5. Taurine metabolism in B. wadsworthia. A schematic representation of taurine 
metabolism modified from Pereira, 2011 is represented.21 Metabolism of taurine is achieved via 
a three-step enzymatic process involving the deanimation of taurine and the successive reduction 
of sulfite. Electrons for taurine reduction are provided by the oxidation of periplasmic and 
cytoplasmic formate, pyruvate, and hydrogen. Electrons are transferred to oxidized DsrC via 
cytoplasmic cytochromes, membrane redox complexes, and periplasmic Hdr. Reduced DsrC 
interacts with the dsrAB complex to complete sulfite reduction. Formate dehydrogenase, blue; 
pyruvate oxidoreductase, orange; heterodisulfide reductase, yellow, hydrogenase, green; 





1. Finegold S., Summanen P., Gerardo S.H. and Baron E. (1992) Clinical importance of 
Bilophila wadsworthia. Eur J Clin Microbiol Infect Dis. 1992;11:1058–63 
2. Claros MC, Schumacher UK, Jacob M, Hunt Gerardo S, Kleinkauf N, Goldstein 
EJC, Finegold SM, Rodloff AC. Characterization of Bilophila wadsworthia isolates using 
PCR fingerprinting. Anaerobe. 1999;5:589–593. 
3. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos 
DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion 
and colitis in Il10-/- mice. Nature. 2012;487(7405):104-8. 
4. Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly 
and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559-63. 
5. O'Keefe SJ, Li JV, Lahti L, Ou J, Carbonero F, Mohammed K, Posma JM, Kinross J, Wahl 
E, Ruder E, Vipperla K, Naidoo V, Mtshali L, Tims S, Puylaert PG, DeLany J, Krasinskas A, 
Benefiel AC, Kaseb HO, Newton K, Nicholson JK, de Vos WM, Gaskins HR, Zoetendal EG. 
Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun. 
2015;6:6342.  
6. Yazici C, Wolf PG, Kim H, Cross TL, Vermillion K, Carroll T, Augustus GJ, Mutlu E, 
Tussing-Humphreys L, Braunschweig C, Xicola RM, Jung B, Llor X, Ellis NA, Gaskins HR. 
Race dependent association of sulfidogenic bacteria with colorectal cancer. Gut. 
2017;66(11):1983-1994. 
7. Baron E.J., Summanen P., Downes J., Roberts M.C., Wexler H.M. and Finegold S.M. (1989) 
Bilophila wadsworthia, gen. nov. and sp. nov., a unique Gram-negative anaerobic rod 
recovered from appendicitis specimens and human faeces. J Gen Microbiol. 135:3405–3411. 
8. Laue H, Denger K, Cook AM. Taurine reduction in anaerobic respiration of Bilophila 
wadsworthia RZATAU. Appl Environ Microbiol. 1997;63:2016–2021 
9. Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon 
cancer. Gut Microbes. 2016;22:1-15. 
10. Hardison WGM. Hepatic taurine concentration and dietary taurine as regulators of bile acid 
conjugation with taurine. Gastroenterology. 1978;75:71-75. 
11. Sjöval J. Dietary glycine and taurine on bile acid conjugation in man. Bile acids and steroids 
75. Proc Soc Exp Biol Med. 1959;100(4):676-8.  
12. Ridlon JM, Harris SC, Bhowmilk S, Kang D, Hylemon PB. Consequences of bile salt 
biotransformations by intestinal bacteria. Gut Microbes. 2016;In Press.  
13. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. 
J Lipid Res. 2006;47(2):241-59. 
14. Narushima S, Itoha K, Miyamoto Y, Park SH, Nagata K, Kuruma K, Uchida K. Deoxycholic 
acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids. 
2006;41(9):835-43. 
15. Oliveira, T. F., Vonrhein, C., Matias, P. M., Venceslau, S. S., Pereira, I. A., and Archer, M. 
The crystal structure of Desulfovibrio vulgaris dissimilatory sulfite reductase bound to DsrC 
provides novel insights into the mechanism of sulfate respiration. J. Biol. Chem. 2008;283: 
34141–34149. 
16. Ljungdahl, L. G. and H. G. Wood. Total synthesis of acetate from CO2 by heterotrophic 
bacteria. Ann. Rev. Microbiol. 1969;23:515–538. 
17. Baldwin JE, Krebs H. The evolution of metabolic cycles. Nature. 1981;291(5814):381-2. 
101 
 
18. Sebban, C., Blanchard, L., Bruschi, M., and Guerlesquin, F. Purification and characterization 
of the formate dehydrogenase from Desulfovibrio vul-garis Hildenborough. FEMS 
Microbiol. Lett. 1995;133:143–149.  
19. Odom JM and Peck HD Jr. Hydrogen cycling as a general mechanism for energy coupling in 
the sul-fate-reducing bacteria, Desulfovibrio sp. FEMS Microbiology Letters. 1981;12(1):47–
50 
20. Heidelberg JF, Seshadri R, Haveman SA, Hemme CL, Paulsen IT, Kolonay JF, Eisen JA, 
Ward N, Methe B, Brinkac LM, Daugherty SC, Deboy RT, Dodson RJ, Durkin AS, Madupu 
R, Nelson WC, Sullivan SA, Fouts D, Haft DH, Selengut J, Peterson JD, Davidsen TM, 
Zafar N, Zhou LW, Radune D, Dimitrov G, Hance M, Tran K, Khouri H, Gill J, Utterback 
TR, Feldblyum TV, Wall JD, Voordouw G, and Fraser CM. The genome sequence of the 
anaerobic, sulfate-reducing bacterium Desulfovibrio vulgaris Hildenborough. Nat Biotechnol. 
2004;22:554–559. 
21. Matias PM, Pereira IA, Soares CM, and Carrondo MA. Sulphate respiration from hydrogen 
in Desulfovibrio bacteria: a structural biology overview. Prog Biophys Mol Biol. 
2005;89:292–329. 
22. Pereira IA, Ramos AR, Grein F, Marques MC, da Silva SM, Venceslau SS. A comparative 
genomic analysis of energy metabolism in sulfate reducing bacteria and archaea. Front 
Microbiol. 2011;2:69. 
23. Costa, KC, Wong PM, Wang T, Lie TJ, Dodsworth JA, Swanson I, Burn JA, Hackett M, and 
Leigh JA. Protein complexing in a meth-anogen suggests electron bifurcation and electron 
delivery from formate to heterodisulfide reductase. Proc Natl Acad Sci. 2010;107:11050–
11055. 
24. Efremov RG, Baradaran R, and Sazanov LA. The architec-ture of respiratory complex I. 
Nature. 2010;465:441–445. 
25. Shibui Y, Sakai R, Manabe Y, Masuyama T. Comparisons of l-cysteine and d-cysteine 
toxicity in 4-week repeated-dose toxicity studies of rats receiving daily oral administration. 
Journal of toxicologic pathology. 2017;30(3):217-29. 
26. Man EH, and Bada JL. Dietary D-amino acids. Annu Rev Nutr. 1987;7:209–225. 
27. Csapo J, Albert C, and Csapo-Kiss Z. The D-amino acid content of foodstuffs. Acta Univ 
Sapientiae Aliment. 2009;2:5–30. 
28. Borisov VB, Forte E, Davletshin A, Mastronicola D, Sarti P, and Giuffre A. Cytochrome bd 
oxidase from Escherichia coli displays high catalase activity: an additional defense against 
oxidative stress. FEBS Lett. 2013;587:2214–2218.  
29. Giuffre A, Borisov VB, Arese M, Sarti P, and Forte E. Cytochrome bd oxidase and bacterial 
tolerance to oxidative and nitrosative stress. Biochim Biophys. 2014;1837:1178–1187.  
30. Jones-Carson J, Husain M, Liu L, Orlicky DJ, Vázquez-Torres A. Cytochrome bd-Dependent 
Bioenergetics and Antinitrosative Defenses in Salmonella Pathogenesis. MBio. 2016;7(6).  
31. Xia X, Wu S, Li L, Xu B, Wang G. The Cytochrome bd Complex Is Essential for Chromate 
and Sulfide Resistance and Is Regulated by a GbsR-Type Regulator, CydE, in Alishewanella 
Sp. WH16-1. Front Microbiol. 2018;9:1849. 
32. Chelikani P, Fita I, Loewen PC. Diversity of structures and properties among 
catalases. Cellular and Molecular Life Sciences. 2004;61(2):192–208.  




34. Konieczna I, Zarnowiec P, Kwinkowski M, Kolesinska B, Fraczyk J, Kaminski Z, and Kaca 






















THE BIFUNCTIONAL TRYPTOPHANASE/L-CYSTEINE DESULFHYDRASE OF  
ODORIBACTER SPLANCHNICUS IS SULFIDOGENIC  
 
ABSTRACT 
The proinflammatory and genotoxic properties of H2S have been implicated as an environmental 
trigger of colonic disease. Recent evidence links sulfidogenic bacteria capable of metabolizing 
organic sulfur substrates, like dietary sulfur amino acids and taurine conjugated bile acids, with 
increased CRC and colitis risk as a consequence of a “western” type diet. The sulfidogenic 
microbe, Odoribacter splanchnicus, is a significant indicator of AA CRC, yet its method of H2S 
production has yet to be characterized. A genomic analysis was performed revealing that O. 
splanchnicus harbors the sulfidogenic genes tryptophanase (tnaA) and cystationine-β-synthase. 
Functional analysis of purified tnaA revealed bifunctionality of the enzyme with positive 
tryptophanase and cysteine desulfhydrase activity with differing substrate. Cysteine 
desulfhydrase activity resulted in consumption of L-cysteine with subsequent production of H2S 
and pyruvate. Thus, tnaA is a functional enzyme which should be considered in future 
evaluations of sulfur metabolism in the diseased human microbiome. Future work examining the 
bifunctional kinects of the enzyme with differing substrate should be done to evaluate the 





Hydrogen sulfide is a potent genotoxin implicated as an environmental trigger of colitis and 
colorectal carcinogenesis.1-3 Up until recently, studies investigating relationships between 
sulfidogenic microbes and CRC have focused on inorganic metabolizers of sulfur with 
inconsistent findings.4 However, sulfidogenic bacteria, which utilize organic sources of sulfur 
like cysteine and taurine, have consistently been linked with CRC and inflammatory bowel 
disease, although few authors make that connection.1,2, 5-8 A recent study examining the mucosal 
microbiome of AA and NHW CRC subjects and controls revealed that sulfidogenic genera were 
significant markers of CRC. Of particular interest was the observation that bacteria that 
performed organic, but not inorganic, sulfur metabolism were significantly associated with CRC. 
In addition, sequencing analysis revealed several significant genera with apparent sulfidogenic 
capability not commonly associated with sulfur metabolism in the human gut.1 This provides 
intriguing rationale by which increased consumption of dietary substrate may shift the gut 
microbial community to a sulfidogenic state due to the abundance of substrate. Therefore, deeper 
understanding of inorganic sulfur metabolism in microbes associated with CRC is needed.  
One such bacterium, Odoribacter splanchnicus, is a gram-negative non-motile bacillus 
commonly isolated in human stool and periodontal plaques.9-10 Formally Bacteroides 
splanchnicus, the original description of O. splanchnicus reported H2S production, though the 
substrate for this production was undetermined.10 Correspondingly, a more recent study revealed 
the bacterium produces abundant H2S with addition of 20% bile.
9 Therefore, while there is 
evidence that O. splanchnicus is sulfidogenic, the mechanism of this metabolism is unknown. 




MATERIALS AND METHODS 
Culture conditions and activity assay 
Odoribacter splanchnicus (DSM 20712) was obtained from DSMZ microorganism collection 
(Braunschweig, Germany) and cultured in enriched anaerobic brain heart infusion (BHI) medium 
at 37°C. Culture was then transferred to anaerobic sulfide, indole, motility (SIM) medium and 
cultivated at 37°C overnight. SIM medium contains Fe(II)Cl2 which reacts to form Fe(III)sulfide 
in the presence of H2S, resulting in a black precipitate.
11 After 24 h and 7 d positive or negative 
precipitate was observed with the known sulfidogenic bacteria Fusobacterium nucleatum serving 
as a control. Due to the innate sulfur amino acids in this rich medium, this assay cannot be used 
for substrate determination.  
Genome search for known sulfidogenic genes 
The genome of O. splanchnicus DSM 20712 (CP002544) was analyzed for known sulfidogenic 
genes.12 Genome searches included the gene names “cysteine desulfhydrase”, “Cdl”, “Lcd”, 
“cystathionine-beta-synthase”, “L-methionine –gamma-lyase”, “dissimilatory sulfite reductase”, 
“dsrA”, “dsrb” and “dsrAB”. 
Preparation of gene insert 
Genomic DNA from O. splanchnicus was extracted using a Mobio Powersoil DNA extraction kit 
(Mobio, Carlsbad, CA) as previously described.1 The gene tryptophanase (tnaA) (locus tag 
ODOSP_RS09105) was amplified via PCR using Phusion high-fidelity polymerase (New 
England Biolabs, Ipswich, MA) and primers designed to incorporate the restriction sites SacI and 
XhoI (F-TTATTTTGCCTTTTCCAATTCGACAGTAAAG; R-
GAATTACCATTTTCAGAATCATTTCGGATTAAG). The amplification cycle used was 1 
cycle of 95°C for 2 min; 30 cycles of 95°C for 30 sec, 61°C for 30 sec, and 72°C for 1 min, and a 
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final elongation at 72°C for 10 min. PCR product was cleaned with a Zymo Research DNA 
Clean and Concentrator and length was confirmed via gel electrophoresis.  
Preparation of plasmids for overexpression 
Cleaned PCR product was double digested with SacI and XhoI and ligated in to the expression 
vector pET28a. To obtain ample copies of the construct, plasmids were transformed into E. coli 
DH5α and grown in LB at 37°C. Plasmids were then extracted via a GeneJET Plasmid Miniprep 
Kit (Thermo Scientific, Waltham, MA), and sequencing was performed by the Core Sequencing 
Facility at Illinois using additional primers designed to account for poor quality reads. Sequences 
were aligned using nucleotide BLAST to confirm successful insertion of desired sequence. 
Verified plasmids were then transformed into E. coli BL21 in preparation for overexpression.  
Overexpression and purification of tnaA 
Escherichia coli BL21 was grown with shaking at 37°C to an OD600 of 0.344, and then induced 
with 0.5mM IPTG. After a 16 hour incubation with shaking at 16°C, culture was centrifuged at 
4000rpm for 20 minutes, and pellets were stored at -80°C until protein purification. Cells were 
resuspended in lysis buffer containing 50mM NaH2PO4, 300mM NaCl, and 10mM imidazole and 
then lysed via ultrasonication. Lysates were centrifuged at 4°C to remove insoluble cell 
components, and then soluble lysate was incubated with Ni-NTA resin at 4°C for 15 min. Resin 
was then washed with buffer containing 50mM NaH2PO4, 300mM NaCl, and 20mM imidazole 
and protein was eluted with buffer containing excess imidazole (250mM). Eluate was desalted 
using lysis buffer without imidazole, successful purification was confirmed via SDS-PAGE, and 




Measurement of enzymatic activity 
Sulfidogenic activity of tnaA was measured via the colorimetric BiCl3 assay revised from 
Yoshida et al. 13,14 To reduce the catalytic components of the enzyme, tnaA was incubated at 
37°C with 5mM DTT for 3 hours.15 1.34 µg of the protein was incubated with a buffer 
containing 400mM Triethanolamine-HCl, 5mM EDTA, 10µM pyridoxal-5-phosphate, and 5mM 
BiCl3 for 16 hours at 37°C to allow tnaA time to shift to the catalytically active holoenzyme.
16 To 
observe enzymatic activity, tnaA was then incubated with various cysteine concentrations, and 
generation of BiS3 was measured with a spectrophotometer at 405nm. Visual assessment of tnaA 
activity without DTT and co-factor preincubation was also performed. In addition, tryptophanase 
activity of tnaA was accessed after 2-step preincubation in a reaction mixture containing 40mM 
phosphate buffer (pH7.6), 5µM pyridoxal-5-phosphate, and 1.34µg of reduced enzyme, and 10 
mM of tryptophan. Production of indole, indicated by red color change after treatment with 
Kovac’s reagent, was measured via spectrophotometer.17  
HPLC of enzymatic products 
A reaction mixture containing 40mM potassium phosphate buffer (pH7.6), 5µM pyridoxal-5-
phosphate, and 1.34µg of reduced enzyme was incubated at 37°C. After 16 h, 10mM cysteine 
was added and mixture was incubated at 37°C.18 Reaction was terminated at 0, 2, 6, and 12 h by 
centrifugation of reaction mixture through an Amicon® Ultra 0.5 mL Centrifugal Filter 
(Millipore Sigma, Burlington, MA). HPLC of ultrafilteration products was then performed by the 






Confirmation of sulfidogenic capability of O. splanchnicus and identification of sulfidogenic 
genes 
To confirm previous observations that O. splanchnicus produces sulfide, a colorimetric SIM 
assay was performed. Visual evaluation of tubes after incubation in medium for 7 d revealed 
positive color change of tubes, indicating production of H2S. An analysis of the O. splanchnicus 
genome was then performed to identify potential sulfidogenic genes to be considered for further 
analysis. Searches for known proteins revealed that O. splanchnicus harbors genes for 
tryptophanase (tnaA), a protein shown to have L-cysteine desulfhydrase capability in some 
bacteria, and cystathionine-β-synthase. 
Sulfidogenic and tryptophanase activity of O. splanchnicus tnaA  
Given that previous analyses observed greater expression of L-cysteine desulfhydrase in the 
known H2S producer F. nucleatum, tnaA became the focus of subsequent analysis. The tnaA of 
O. splanchnicus was amplified from genomic DNA of the bacterium, and successful insertion of 
the gene into the pET-28a expression vector was confirmed via sequencing analysis. Isolation of 
overexpressed protein yielded 0.670 ng/ml of purified protein which was confirmed via SDS-
PAGE by visualization of a distinct band located near the predicted molecular weight of 48.04 
kDa (Figure 5.1). Incubation of enzyme with BiCl3 without DTT preincubation resulted in 
negative color change, and commencement of assay without preincubation of enzyme with 
pyridoxal 5 phosphate resulted in positive visual color change after 24 hours. Initiation of 
activity assay with 10mM cysteine after two step preincubation resulted in rapid visual color 
change with peak sulfide production measured after 30 minutes (Figure 5.2a). Analysis of 
reaction products by HPLC confirmed consumption of cysteine over a 12 hour period, with 
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subsequent production of pyruvate. (Figure 5.2b). Production of H2S, as measured by 
precipitation of NaS3 detected spectophotometrically, was greatest at a cysteine concentration of 
1mM. Addition of increased substrate appeared to have an inhibitory effect on H2S production 
(Figure 5.2c). Therefore, activity assay was reassessed with a cysteine concentration of 1mM 
which demonstrated increase H2S production throughout the 2-hour assay period (Figure 5.2d). 
Execution of tryptophanase assay with 10mM tryptophan demonstrated positive indole 
production (Figure 5.2e).  
DISCUSSION 
Odoribacter splanchnicus, a common resident of the human gut microbiome, was recently 
observed to be a significant indicator of AA CRC.1,10 This observation was particularly 
intriguing given that O. splanchnicus is butyrogenic and butyrate producing microbes are 
typically associated with colonic health.10,19 A literature search of papers defining the bacterium 
revealed that, in addition to butyrate, the bacterium has the capability of producing genotoxic 
H2S.
9,10 Therefore, a study was performed aimed at investigating the sulfidogenic capacity of O. 
splanchnicus.  
 After confirming that the bacterium was able to produce H2S, a search of the O. 
splanchnicus genome identified two potential sulfidogenic genes, namely L-cysteine 
desulfhydrase and cystathionine-β-synthase. L-cysteine fermentation by these enzymes in F. 
nucleatum produces pyruvate or serine respectively and genotoxic H2S.
13 An analysis of the four 
sulfidogenic enzymes of F. nucleatum revealed that while cystathionine-β-synthase has a greater 
affinity for L-cysteine, L-cysteine desulfhydrase expression was more abundant, suggesting that 
L-cysteine desulfhydrase is more important for microbial L-cysteine metabolism.13  
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 Thus, the L-cysteine desulfhydrase of O. splanchnicus was further analyzed to confirm that 
the enzyme was sulfidogenic. Of note, the annotation of the enzyme within the O. splanchnicus 
genome indicated the protein region tnaA as a PLP-dependent tryptophanase/L-cysteine 
desulfhydrase (Figure 5.3). Bifunctional tryptophases have been described previously in 
Salmonella enterica Serovar Typhimurium and Eschericia coli strains K-12 and JM39, but not 
all trytophanases are capable of producing H2S.
16,,20,21 Therefore, demonstration of predicted 
bifunctional capacity of the enzyme is important to understand the microbe’s impact in the gut 
microenvironment. This study revealed that the tnaA of O. splanchnicus demonstrates both 
tryptophase and L-cysteine desulfhydrase function dependent on substrate. More specifically, 
this study demonstrated that tnaA produces pyruvate and genotoxic H2S as a consequence of L-
cysteine metabolism.  
 Activity of tnaA was limited by oxidative conditions, slow transformation to the 
holoenzyme, and excess substrate concentration. Previous studies which well characterized tnaA 
in E.coli K-12 observed that oxidation of -HS bonds within the enzyme reduced activity, but that 
95% of activity could be recovered with incubation of enzyme in 5mM DTT.15 Additionally, 
researchers observed that a 16 hour incubation was need with pyridoxal-5-phosphate to observe 
complete transformation of the enzyme from the apo- to the holoenzymatic form.16 Thus, a two-
step incubation protocol was developed to reduce catalytic ends of the enzyme, and to allow time 
for activation of the enzyme by the co-factor pyridoxal-5-phosphate. Given that the velocity of 
the initial reaction was greatly reduced with two-step preincubation, this suggests that the tnaA 
of O. splanchnicus has a catalytic morphology similar to E. coli K-12. The abundance of enzyme 
needed to optimize this protocol limited enzyme availability for proper calculation of kinetics to 
compare the tryptophanase and L-cysteine desulfhydrase activities of tnaA. Therefore, additional 
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assays are needed to fully characterize the activity of this enzyme. A recent study of the tnaA of 
E.coli MG1655 demonstrated that activity of tryptophanase was inhibited by indole 
concentrations, but expression of the tnaA enzyme was not.17 Thus, it is possible that tnaA works 
as a driver of L-cysteine metabolism in abundant indole conditions. Hence, additional work 
comparing L-cysteine desulfhydrase and tryptophase activity in with abundant cysteine and 





























Figure 5.1. Successful purification of tnaA from O. splanchnicus. SDS-PAGE of insoluble 
crude, soluble crude, purified and desalted elutions of tnaA from freshly prepared E. coli 
BL21induced at an OD 600 of 0.344, and incubated at 16° C for 16 h. The predicted molecular 




























Figure 5.2. Bifunctional activity of tnaA from O. splanchnicus. a. H2S production by isolated 
tnaA incubated with 10 mM cysteine as measured spectrophotometrically as production of BiS₃ 
precipitate over time. b. Measurement of cysteine consumption and pyruvate formation by tnaA 































































Figure 5.2. Bifunctional activity of tnaA from O. splanchnicus. c. Measurement of H2S 
formation via BiCl₃ assay by tnaA incubated with varying concentrations of cysteine for 2 hr. d. 
H2S production by tnaA incubated with 1mM cysteine as measured spectrophotometrically as 














































Figure 5.2. Bifunctional activity of tnaA from O. splanchnicus. e. Visualization of 
tryptophanase activity with 10 mM tryptophan as measured by red color production as a 
consequence of indole interaction with Kovac’s reagent. BiCl₃ assays were performed in 
































































1. Yazici C, Wolf PG, Kim H, Cross TL, Vermillion K, Carroll T, Augustus GJ, Mutlu E, 
Tussing-Humphreys L, Braunschweig C, Xicola RM, Jung B, Llor X, Ellis NA, Gaskins 
HR. Race dependent association of sulfidogenic bacteria with colorectal cancer. Gut. 
2017;66(11):1983-1994. 
2. Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and 
colon cancer. Gut Microbes. 2016;22:1-15.  
3. Laue H, Denger K, Cook AM. Taurine reduction in anaerobic respiration of Bilophila 
wadsworthia RZATAU. Appl Environ Microbiol. 1997;63(5):2016-21. 
4. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in 
colonic sulfur metabolism and links with health and disease. Front Physiol. 2012;3:448.  
198.  
5. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, 
Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, 
Garrett WS. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates 
the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207-15. 
6. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-
immune microenvironment. Cell Host Microbe. 2013;14(2):207-15. 
7. Kostic AD, Gevers D, Pedamallu CS, Michaud, M, Duke F, Earl AM, Ojesina AI, Jung J, 
Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower 
C, Garrett WS, Meyerson M. Genomic analysis identifies association of Fusobacterium 
with colorectal carcinoma. Genome Res. 2012;22(2):292-8. 
8. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, 
Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is 
prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299-306. 
9. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, 
Brunetti F, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, 
Schrotz-King P, Tournigand C, Tran Van Nhieu J, Yamada T, Zimmermann J, Benes V, 
Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P. Potential of fecal 
microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014;10:766  
10. Hardham JM, King KW, Dreier K, Wong J, Strietzel C, Eversole RR, Sfintescu C, Evans 
RT. Transfer of Bacteroides splanchnicus to Odoribacter gen. nov. as Odoribacter 
splanchnicus comb. nov., and description of Odoribacter denticanis sp. nov., isolated from 
the crevicular spaces of canine periodontitis patients. Int J Syst Evol Microbiol. 2008;58(Pt 
1):103-9. 
11. Werner H, Rintelen G, and Kunstek-Santos H. A new butyric acid-producing Bacteroides 
species: B. splanchnicus n. sp. Zentralbl Bakterio.l 1975;[Orig A]231:133–144.  
12. Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, and Finegold SM. 
2002. Wadsworth-KTL anaerobic bacteriology manual, 6th ed. Star Publishing Company, 
Belmont, Calif. 
13. Göker M, Gronow S, Zeytun A, Nolan M, Lucas S, Lapidus A, Hammon N, Deshpande S, 
Cheng JF, Pitluck S, Liolios K, Pagani I, Ivanova N, Mavromatis K, Ovchinikova G, Pati 
A, Tapia R, Han C, Goodwin L, Chen A, Palaniappan K, Land M, Hauser L, Jeffries CD, 
Brambilla EM, Rohde M, Detter JC, Woyke T, Bristow J, Markowitz V, Hugenholtz P, 
118 
 
Eisen JA, Kyrpides NC, Klenk HP. Complete genome sequence of Odoribacter 
splanchnicus type strain (1651/6T). Stand Genomic Sci. 2011;4(2):200-209. 
14. Yoshida A, Yoshimura M, Ohara N, Yoshimura S, Nagashima S, Takehara T, Nakayama 
K. Hydrogen sulfide production from cysteine and homocysteine by periodontal and oral 
bacteria. J Periodontol. 2009;80:1845–51.  
15. Basic A, Blomqvist S, Carlén A, Dahlén G. Estimation of bacterial hydrogen sulfide 
production in vitro. J Oral Microbiol. 2015;7:28166.  
16. Raibaud O, Goldberg ME. The tryptophanase from Escherichia coli K-12. II. Comparison 
of the thermal stabilities of apo-, holo-, and hybrid enzymes. J Biol Chem. 
1973;248(10):3451-5. 
17. Högberg-Raibaud A, Raibaud O, Goldberg ME. Kinetic and equilibrium studies on the 
activation of Escherichia coli K12 tryptophanase by pyridoxal 5'-phosphate and 
monovalent cations. J Biol Chem. 1975;250(9):3352-8. 
18. Li G, Young KD. Indole production by the tryptophanase TnaA in Escherichia coli is 
determined by the amount of exogenous tryptophan. Microbiology. 2013;159(Pt 2):402-10.  
19. Swabe K, Yoshida Y, Nagano K, Yoshimura F. Identification of an L-methionine-gamma-
lyase involved in the production of hydrogen sulfide from L-cysteine in Fusobacterium 
nucleatum subsp. nucleatum ATCC 25586. Microbiology. 2011;157(10):2992-3000. 
20. Sheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, 
Dusel G, Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative 
colitis. Gastroenterology. 1992;103:51-56. 
21. Oguri T, Schneider B, Reitzer L. Cysteine catabolism and cysteine desulfhydrase 
CdsH/STM0458) in Salmonella enterica serovar typhimurium. J Bacteriol. 
2012;194(16):4366-76. 
22. Awano N, Wada M, Mori H, Nakamori S, Takagi H. Identification and functional analysis 












GENOMIC SURVEY OF BACTERIAL SULFIDOGENIC ENZYMES  
WITHIN THE HUMAN GUT MICROBIOME 
 
ABSTRACT 
Bacteria capable of sulfur metabolism are important members of the human gut microbial 
community which release genotoxic H2S as a byproduct of H2 catabolism. Of the sulfidogenic 
bacteria, the most thoroughly studied are the SRB, which are metabolizers of inorganic sulfate. 
While the genotoxic properties of H2S are well established, and fecal concentrations of H2S have 
been observed in patients with UC and CRC, associations between SRB abundance and colonic 
disease have been limited. Resent evidence points to organic microbial sulfur metabolism as a 
mechanism of H2S production which increases host sulfide concentrations to genotoxic levels. 
Therefore, a genomic survey of sulfur metabolism was performed to establish the pervasiveness 
of sulfidogenic metabolic genes within the human gut community. The survey revealed that over 
a third of human gut microbial species harbor sulfidogenic genes, and that metabolism of the 
sulfur amino acid cysteine may be the most important sulfidogenic pathway of the gut. 
Additionally, analysis of identified genomes revealed sulfidogenic capacity of several bacteria 
revealed to be microbial indicators of CRC. Thus, this analysis established that metabolic genes 
for organic sulfur metabolism are wide-spread throughout the human gut microbiome, and may 
be a significant driver of colorectal carcinogenesis. Future studies testing the function and 





The human gut is a dynamic and nutrient rich environment, which harbors a diverse and 
metabolically active micro community. Given observations that the abundance and diversity of 
this community changes with disease and dietary intake, it is likely that the gut microbiome plays 
a considerable role in the etiology of cancer and inflammatory syndromes.1-3 Over the past 
decade, there has been considerable effort attempting to establish gut microbiome phenotypes of 
health and disease with conflicting results.1-3 This is not surprising given the ability of many 
microbes to shift metabolism based on available substrate and observations of species specific 
differences in microbial functionality.4,5 Therefore, the field has more recently shifted to using 
functional genomics for hypothesis development, which verified via transcriptomics and 
metabolomics, and paired with dietary analysis, may develop a clearer picture of human gut 
dynamics.  
 Recent evidence implicates increased abundance of microbes capable genotoxic H2S 
production as an environmental trigger of CRC.6 Most studies considering the role of 
sulfidogenesis on colonic disease have focused on the four known resident genera capable of 
inorganic sulfur metabolism, namely Desulfovibrio spp., Desulfobulbous spp., Desulfobacter 
spp., and Desulfotomaculum spp.7-10 Of late, bacteria capable of organic sulfur metabolism, like 
B. wadsworthia and F. nucleatum, have been given increased attention due to their association 
with a western diet,11,12 colonic inflammation,13 and CRC.6,14-19 Indeed, a recent study from our 
group revealed B. wadsworthia to be a significant indicator of CRC.6 Additionally, sulfidogenic 
microbes not usually considered in studies evaluating microbial sulfur metabolism were found to 
be significant.6 This indicated that microbial sulfur metabolism may be more wide spread in the 
human microbiome than originally supposed, and exposed a need for a greater understanding of 
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the sulfidogenic capacity of that community. Thus, a survey of sulfidogenic functional genes was 
performed of the human gut microbiome. 
METHODS 
A genomic survey was performed using 514 gastrointestinal genomes obtained from the 
Human Microbiome Project (HMP).20,21 Reference sequences were obtained from the National 
Center for Biotechnology Information (NCBI) using searches for sulfidogenic genes from known 
residents of the human gut including “cysteine desulfhydrase”, “Cdl”, “Lcd”, “cystathionine-
beta-synthase”, “L-methionine–gamma-lyase”, “dissimilatory sulfite reductase”, “dsrA”, “dsrb” 
and “dsrAB”. Searches of the HMP genes were then performed using BLAST (BLASTv2.8.1+), 
and alignments with greater than 60% identity and a minimum query coverage of 40 amino acids 
were retained. To filter non-homologous proteins, gene hits were compared to KEGG. Genes 
were then aligned by Clustal Omega and a phylogenetic tree was produced using the Interactive 
Tree of Life (iTOL) v3.22,23  
RESULTS 
Sulfidogenic functional genes are widespread in the human gut microbiome 
Over one third (35.6%) of the microbes from the human microbiome harbor potential 
sulfidogenic genes. Genomic survey identified 313 sulfidogenic genes from 183 genomes after 
filtering for identity and homology. Sulfidogenic genes spanned across six phyla including 
Proteobacteria (36.1%), Firmicutes (26.2%), Bacteroidetes (20.2%), Fusobacteria (15.8%), 
Actinobacteria (1.1%), and Synergistetes (0.5%) (Figure 6.1). Phylogenetic analysis revealed 




Organic sulfur metabolism is an important pathway for H2S production 
Functional genes encoding proteins for cysteine metabolism included cystathionine-β-lyase 
(11.8%), cystathionine-β-synthase (27.5%), cysteine desulfhydrase (2.6%), D-cysteine 
desulfhydrase (17.9%), methionine-γ-lyase (14.7%), and tryptophanase (7.3%) made up the 
majority of sequences. The conserved gene from the final step of sulfate and taurine reduction, 
dissimilatory sulfite reductase, made up 18.2% of genes.  
Identified genomes are associated with CRC 
Of the 313 gene hits identified in this analysis, microbes commonly associated with sulfur 
metabolism in the human microbiome represented only 32.4%. Genera previously associated 
with CRC with known ability to produce H2S included Fusobacterium nucleatum, Odoribacter 
spp., Eschericia coli, and Bilophila wadsworthia. Additionally, several other CRC associated 
genera were identified to harbor sulfidogenic genes including Alistipes spp., Anaerococcus spp., 
Cetobacterium spp., Clostridium spp., Enterococcus spp., Prevotella spp., and Ruminococcus 
spp.. 
DISCUSSION 
The genotoxic properties of H2S have been established for over a decade,
 24-27 and the importance 
of microbial sulfur metabolism for gut hydrogen cycling has long been recognized.28-30 What is 
less certain is the role microbial sulfur metabolism plays in disease etiology. Sulfate reducing 
bacteria have been observed to be more abundant in patients with inflammatory bowel disease 
with a corresponding elevation of fecal sulfide levels.9,10 However, there is less evidence that 
SRB are more abundant in CRC. In fact, one study observed higher SRB abundance in low CRC 
risk NA subjects consuming their regular diet, which decreased upon switching to a “western” 
type diet.12 In accordance with this, AAs with CRC had higher SRB abundance compared to AA 
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controls, but AAs had a higher overall abundance of SRBs compared to lower risk NHWs.6 
Therefore, while SRBs may be associated with other colonic disease, SRB abundance alone is 
not an indicator of CRC risk.  
 There is recent evidence connecting microbial metabolism of organic sulfur from a 
westernized diet with CRC risk. A dietary exchange between high CRC risk AA subjects and 
low CRC rick NA subjects observed a decrease of the sulfidogenic B. wadsworthia in AAs 
consuming a diet low in animal protein and fat. Correspondingly, NA subjects were found to 
have higher abundance of F. nucleatum when consuming a “western” type diet.12 Bilophila 
wadsworthia and F. nucleatum metabolize the sulfur amino acids taurine and cysteine, 
respectively. Production of H2S by F. nucleatum has been linked with the development of 
periodontal plaques,31 and numerous studies have associated the microbe with CRC.14-19 
Bilophila wadsworthia abundance has been correlated with disease severity in a DSS-induced 
model of colitis,13 and the bacterium is a significant indicator of CRC in AAs.6  
 Thus, it is possible that metabolism of inorganic sulfur by SRBs has beneficial effects, such 
as hydrogen catabolism and protection from pathogens via H2S toxicity, but then the aggregate 
metabolism of organic sulfur substrates increases H2S concentrations to host genotoxic levels. 
The genomic survey performed in this study corresponds with this hypothesis. Indeed, less than 
20% of the genes identified in this survey corresponded to proteins involved in inorganic sulfur 
metabolism. Additionally, the Proteobacteria, the phylum usually considered for sulfur 
metabolism in microbiome studies, represented roughly a third of genomes observed in this 
survey. Rather, sulfidogenic genes were spread throughout many human microbiome phyla. In 
terms of the number of genes, cysteine metabolism appears to be a more important substrate for 
H2S production than sulfate.  
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 In the addition to the potential importance of sulfidogenic cysteine metabolism in the human 
gut microbiome, this study revealed an abundance of potential microbial targets to consider in 
future studies. Over two-thirds of the genomes identified represented bacteria not commonly 
associated with sulfur metabolism in human microbiome studies. Perhaps more significantly 
several of the genera identified have been associated previously with CRC with no established 
mechanistic hypothesis.6,32 Phylogenetic analysis of the identified genomes confirms that many 
of the functional proteins are located in distinct clades, establishing optimism that degenerate 
functional gene primers may be created for such targets for future studies.  
 Taken together, this analysis adds to our foundational understanding of sulfur metabolism in 
the colon, and provides intriguing evidence that organic sulfur metabolism may be pervasive in 
the human gut. Further functional analysis of these proteins, as well as transcriptomic studies 





















Figure 6.1. Sulfidogenic functional genes are widespread in the human gut microbiome. a. 
Identified sulfidogenic gastrointestinal genomes from the Human Microbiome Project distributed 
by phyla. b. Distribution of sulfidogenic genes from human gut genomes by phyla and functional 
gene class.  

























Figure 6.2. Phylogenetic trees showing distribution of sulfidogenic genes. Trees represent 
alignments of sulfidogenic functional genes identified from human gut genomes. Clades are 
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CONCLUSIONS AND FUTURE DIRECTIONS 
The work herein represents important foundational evidence substantiating the hypothesis that 
H2S production by resident gut microbes are an environmental trigger of CRC.
1 Specifically, 
bacteria capable of organic, but not inorganic sulfur metabolism were significant indicators of 
AA CRC.2 This may explain the lack of prior evidence associating H2S production and CRC. A 
genomic survey of human gut microbes revealed that indeed organic sulfur metabolism may be a 
more important driver of H2S production in the human gut, and a retrospective analysis of genera 
from our first study revealed additional genera significantly associated with CRC harboring 
sulfidogenic genes.2  
The association of sulfidogenic genera with organic sulfur metabolic capacity with CRC 
provides rationale that links observations of increased CRC risk with a diet high in animal 
protein and fat.3-7 A “western” type diet is abundant in the sulfur amino acids cysteine and 
taurine, and this type of diet is significantly associated with sulfidogenic bacteria that metabolize 
organic sulfur.1 In regard to taurine metabolism, organic substrate is provided via diet and 
metabolism of taurine conjugated bile acids.1 Indeed, transcriptomic analysis of a synthetic 
microbial community in vivo revealed that taurine metabolism was the most abundantly 
expressed metabolic pathway of B. wadsworthia, and that expression of bsh by two 
Bacteroidetes coordinated with expressed taurine metabolic proteins of B. wadswothia. This 
indicates genotoxic H2S is likely released in the colon as a consequence of taurine metabolism by 
B. wadsworthia, and that liberated taurine from TCA metabolism likely serves as substrate.  
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As a follow-up to this analysis, a study is underway examining dietary and microbial 
differences in low and high CRC risk AAs and NHWs. As a second arm of the study, a dietary 
intervention will be conducted investigating the impact of taurine and saturated fat on the 
abundance of TCA metabolizers and associated changes in fecal bile acids and inflammatory 
markers. In parallel, we will examine the effect of a diet supplemented with TCA on tumor 
formation in a colon specific mouse model of CRC using our established synthetic microbial 
community and mice inoculated with high and low CRC risk human stool. Completion of these 
aims will allow us to determine systematically the impact of diet and TCA metabolism on 
tumorogenesis.  
In addition to abundant taurine metabolizing genes in the B. wadsworthia transcriptome, genes 
for D-cysteine desulfhydrase activity were highly expressed. D-cysteine metabolism is not often 
regarded as important in the human gut, as L-cysteine is the more abundant enantiomer of amino 
acid containing foods.8 However, the conditions necessary for processed food production results 
in the racemization of L-cysteine to D-cysteine.9,10 This finding may be critical to explain 
inconsistencies observed with racial disparities and diet. One might presume that socioeconomic 
disparities would fully explain increased risk of CRC in AAs. However, research has shown that 
disparities in healthcare access does not fully account for differences in risk, that other 
economically repressed ethnic groups do not have increased CRC risk, and comparison of overall 
food patterns between AAs and NHWs does not reveal significant differences in protein and fat 
consumption.11-14 It is possible that while overall food pattern may be consistent between groups, 
that increased consumption of processed foods, due to limited fresh food access or cultural norms, 
may increase D-cysteine abundance in the colon creating a niche for sulfidogenic bacteria 
harboring D-cysteine desulfhydrase. Additional studies comparing estimates of D-cysteine 
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consumption between racial/ethnic and socioeconomic groups, and quantifying the abundance of 
these bacteria in subjects with CRC are needed to validate this hypothesis.  
L-cysteine metabolism also appears to play an important role in microbial sulfur metabolism 
of the gut. Indeed, the cysteine fermenting bacterium F. nucleatum has been consistently 
associated with CRC, and two sub-species of F. nucleatum were implicated as part of a microbial 
marker of CRC.15-19 Genomic survey analysis demonstrated that genes involved in cysteine 
metabolism made up the majority of sulfidogenic genes in the colon, and retrospective analysis 
revealed additional genera from our CRC study, which harbor genes with sulfidogenic capacity. 
Due to the bifunctional nature of many of these enzymes, studies comparing the kinetics of these 
pathways should be observed in vivo. For example, the tnaA of O. splanchnicus is capable of 
metabolizing both taurine and tryptophan. Studies on this enzyme from E. coli observed that while 
tryptophanase activity was inhibited by product concentration of product, expression of the 
enzyme was not down-regulated.20 Therefore, it is possible that tnaA primarily functions as a 
tryptophase, but then the activity shifts with increased titration of cysteine. Additional work 
characterizing sulfidogenic proteins of human gut bacteria is needed.  
In conclusion, enzymes for organic sulfur metabolism appear to be abundant and wide-spread 
in the human microbiome. Given the ability of these microbes to persist in dynamic environments, 
and the ability of many microbes to perform multiple metabolic pathways, it is probable that 
sulfidogenesis is abundant and highly dependent upon available substrate provided by diet. A 
combination of in vitro and in vivo functional assays combined with genomics taken from human 





1. Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and 
colon cancer. Gut Microbes. 2016;22:1-15. 
2. Yazici C, Wolf PG, Kim H, Cross TL, Vermillion K, Carroll T, Augustus GJ, Mutlu E, 
Tussing-Humphreys L, Braunschweig C, Xicola RM, Jung B, Llor X, Ellis NA, Gaskins 
HR. Race dependent association of sulfidogenic bacteria with colorectal cancer. Gut. 
2017;66(11):1983-1994. 
3. O'Keefe SJ, Li JV, Lahti L, Ou J, Carbonero F, Mohammed K, Posma JM, Kinross J, 
Wahl E, Ruder E, Vipperla K, Naidoo V, Mtshali L, Tims S, Puylaert PG, DeLany J, 
Krasinskas A, Benefiel AC, Kaseb HO, Newton K, Nicholson JK, de Vos WM, Gaskins 
HR, Zoetendal EG. Fat, fibre and cancer risk in African Americans and rural Africans. 
Nat Commun. 2015;6:6342.  
4. Wynder EL. The epidemiology of large bowel cancer. Cancer Res. 1975;35(11 
Pt.2):3388-94. 
5. Wynder EL, Lemon FR, Bross IJ. Cancer and coronary artery disease among Seventh-Day 
Adventists. Cancer. 1959;12:1016-28. 
6. Wynder EL, Kajitani T, Ishikawa S, Dodo H, Takano A. Environmental factors of cancer 
of the colon and rectum. II. Japanese epidemiological data. Cancer. 1969;23(5):1210-2 
7. Haenszel W, Berg JW, Segi M, Kurihara M, Locke FB. Large-bowel cancer in Hawaiian 
Japanese. J Natl Cancer Inst. 1973;51(6):1765-79.  
8. Shibui Y, Sakai R, Manabe Y, Masuyama T. Comparisons of l-cysteine and d-cysteine 
toxicity in 4-week repeated-dose toxicity studies of rats receiving daily oral 
administration. Journal of toxicologic pathology. 2017;30(3):217-29.  
9. Man EH, and Bada JL. Dietary D-amino acids. Annu Rev Nutr. 7: 209–225. 1987. 
10. Csapo J, Albert C, and Csapo-Kiss Z. The D-amino acid content of foodstuffs. Acta Univ 
Sapientiae Aliment. 2009;2:5–30. 
11. Irby K, Anderson WF, Henson DE, Devesa SS. Emerging and widening colorectal 
carcinoma disparities between Blacks and Whites in the United States (1975-2002). 
Cancer Epidemiol Biomarkers Prev. 2006;15:792-797. 
12. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal 
A. Contribution of screening and survival differences to racial disparities in colorectal 
cancer rates. Cancer Epidemiol Biomarkers Prev 2012;21:728-736. 
13. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: an 
update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer. 
1999;85:1670-6.  
14. U.S. Department of Agriculture, Agricultural Research Service. 2018. Energy Intakes: 
Percentages of Energy from Protein, Carbohydrate, Fat, and Alcohol, by Race/Ethnicity 
and Age, What We Eat in America, NHANES 2015-2016. 
15. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, 
Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, 
Garrett WS. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates 
the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207-15. 
16. Gao Z, Guo B, Gao R, Zhu Q, Qin H. Microbiota disbiosis is associated with colorectal 
cancer. Front Microbiol. 2015;6:20.  
134 
 
17. Kostic AD, Gevers D, Pedamallu CS, Michaud, M, Duke F, Earl AM, Ojesina AI, Jung J, 
Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, 
Huttenhower C, Garrett WS, Meyerson M. Genomic analysis identifies association of 
Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292-8. 
18. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, 
Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is 
prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299-306. 
19. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, 
Brunetti F, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, 
Schrotz-King P, Tournigand C, Tran Van Nhieu J, Yamada T, Zimmermann J, Benes V, 
Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P. Potential of fecal 
microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014;10:766.  
20. Li G, Young KD. Indole production by the tryptophanase TnaA in Escherichia coli is 

























H2 METABOLISM IS WIDESPREAD AND DIVERSE AMONG  
HUMAN COLONIC MICROBES 
 
ABSTRACT 
Microbial molecular H2 cycling is central to metabolic homeostasis and microbial composition in 
the human gastrointestinal tract. Molecular H2 is produced as an endproduct of carbohydrate 
fermentation and is reoxidised primarily by sulfate-reduction, acetogenesis, and methanogenesis. 
However, the enzymatic basis for these processes is incompletely understood and the hydrogenases 
responsible have not been investigated. In this work, we surveyed the genomic and metagenomics 
of hydrogenases in the human colon to infer dominant mechanisms of H2 cycling. The data 
demonstrate that 70% of gastrointestinal microbial species listed in the Human Microbiome 
Project encode the genetic capacity to metabolise H2. A wide variety of anaerobically-adapted 
hydrogenases were present, with [FeFe]-hydrogenases predominant. We subsequently analysed 
the hydrogenase gene content of stools from 20 healthy human subjects. The hydrogenase gene 
content of all samples was overwhelmingly dominated by fermentative and electron-bifurcating 
[FeFe]-hydrogenases emerging from the Bacteroidetes and Firmicutes. This study supports that H2 
metabolism in the human gut is driven by fermentative H2 production and interspecies H2 transfer. 
However, it suggests that electron-bifurcation rather than respiration is the dominant mechanism 
of H2 reoxidation in the human colon, generating reduced ferredoxin to sustain carbon-fixation 
(e.g. acetogenesis) and respiration (via the Rnf complex). This work provides the first 
comprehensive bioinformatic insight into the mechanisms of H2 metabolism in the human colon. 
______________________________________________________________________________ 
1 Reprinted with permission from Patricia G. Wolf, Ambarish Biswas, Sergio E. Morales, Chris Greening, H. Rex 
Gaskins. H2 metabolism is widespread and diverse among human colonic microbes. Gut Microbes 2016 May 




Harboring more than 1011 organisms per gram of content, the human colonic microbiota is a 
diverse ecological landscape, with impacts to health and disease that are just beginning to be 
elucidated. The advancement of molecular based techniques has allowed researchers to explore 
the residents of the colonic microenvironment, revealing specific microbes and microbial patterns 
associated with human health and disease. 1–3 Reproduction of disease states in gnotobiotic mice 
upon fecal transplant implicates resident microbiota as significant contributors to disease etiology. 
As in the case of stomach cancer and Helicobacter pylori, some disease states are the result of 
specific microbial infection. However, the majority of disease appears to be determined by the 
compilation of host genetic and environmental impacts to microbial community structure such as 
diet, medication, and mode of delivery at birth. In short, it is not pathology emanating from a 
specific organism, but rather the accumulation of microbial metabolites from the resident 
community that contributes to the etiology of most colonic-related disorders. One especially 
abundant metabolite in the gastrointestinal tract is molecular H2, a diffusible gas produced and 
consumed by resident anaerobic microorganisms. 4 The dynamics of hydrogen cycling are thought 
to be central to colonic metabolic homeostasis and shaping of the microbial community. As we 
have recently reviewed, 4–6 there is growing evidence that colonic H2 metabolism in turn influences 
inflammatory bowel disease, colorectal cancer, gastrointestinal infections, obesity and associated 
metabolic disorders.  
Most of our understanding of the ecology of anaerobic H2 cycling is based on studies in aquatic 
sediments.7 In such environments, H2 is produced predominantly by fermentative bacteria 
(hydrogenogens) and is thought to be reoxidised primarily by anaerobic respiratory 
microorganisms (hydrogenotrophs). H2 consumption is thermodynamically essential in any 
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environment to maintain fermentative processes, and is accomplished in the sediment through 
interspecies hydrogen transfer or competitive hydrogenotroph.7 Interspecies hydrogen transfer is 
the syntrophic evolution and consumption of hydrogen between organisms in such close proximity 
that hydrogen never joins the dissolved hydrogen pool.8,9 In contrast, competitive hydrogenotrophy 
pairs the oxidation of organic substrates by hydrogenogens with the reduction of terminal electron 
acceptors by hydrogenotrophs, which results in a well described ecological framework determined 
by H2 concentration and substrate availability. In a substrate-rich environment, competitive 
advantage is gained by hydrogenotrophs able to reduce substrates at low hydrogen concentrations, 
as the concentration is maintained too low to make growth thermodynamically favorable for other 
hydrogenotrophic organisms. A classic example are studies describing sulfate-reducing bacteria 
outcompeting methanogens. 10 In a hydrogen-competitive environment, hydrogenotrophs are able 
to coexist through use of alternate substrates and interspecies hydrogen transfer. 9  
Far less is understood about the H2 economy of the human gastrointestinal tract. H2 is formed in 
large volumes in the colon as an endproduct of carbohydrate fermentation, for example by 
Bacteroidetes. 11 There are at least three major pathways for disposal of the H2 produced, namely 
methanogenesis, sulfate reduction, and acetogenesis. 12 The dominance of these pathways appears 
to vary among subjects, possibly as a result of competitive hydrogenotrophy. 13–15 However, there 
are also many reports of methanogens and sulfate-reducers co-existing in the colon. 12,16,17 We have 
hypothesized that this is due to the large spatial and temporal variations in the chemical 
composition of the human colon, which would enable the formation of specific microhabitats 
dominated by different types of hydrogenotrophs.4 Interspecies hydrogen transfer has been 
proposed to occur in the hydrogen-rich human colon, though microenvironmental niches in this 
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mucosal ecosystem have not been studied and both the cellular and genetic bases for H2 cycling 
are underexplored. 11,18 
To gain a better understanding of H2 metabolism in the colon, we identified the classes of 
hydrogenases in genomic and metagenomic databases based on annotation. Hydrogenases are 
metalloenzymes that reversibly oxidize H2 via the reaction H2 → 2 H+ + 2 e-. These ubiquitous 
enzymes are found in archaea, bacteria, and some eukarya, and include both anaerobically- and 
aerobically-adapted variants. 7,19 In anoxic environments such as the human colon, hydrogenases 
can potentially conserve energy through three major processes: 1) hydrogenotrophic respiration 
by coupling oxidation of the high-energy fuel H2 to the reduction of exogenous oxidants such as 
sulfate; 20,21 2) hydrogenogenic fermentation by coupling oxidation of ferredoxin or formate to the 
production of the dissipatable H2;
 22,23 or 3) hydrogenogenic respiration by coupling ferredoxin 
oxidation to proton reduction in cation-translocating complexes. 24,25 More recently, a fourth 
mechanism of H2-dependent energy conservation has been described in acetogens and 
methanogens: flavin-based electron bifurcation. 26 In this process, multimeric complexes mediate 
the simultaneous transfers of H2-derived electrons to high-potential (NAD+, NADP+, or 
heterodisulfide) and low-potential (ferredoxin) compounds, with the exergonic electron transfer 
driving the endergonic one. 27,28 The reductant generated can be used to support biosynthetic 
pathways, carbon-fixation, ferredoxin respiration, and further fermentation processes. 26 There is 
also growing evidence that H2 sensing has a role in anaerobic microorganisms. 19,29 
This assortment of functions is supported by the great phylogenetic diversity of the 
hydrogenases.19 Hydrogenases can be subdivided into three distinct classes based on their metal 
site, the [NiFe], 20 [FeFe], 23 and the [Fe] 30 hydrogenases. Whereas the [Fe] hydrogenases form a 
small homogenous group, 19 the [NiFe] and [FeFe] hydrogenases are highly diverse in their redox 
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centres, associated subunits, and wider cellular integration. 19,31 We recently developed a 
comprehensive classification scheme that correlated the primary phylogeny of these enzymes with 
their functions. This showed there were at least four groups and 22 subgroups of [NiFe]-
hydrogenases, and three groups and six subtypes of [FeFe]-hydrogenases, each with distinct 
functions.19 This enabled the identification of the major classes of enzymes responsible for 
hydrogenotrophic respiration (NiFe Groups 1a, 1b, 1c), hydrogenogenic respiration (NiFe Groups 
4b, 4c, 4d, 4e), hydrogenogenic fermentation (FeFe Groups A1, B; NiFe Group 4a), electron-
bifurcation (FeFe Group A3, A4; NiFe Group 3c), and sensing (FeFe Group C) in anoxic 
environments. 19 In turn, these enzymes are likely to be dominant in the human colon. The aim of 
this work is to use these new sequence-structure-function relationships to explore the dynamics 
and ecology of H2 metabolism in the human colon.  
MATERIALS AND METHODS 
This work analysed the hydrogenase content of the public genomes and metagenomes represented 
in the Human Microbiome Project. 3,32 We analysed the capacity of the 343 microbial species to 
metabolize H2 by retrieving their hydrogenase protein sequences using BLAST searches against 
reference [NiFe], [FeFe], and [Fe] hydrogenases. The amino acid sequences encoding the 
hydrogenase catalytic subunits (for NiFe hydrogenases) or domains (for [FeFe]-hydrogenases) 
were aligned with ClustalW 33. The relationships between these sequences were visualized in 
neighbour-joining phylogenetic trees bootstrapped with 500 replicates using MEGA6.34 For 
metagenome data-mining, we downloaded 20 metagenomes selected at random from the ‘Human 
stool microbial communities from National Health Institute, USA’ project. The metagenomes were 
screened at a depth of five million reads for the presence of hydrogenase genes using a translated 
BLAST search referencing the 3248 sequences in our hydrogenase database.19 To remove false 
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positives, hits within the initial screen were further sieved by removing any result with a minimum 
identity less than 60% and minimum query coverage less than 40 amino acids. The closest-matched 
BLAST hits were recorded. 
RESULTS 
Two thirds of sequenced human gut microbes harbour hydrogenases 
We analysed the capacity of the 343 microbial species listed in the Human Microbiome Project 
Gastrointestinal Tract (HMP GI) reference genome database to metabolize H2. Some 71% of these 
microorganisms encoded hydrogenases. In total, 60% of organisms encoded [FeFe]-hydrogenases, 
21% encoded [NiFe]-hydrogenases, and one organism (the methanogen Methanobrevibacter 
smithii) encoded an [Fe]-hydrogenase (Figure A.1a; Table A.S1). The hydrogenase sequences 
were distributed unevenly at the taxonomic level. All sequenced human gut representatives of 
Clostridiales and Bacteroidaceae harbor [FeFe]-hydrogenase genes, as do some Proteobacteria, 
Fusobacteria, Actinobacteria, and Synergistetes (Figure A.1a). [NiFe]-hydrogenase genes were 
present in all microbial phyla relevant to the human gut, with the exception Fusobacteria, but were 
unevenly distributed within many of these groups (Figure A.1a). Hydrogenases were entirely 
absent from both the Bacilli and Bifidobacteria (Table A.S1).  
Human gut microbiota encode a variety of anaerobe-type fermentative, respiratory, and 
bifurcating hydrogenases 
We subsequently investigated the molecular phylogeny of the hydrogenases present in these 
organisms using a previously-curated hydrogenase database.19 The taxonomic distribution of these 
enzymes is visualised in Figure A.1b and their phylogenetic diversity is represented in the 
phylogenetic trees of Figure A.2. The most abundant hydrogenases encoded in sequenced human 
gut genomes were [FeFe]-hydrogenases that mediate fermentative H2 production (Groups A1, B), 
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flavin-based electron-bifurcation (Group A3), and possibly H2 sensing (Group C) (Figure A.1b; 
Table A.S2). These enzymes were especially widespread in the dominant gut phyla Firmicutes 
and Bacteroidetes. A diverse range of [NiFe]-hydrogenase genes were observed. The most 
abundant are subgroups 1a, 1b, 1c, and 1d, which couple H2 oxidation to physiologically-relevant 
electron acceptors such as sulfate and fumarate, primarily in enterobacteria. Also detected were 
enterobacteria-type formate hydrogenlyases (NiFe Group 4a), which couple formate oxidation to 
fermentative H2 production, and methanogenic Eha, Ehb, and Ech hydrogenases (NiFe Group 4d 
& 4e), which form minimalistic proton/sodium-translocating respiratory chains that reversibly 
couple ferredoxin oxidation to proton reduction. The other subgroups were present in one to three 
sequenced species each and hence are likely to only have a marginal impact on colonic H2 cycling. 
H2 cycling in the human gut is dominated by [FeFe]-hydrogenases from Bacteroidetes and 
Firmicutes 
We subsequently surveyed the abundance and affiliations of hydrogenase genes using the 
metagenomes of stool samples from 20 healthy human subjects. There were major differences in 
the normalised abundance, classification, and affiliations of the hydrogenase genes among the 
subjects (Figure A.3; Table A.S3). However, the overall distribution of hydrogenases was similar, 
with the most abundant hydrogenase genes encoding fermentative (55% Group B, 11% Group 
A1), bifurcating (20% Group A3), and sensory (6% Group C) enzymes among the samples. [NiFe] 
enzymes accounted for just 6% of the sequences detected, with the 1d subgroup of O2-tolerant 
respiratory uptake enzymes proving the most abundant. Other sequences such as the methanogen-
type 4d and Verrucomicrobia-type 1f categories were only found in several samples each, which 
is consistent with the occurrence of these organisms in only a subset of the human population 3. 
The vast majority of the genes were affiliated with the Bacteroidetes (73%) and Firmicutes (21%), 
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which is consistent with their genomic hydrogenase content (Figure A.1 & A.2) and known 
dominance in stool samples 3. While Bacteroidetes hydrogenases were generally more abundant 
than those in Firmicutes, this relationship was reversed in samples O and P (Figure A.3). 
DISCUSSION 
Publicly available genome and metagenome resources were used in this work to comprehensively 
analyse the distribution of hydrogenases in the human colon. The data indicate that H2 metabolism 
is more diverse and widespread on both the taxonomic and community levels than previously 
appreciated. Greater than seventy percent of microbial genomes in the HMP GI database harbor 
the capacity to synthesize hydrogenases, showing H2 cycling is a dominant mode of energy-
conservation in this anaerobic ecosystem (Figure A.1). These organisms encoded a wide range of 
anaerobe-type fermentative, electron-bifurcating, and, to a lesser extent, respiratory [FeFe] and 
[NiFe] hydrogenases (Figure A.2). The capacity for H2 sensing was also inferred. The 
metagenome survey detected a similar diversity of hydrogenase-encoding gene sequences. 
However, just three hydrogenase classes (FeFe Groups B, A3, A1) and two microbial phyla 
(Bacteroidetes, Firmicutes) accounted for > 85% of the genes detected (Figure A.3). This reflects 
the well-described microbial community structure of the human colon, which is overwhelmingly 
dominated by Bacteroidetes and Firmicutes 3.  
Together, the survey infers the predominant routes of H2 evolution and reoxidation in the 
human colon (Figure A.4). It indicates that the predominant mechanism of H2 evolution in this 
ecosystem is through fermentative processes mediated by Bacteroidetes and Clostridial members 
of the Firmicutes. Of the major pathways of hydrogenogenesis, 4,19 ferredoxin-coupled H2 
fermentation appears to the predominant; [FeFe]-hydrogenases responsible for this process (Group 
A1, likely B) were more abundant than [NiFe]-hydrogenases responsible for formate-coupled 
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fermentation (Group 4a, likely 4f), NAD(P)H-coupled fermentation (Group 3b & 3d), and 
hydrogenogenic respiration (Groups 4b, 4c, 4e).  
Of the mechanisms of hydrogenotrophy, the survey strongly implies that the majority of H2 is 
reoxidised through electron-bifurcation coupled to ferredoxin respiration. This depends on the 
highly abundant Group A3 [FeFe]-hydrogenases, which account for 20% of the total hydrogenase 
genes in the human colon. These trimeric enzymes reversibly bifurcate electrons from H2 to 
ferredoxin and NAD. 26,35 The reductant generated can be used to sustain anabolic processes, 
carbon-fixation (e.g. via reductive acetogenesis), or further fermentation (via [FeFe]-
hydrogenases). However, based on recent models, it is likely that a large proportion is reoxidised 
through the respiratory Rnf complex, which generates sodium/proton-motive force by coupling 
Fdred oxidation to NAD+ reduction.26,36 The only quantitatively abundant [NiFe] uptake 
hydrogenases detected were the oxygen-tolerant respiratory uptake hydrogenases (Group 1d 
[NiFe]-hydrogenases); 37 such enzymes have been linked to reoxidation of fermentatively-
produced H2 and might also contribute the metabolic flexibility needed for facultative anaerobes 
such as E. coli to transition between host-associated and free-living states. 38 Between them, such 
processes would enable the majority of H2 produced in the human colon to be reoxidised without 
formation of detectable endproducts. We predict that the majority of H2 produced by fermentative 
processes is immediately recycled through a combination of internal reoxidation and interspecies 
H2 transfer without ever entering the H2 pool.  
Our proposal that electron-bifurcation serves as the primary mechanism of colonic 
hydrogenotrophy deviates from classical literature emphasizing the roles of pathway necessitating 
endproduct secretion. It is probable that the best-characterised pathways of colonic H2 reoxidation, 
namely methanogenesis, sulfate-reduction, and potentially acetogenesis, 4,12,14,39 serve as only 
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fractional sinks in the colonic H2 budget. These processes have a major influence on the chemical 
composition of the human colon and its flatus, 4,12 enhance the diversity of gut microflora, 3 and 
particularly in the case of sulfate-reducers, have been extensively linked to human health and 
disease. 40 However, they appear to be quantitatively less significant than electron-bifurcation. This 
likely reflects that previous studies on colonic hydrogenotrophy have focused on endproduct 
formation rather than molecular mechanisms of H2 oxidation. HMP studies on the community 
structure of the human colon indicate the abundance of sulfate-reducers and methanogens is too 
low and variable for these organisms to be the dominant hydrogenotrophs. 3,32 Furthermore, our 
survey showed the key H2-oxidising enzymes responsible for methanogenesis (NiFe Groups 3a, 
3c, 4d, 4e) and sulfate-reduction (NiFe Groups 1a, 1b) were either absent or in low abundance in 
the 100 million sequence reads analysed. Consistently, the levels of methane and hydrogen sulfide 
produced in human flatus is many orders of magnitude lower than the H2 available.
 5 It remains to 
be debated whether the energetically-constrained process of reductive acetogenesis is an important 
hydrogenotrophic pathway; the clostridial electron-bifurcating hydrogenases that mediate this 
process are abundant in the human gut, but have flexibility to support other processes such as 
fermentation and ferredoxin respiration.  
A further surprising finding of our metagenome survey is that it emphasizes a dominant role 
for Bacteroidetes in H2 cycling. Genes encoding Bacteroidetes hydrogenases were more abundant 
than those encoding clostridial hydrogenases in 18 of the 20 samples (Figure A.3). It is established 
that colonic Bacteroidetes produce H2 as an endproduct of cellulolytic fermentation processes 
41,42 
and that this process supports symbiotic interactions with clostridia.11,42 Given colonic 
Bacteroidetes genomes lack classical Group A1 [FeFe]-hydrogenases, such processes are probably 
supported by Group B [FeFe]-hydrogenase, a large uncharacterized class of enzymes predicted to 
145 
 
couple Fdred oxidation to H2 evolution.
19,43 The genome and metagenome surveys also detected 
Group A3 [FeFe]-hydrogenases from members of the genera Bacteroides, Parabacteroides, and 
Alistipes (Figures A.1 & A.3). While the roles for these enzymes in processes such as clostridial 
reductive acetogenesis is well-resolved, 26,44 their role in Bacteroidetes is less clear. It is probable 
that the majority of the reductant formed through this process respires through the Rnf complex, 
an example of which was recently characterized in Bacteroides fragilis. 45 It is conceivable that 
Bacteroidetes also oxidizes internally- and externally-produced H2 to maintain redox homeostasis 
and support reductive processes such as CO2 fixation.
 46  
Looking forward, there are now multiple ways to expand on these studies to develop a deeper 
understanding of the mechanisms of hydrogenogenesis and hydrogenotrophy in the human gut. 
Firstly, this study only analyses the genetic determinants of H2 metabolism; it is imperative to test 
the hypothesis that electron-bifurcation is the dominant mechanism of hydrogenotrophy via 
expression and activity studies. Secondly, fecal samples do not fully reflect the heterogeneity of 
the human colon over space and time.12 Biopsy studies are likely to reveal more about the diversity 
and distribution of H2 cycling, including why methanogens and sulfate-reducers are present and 
active in the human colon despite being outnumbered.12 As reflected by our findings on the 
demography of colonic methanogenesis,47 there is also need for clinical studies to explore how 
hydrogenase abundance and activity varies with factors such as subject weight, gender, race, and 
disease states. Our findings that over 70% of sequenced human colonic microorganisms harbor 
hydrogenases indicates H2 cycling may be a far more important process in human health and 
disease than previously recognized.4,5 Finally, there is also need for biochemical and physiological 
studies to resolve the physiological roles of the unexplored Group A2, B, and C [FeFe]-
hydrogenases, as well as the wider roles of H2 cycling in Bacteroidetes. A deeper understanding 
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of phylogeny as it pertains to function is necessary to fully understand the relationship among 
hydrogenogenic and hydrogenotrophic microbes in the human colon. 
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Figure A.1. Genomic distribution of hydrogenases in human colonic microorganisms. a. 
The proportion of microbial species that encode hydrogenases. This was determined using the 
343 microbial species represented in the Human Microbiome Project Gastrointestinal Tract 
(HMP GI) genome database. b. Distribution of human colonic hydrogenase sequences by 
microbial phyla and hydrogenase class. Hydrogenase sequences were obtained from human 
colonic microorganisms represented in the NCBI Reference Sequence database and were 




















Figure A.2. Phylogenetic trees showing the diversity of the human colonic hydrogenases. 
The trees represent the protein sequences of the [FeFe]-hydrogenase catalytic domains (a) and 
[NiFe]-hydrogenase catalytic subunits (b) derived from the genomes of human colonic 
microorganisms. The trees were constructed by the neighbour-joining method, are bootstrapped 
















Figure A.3. Distribution of hydrogenase-encoding genes in human colonic metagenomes. 
The hydrogenase content of 20 metagenomes derived from the HMP GI metagenome database 
was determined at a depth of five million reads. a. Probable phylum-level affiliation of 
hydrogenases detected. This was determined by recording the closest BLAST hit for each read 
against a databank of 3284 hydrogenase sequences19. b. Number of reads corresponding to each 





Figure A.4. Summary of human colon H2 metabolism based on the described genome and 
metagenome surveys. a. Summary of the predominant known routes of H2 evolution and 
reoxidation in the human colon. The microbial phyla and hydrogenase classes mediating these 
processes are shown. The hydrogenases are sized according to the relative abundance of the 
genes encoding them in the 20 metagenomes surveyed. The most dominant hydrogenogenic 
hydrogenases were the Group A1 and Group B [FeFe]-hydrogenases that mediate ferredoxin-
dependent H2 evolution. NADPH- or formate-dependent H2 evolution appears to be 
quantitatively less important. The electron-bifurcating Group A3 [FeFe]-hydrogenases were by 
far the most abundant hydrogenotrophic hydrogenases identified in our genome and metagenome 
surveys. These enzymes are linked to acetogenesis, though our metagenomes surveys suggest 
that many hydrogenotrophs are also capable of oxidising H2 without producing detectable 
endproducts, i.e. through H2-mediated ferredoxin reduction followed by subsequent ferredoxin 
respiration. The determinants of hydrogenotrophic methanogenesis, sulfate reduction, and 




Figure A.5. Summary of human colon H2 metabolism based on the described genome and 
metagenome surveys. b. Simplified pathways showing interspecies hydrogen transfer between 
the two most dominant H2-metabolising phyla in the human colon. The H2 evolved by a 
carbohydrate-fermenting Bacteroides species by the [FeFe] Group B hydrogenase. The H2 is 
transferred to a hydrogenotroph of the genus Clostridium and is bifurcated at [FeFe] Group A3 to 
reduce ferredoxin and NADH. The derived reductant sustains respiration through the Rnf 
complex and CO2 fixation through reductive acetogenesis. Our survey suggests alternative 
pathways may also occur in the human colon resulting in H2 oxidation in Firmicutes, H2 
production in Bacteroidetes, and internal recycling of H2. It is probable that the [FeFe] Group A3 
hydrogenase can generate reductant in Firmicutes and Bacteroidetes independently of 
acetogenesis. Key: Nuo = NADH dehydrogenase, Frd = fumarate reductase, Rnf = 
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ASSESSING THE COLONIC MICROBIOME, HYDROGENOGENIC AND 
HYDROGENOTROPHIC GENES, TRANSIT AND BREATH METHANE IN 
CONSTIPATION 
ABSTRACT 
Differences in the gut microbiota and breath methane production have been observed in chronic 
constipation, but the relationship between colonic microbiota, transit, and breath tests remains 
unclear. In 25 healthy and 25 constipated females we evaluated the sigmoid colonic mucosal and 
fecal microbiota using 16S rRNA gene sequencing, abundance of hydrogenogenic FeFe (FeFe-
hydA) and hydrogenotrophic (methyl coenzyme M reductase A [mrcA] and dissimilatory sulfite 
reductase A [dsrA]) genes with real-time qPCR assays, breath hydrogen and methane levels after 
oral lactulose, and colonic transit with scintigraphy. Breath hydrogen and methane were not 
correlated with constipation, slow colon transit, or with abundance of corresponding genes. After 
adjusting for colonic transit, the abundance of FeFehydA, dsrA, and mcrA were greater (P<.005) 
in colonic mucosa, but not stool, of constipated patients. The abundance of the selected 
functional gene targets also correlated with that of selected taxa. The colonic mucosal abundance 
of FeFe-hydA, but not mcrA, correlated positively (P<.05) with breath methane production, slow 
colonic transit, and overall microbiome composition. In the colonic mucosa and feces, the 
abundance of hydrogenogenic and hydrogenotrophic genes were positively correlated (P<.05). 
Breath methane production was not associated with constipation or colonic transit.  
Corroborating our earlier findings with 16S rRNA genes, colonic mucosal but not fecal 
hydrogenogenic and hydrogenotrophic genes were more abundant in constipated versus healthy 
156 
 
subjects independent of colonic transit. Breath gases do not directly reflect the abundance of 
target genes contributing to their production. 
______________________________________________________________________________ 
1 Reprinted with permission from Patricia G. Wolf, Gopanandan Parthasarathy, Jun Chen, Nicholas Chia, Adil E. 
Bharucha, H. Rex Gaskins. Assessing the colonic microbiome, hydrogenogenic and hydrogenotrophic genes, transit 
and breath methane in constipation. Neurogastroenterology and Motility 2017 Oct;29(10):1-9. © (2017). John Wiley 





Considerable evidence exists which highlights associations between the colonic microbiota and 
chronic constipation.1 Colonic mucosal and fecal microbiota differ between constipated patients 
and healthy people. 2-4 Breath methane, which is derived from intestinal methanogenesis, is 
increased in constipated patients,5 associated with slow colon transit, and with altered colonic 
microbiota.2,4  
An earlier study suggested that breath hydrogen and methane excretion after lactulose 
ingestion were proportional to the production of these gases measured with whole-body 
calorimetry.7 However, more recently, breath methane excretion was not an accurate marker of 
colonic methane production in healthy people and irritable bowel syndrome (IBS) patients, nor 
was it associated with the clinical features or colonic transit in IBS.8 Indeed, several aspects of 
microbial carbohydrate fermentation limit the utility of using breath gases to assess the 
abundance or activity of hydrogen-producing (hydrogenogenic) microbes or intestinal gas 
production. First, the accuracy of breath hydrogen excretion is limited by rapid small intestinal 
transit, and rapid alterations in intestinal content.9 Second, the proportion of H2 excreted in 
breath depends on total production. At a low production rate (<200 mL/day), 65% of H2 is 
exhaled,7 but at a high rate (>500 mL/day), most was expelled as flatus and only 25% was 
exhaled.7 Third, the magnitude of fermentation varies among carbohydrates.7 Fourth, hydrogen 
from hydrogenogenic microbes is utilized by hydrogenotrophic microbes,6 which reduces the 
accumulation of hydrogen, thereby decreasing feedback inhibition of fermentation.  
Microbial hydrogenogenesis and hydrogenotrophy involves the reversible oxidation of H2 by 
hydrogenase harboring organisms. Categorized by their metal functional cores, hydrogenases are 
phylogenetically widespread and functionally diverse and include both hydrogen evolving and 
hydrogen uptake [NiFe] hydrogenases, hydrogen evolving [FeFe] hydrogenases, and hydrogen 
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uptake [Fe]-only hydrogenases.10 Hydrogenotrophic microbes utilize hydrogen to convert carbon 
dioxide to acetate (i.e., acs, fhs genes),11 methane (mcrA gene),12 and hydrogen sulfide (dsrA 
gene).13 Conceivably, low methane production may reflect low hydrogenotrophic methanogenic 
abundance or low substrate availability (i.e., hydrogen), perhaps due to fewer hydrogenogenic 
microbes. Measuring the colonic abundance of hydrogenogenic and hydrogenotrophic microbes 
may distinguish amongst these possibilities. Previous studies have characterized 
hydrogenogens14 or methanogens 12 with functional genomics, but none have done so 
concurrently.  
This study aimed to (i) compare the abundance of hydrogenogenic and hydrogenotrophic 
genes in colonic mucosa and feces between healthy people and constipated patients, and to 
assess the relationship between gene abundance and (ii) colonic transit, (iii) breath hydrogen and 
methane production, and (iv) overall composition and specific microbiota.  
METHODS 
Participants 
As detailed previously, 25 women who had Rome III symptom criteria for IBS-C or functional 
constipation (FC) and 25 healthy people were recruited between February 2013 and April 2014 
at Mayo Clinic.4 All participants were nonsmokers aged 18-80 years, who had no clinical 
evidence of significant systemic disease, inflammatory bowel disease, gastrointestinal cancer, 
gastric, intestinal, or colonic resection, or antibiotic use within 30 days. This study was approved 
by the Mayo Clinic Institutional Review Board, and written informed consent was obtained from 
all participants.  
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Assessment of Dietary Intake 
Briefly, a registered dietitian advised participants to maintain a stable diet for 1 week before and 
throughout the study; to follow a low fiber diet and avoid interfering foodstuffs for 24 hours 
prior to lactulose breath test; and to complete a food record for 3 days before stool collection (4). 
Food records were analyzed with ESHA Food Processor software (Version 10.14, ESHA 
Research, Salem, OR). 
Lactulose breath test 
After an overnight fast, an antiseptic mouthwash (30 mL) was provided immediately before the 
procedure to preclude lactulose fermentation by oropharyngeal bacteria. Participants ingested 
lactulose syrup (10 g). Breath samples were collected every 15 minutes for 60 minutes, and then 
every 30 minutes for the next 120 minutes. Breath hydrogen and methane concentrations were 
measured with model SC Quintron gas chromatograph (Quintron Instrument Company, 
Milwaukee, WI), and summarized as area under the curve (AUC). A positive breath test was 
defined by an increase in breath hydrogen and methane exceeding 20 ppm over baseline.15  
GI and colonic transit by scintigraphy 
Colonic transit was measured by asking participants to ingest a methacrylate-coated, delayed-
release capsule containing indium-111 (111In) adsorbed on activated charcoal particles.4 The 
delayed-release coating dissolves in the alkaline pH of the terminal ileum, releasing 111In in the 
cecum. Gastric and small bowel transit was evaluated with two scrambled eggs labelled with 
technetium-99m (99mTc) sulfur-colloid that were eaten with one slice of whole wheat bread and 
one glass of whole milk (300 kcal total). Established approaches were used to summarize the 
gastric emptying (GE) half time (t1/2), small intestinal transit (i.e., proportion of 99mTc in the 
colon at 6 hours) and colonic transit, expressed as the geometric center (GC) at specified times. 
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The GC is the weighted average of counts in the different colonic regions (ascending, transverse, 
descending, rectosigmoid colon) and stool, respectively, 1 to 5. A higher GC reflects a faster 
colonic transit.  
Stool collection 
Using stool kits and standardized instructions, patients collected stool samples according to the 
Manual of Procedures for Human Microbiome Project (Version Number 11.0, 29 March 2010). 
Stool samples were frozen and stored in -20°C freezer. One patient required an enema, and one 
patient required a laxative before providing a stool sample. 
Colonic biopsies 
Using 2 mm forceps, five mucosal biopsies were obtained from normal colorectal mucosa in the 
sigmoid colon during a flexible sigmoidoscopy. Mucosal biopsies were snap frozen and stored in 
a -70°C freezer. 
Sequencing and Analytical Methods 
DNA was extracted from stool with a commercial kit (MoBio DNA extraction kit, Carlsbad, CA) 
following standard Human Microbiome Project guidelines.16 After extraction, total DNA was 
quantified using a Qubit assay kit (Life Technologies Corporation, NY, USA), with an average 
yield of 4.1 (range 0-22.5) ng/µL. 16S rRNA-based sequencing was performed with an Illumina 
MiSeq sequencer (Illumina Inc., San Diego, CA). Phylotype profiles of the microbiota from 
healthy and constipated populations were generated using deep rDNA hypervariable tag 
sequencing of the hypervariable V3-V5 region of the small subunit (SSU) rRNA gene, which has 
been validated for use with human microbiota and is the preferred technique in the Human 
Microbiome Project. With the longer reads from the MiSeq (300x300 paired end reads), 
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sequencing included the V3-V5 regions, thereby optimizing the phylogenetic analysis;17 the 300 
base pair reads ensured optimal phylogenetic identification. Barcoding of samples prior to 
sequencing yielded a range of 3,116 – 425,701 reads per sample, ensuring detection of both 
dominant (core microbiota) and poorly represented taxa (variable microbiota). Paired end reads 
were stitched, aligned, and classified using a custom pipeline (TORNADO v2.0).18 Briefly, low 
base quality reads were either trimmed or discarded,19 and these reads were not classified as a 
bacteria kingdom20 or matched to the bacteria 16S rRNA secondary structure.21 To evaluate the 
microbial diversity and abundance, UPARSE was used for Operational Taxonomical Units 
(OTU) clustering,22 and FastTree was used for phylogeny.23 The 16S data were clustered into 
OTUs at 97% sequence similarity, and the taxonomy was assigned using the Ribosomal 
Database Project classifier.  
PCR amplification of functional gene targets 
Stool and mucosa DNA were extracted with a MoBio DNA extraction kit and QIAmp Stool 
DNA mini kit, respectively. Stool and sigmoid colonic mucosal biopsy microbial abundance 
were quantified using Real-Time quantitative PCR assays performed with a 7900HT Fast Real-
Time PCR System (Applied Biosystems, Foster City, CA), and expressed as gene copies per 
nanogram of DNA. Because a recent metagenomic survey observed that [FeFe] hydrogenases 
made up the vast majority of hydrogenases in the human microbiome,14 this was the focus of 
hydrogenogenic genes. The functional hydrogenogenic FeFe (FeFe-hydA) gene24 and 
hydrogenotrophic methyl coenzyme M reductase A (mcrA)25 and dissimilatory sulfite reductase 
A (dsrA) genes26 were targeted.27 Standard curves were constructed using cloned 16S rRNA and 





Demographic features, diet, transit, and gene abundance in healthy people and constipated 
patients were compared using the Student’s t test or Wilcoxon test as appropriate. Results with 
P values <.05 were considered significant. Univariate regression with permutation based on F-
statistics assessed differences in breath tests, and gene abundance between health and 
constipation. Associations between (i) breath tests and diet and separately with colonic transit, 
and (ii) gene abundance and demographic factors (i.e., age and body mass index [BMI]), diet, 
colonic transit, and breath methane production were evaluated with multiple variable regression 
with permutation based on the F-statistic, all adjusted for constipation status. Associations 
between breath tests, gene abundance, demographic factors (i.e., age and BMI), diet, and colonic 
transit were assessed by multivariable models after adjusting for constipation status. Variables 
were log transformed as appropriate. Associations between hydrogenogenic genes and breath 
hydrogen production, and separately, hydrogenotrophic genes and breath methane production, 
were assessed after adjusting for methane production and hydrogen production, respectively. To 
assess the differences between microbiota profiles, i.e., β diversity, we used both unweighted and 
weighted Unifrac distances (‘GUniFrac’ function in the R package ‘GUniFrac’) and the Bray-
Curtis dissimilarity. These metrics capture different parameters, with unweighted UniFrac 
reflecting differences in community membership (i.e., presence or absence of OTU), while the 
weighted UniFrac and Bray-Curtis dissimilarity better reflect differences in OTU abundance.28 
To prevent artifacts in the analysis that can arise from unequal sequencing depth, rarefaction was 
performed on the OTU table before calculating the unweighted UniFrac distance. In order to 
identify associations between microbial community profiles and variables of interest (e.g., 
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constipation status, colonic transit), we used the Microbiome Regression-Based Kernel 
Association Test (MiRKAT) that adjusts for potential confounding covariates.29 
In addition to performing an association analysis with the OTU-based microbiome profiles, 
we also tested for associations between specific taxa and variables of interest. This was done by 
comparing relative taxa abundance and variables of interest using a linear model with 
adjustments for covariates where appropriate. Because the taxa data is not normally distributed, 
assessment of statistical significance considered 1,000 permutations with the F-statistic as the 
test statistic. Associations were evaluated at the phylum, family, and genus level. The false 
discovery rate (FDR) control was performed based on the Benjamini-Hochberg procedure to 
correct for multiple testing, i.e., ‘p.adjust’ in R. Analysis was confined to taxa with a prevalence 
greater than 10% and a maximum proportion (relative abundance) greater than 0.002. An FDR-
adjusted P value (or Q-value) less than 5% was considered to be significant. Associations 
between gene abundance and microbiota, and separately with breath tests, were assessed in 
multivariable models, after adjusting for both constipation and colonic transit. Spearman 
correlation coefficients assessed associations between abundance of genes in stool and colonic 
mucosa. All statistical analyses were performed in R-3.0.2 (R Development Core Teams, 
Vienna, Austria). 
RESULTS 
Participant characteristics  
The results of symptoms, diet, colonic transit, breath hydrogen and methane excretion, and 
phylogenetic assessment of the colonic and mucosal microbiome with 16S rRNA gene 
techniques in these participants have been published.4 This paper focuses on the results of 
functional genes and their relationship with other characteristics in this cohort.  
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Of the 25 patients, 13 had symptoms of FC, 6 had IBS-C, and 6 had mixed IBS, with 
predominant constipation. Compared to patients, healthy participants also consumed more 
calories (P=.005), carbohydrate (P=.054), protein (P=.002), fat (P=.03), and fiber (P=.01) when 
expressed as an absolute amount, but not as a proportion of the total calorie intake (Table B1). 
Gastric emptying at 2 hours was lower (P=.005) in constipated patients than in healthy 
participants. Fourteen patients (9 with FC, 3 with IBS-C, and 2 with mixed IBS) but only 2 
controls (P=.0001) had delayed colonic transit. Colonic transit (GC24) was directly correlated 
with total calorie intake (P=.03) and total fiber intake (P=.01), and inversely correlated with age 
(P=.03).  
Relationship between breath tests and other parameters 
Breath methane excretion was numerically greater in constipated subjects than in controls at all 
timepoints (Figure B1). However, breath hydrogen and methane excretion (AUC) were not 
different (P=.20) between patients and controls. After adjusting for constipation status, a positive 
hydrogen breath test was associated with higher dietary protein intake (P=.05) and slow colonic 
transit (P<.05). Breath methane excretion (AUC) was positively associated with dietary fiber 
intake (P<.05).  
Relationship between abundance of functional genes in the colonic mucosa and other parameters 
The colonic mucosal abundance of hydrogenogenic and hydrogenotrophic genes was not 
associated with age, sex, or body mass index (BMI) (data not shown). However, these genes 
(FeFe-hydA, mcrA, and dsrA) were more abundant in constipated patients than healthy people 
(Figure B2), even after adjusting for colonic transit. The abundance of FeFe-hydA was 
correlated positively with methane production (AUC) (P<.05) and with slow colonic transit 
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(P<.05). No other associations between these genes and diet, colonic transit, and breath methane 
or hydrogen excretion were significant. 
Relationships between abundance of functional gene targets in stool and other parameters 
The abundance of hydrogenogenic and hydrogenotrophic genes in feces was not associated 
with age, sex, or BMI (data not shown). None of the genes in stool were associated with 
constipation or colonic transit. The abundance of fecal mcrA was positively associated with a 
positive hydrogen breath test (P<.05). The abundance of fecal FeFe-hydA was positively 
associated with dietary carbohydrate intake (P<.05). Associations between the abundance of 
fecal FeFe-hydA and breath hydrogen production remained nonsignificant even after adjusting 
for methane production and separately, for abundance of individual hydrogenotrophic genes. 
Conversely, associations between the abundance of individual hydrogenotrophic genes and 
breath methane production remained nonsignificant even after adjusting for hydrogen production 
and separately, abundance of fecal FeFe-hydA. No other associations between the fecal 
abundance of these genes and diet, colonic transit, and breath methane or hydrogen excretion 
were statistically significant. 
Associations between abundance of functional genes and the colonic mucosal microbiota  
The abundance of FeFe-hydA and dsrA in the colonic mucosa were separately associated 
with the overall microbiome composition assessed with both unweighted and weighted Unifrac 
distance (Table B2).  
The abundance of mcrA in the colonic mucosa was associated with the overall microbiome 
composition assessed with unweighted but not weighted Unifrac distance. The abundance of 
several taxa in the mucosa correlated with the abundance of FeFe-hydA, mcrA, and dsrA in tissue 
(Table B3).  
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The genera Sphingobacterium and Pseudomonas correlated positively with dsrA and mcrA 
respectively, before, but not after, adjusting for false discovery rate. As previously reported, 
16sRNA analyses disclosed that some of these microbes were also differentially (i.e., more or 
less) abundant in the colonic mucosa of constipated patients.4 In contrast, the abundance of these 
genes in stool was not associated with the composition of stool microbiome (data not shown).  
Correlations between abundance of functional gene targets in stool and colonic mucosa 
In the colonic mucosa, the abundance of FeFe-hydA correlated positively with the abundance of 
hydrogenotrophic genes. The abundance of hydrogenotrophic genes also correlated positively 
with each other (Figure B3).  
In stool samples, the abundance of FeFe-hydA was positively correlated with mcrA (ρ=0.21, 
P<.05). The abundance of fecal FeFe-hydA tended to correlate with its abundance in mucosa 
(ρ=0.30, P=.06).  
DISCUSSION 
We observed previously that phylogenetic assessment of mucosal microbiota distinguished 
constipated and healthy subjects with 94% accuracy independent of colonic transit.4 Extending 
those findings, this study found that hydrogenogenic and hydrogenotrophic gene targets were 
more abundant in the colonic mucosa of constipated patients, and provides several insights into 
the relationship between gene abundance, colonic transit, and gases.30  
Gaseous byproducts of colonic fermentation have been implicated in IBS in general , and 
IBS-C in particular.5 Methane delivered at very high concentrations increased ileal muscle 
contractility in an ex vivo model of the guinea pig ileum and delayed small bowel transit in 
dogs.31 In this study, breath methane excretion was numerically greater in patients than in 
controls at individual time points. However, the overall breath methane excretion profile was not 
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associated with constipation or slow colonic transit. One explanation is that only a subset of 
healthy individuals, approximately 30% in our population, produce methane at quantities 
detectable in breath,32 which is lower than the corresponding proportion (53%) in a study from 
Spain.33 The abundance of individual hydrogenogenic genes was not significantly associated 
with breath hydrogen production, even after adjusting for its utilization, i.e., to produce methane. 
Similarly, the abundance of individual hydrogenotrophic genes was not associated with breath 
methane production, even after adjusting for the availability of hydrogen, its substrate. Taken 
together, these observations suggest that breath methane and hydrogen excretion is not a useful 
measure of the abundance of hydrogenogenic and hydrogenotrophic genes in humans.  
The abundance of hydrogenotrophic and hydrogenogenic genes was significantly correlated 
in both colonic mucosa and feces. This is beneficial because the hydrogenotrophic process 
prevents accumulation of hydrogen, which would thermodynamically restrict further 
fermentation.6 Thus, hydrogen removal ensures fermentation of substrates to more oxidized end 
products, hence increasing the energy yield of fermentative microbes. Additionally, breath 
methane production correlated with colonic mucosal abundance of the hydrogenogenic gene 
FeFe-hydA but not the methanogenic gene mcrA. Hydrogen produced by hydrogenogenic 
organisms serves as a methanogenic substrate,34, 35 therefore more FeFe-hydA may increase 
colonic, and hence breath, methane levels. In contrast, the abundance of the methanogenic gene 
mcrA was not correlated with breath methane production, perhaps because breath methane is not 
an accurate marker of colonic methane production.8 In other words, the abundance of the 
methanogenic gene mcrA may not reflect its activity.36  
The colonic mucosal abundance of hydrogenogenic and hydrogenotrophic genes were 
associated with the overall composition of the colonic mucosal microbiome evaluated with 
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unweighted and weighted analyses. Indeed, several taxa that correlated with the abundance of 
genes in this study were also differentially abundant in the mucosal microbiota of healthy and 
constipated persons.4 Moreover, taxa that were more abundant (i.e., Bacteroidetes, 
Proteobacteria; Pseudomonas) in constipated patients were positively correlated with FeFe-
hydA, dsrA, and mcrA. Conversely, taxa that were less abundant (i.e., Proteobacteria; 
Comamonas, Proteobacteria; Delftia, Proteobacteria; Agrobacterium) in constipated patients 
inversely correlated with FeFe-hydA, dsrA, and mcrA. Hence, it is conceivable that differences in 
these taxa at least partly explain why hydrogenogenic and hydrogenotrophic genes were more 
abundant in constipation.  
Relationships between taxa abundance and functional gene targets may provide insights into 
the contribution of individual organisms to the overall microbial hydrogen economy. For 
example, first, some Bacteroidetes express the gene FeFe-hydA, which may explain the 
correlation between this phylum and FeFe-hydA.24, 37 Second, taxa belonging to phyla 
Proteobacteria and Actinobacteria correlated inversely with FeFe-hydA. To speculate, the 
colonic abundance of these phyla may be inversely correlated with the abundance of the phylum 
Firmicutes, which are strong hydrogen producers.6 Third, Bacteroidetes encode sulfatases,38 
which liberate sulfate from sulfated mucins. Sulfate-reducing bacteria (SRB) contain dsrA, 
which utilizes sulfate and hydrogen to produce hydrogen sulfide. Sulfate promotes the growth of 
SRB.39 Perhaps this explains the correlation between Bacteroidetes and dsrA-harboring SRB, 
which generate sulfate and synthesize hydrogen sulfide, respectively. Subject to the caveat that 
the phylogenetic assessment relied on 16S rRNA gene sequences while the functional gene 
abundance was evaluated with qPCR techniques, taxa that are known hydrogen producers (e.g., 
Roseburia spp. and Ruminococcus spp) were not significantly different between healthy and 
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constipated subjects. Refining our understanding of the relationships between specific taxa and 
functional genes will require metagenomic approaches. 
In contrast to the colonic mucosa, few correlations were observed between hydrogenogenic 
and hydrogenotrophic gene abundance in stool and constipation or the stool microbiome. 
Correlations between the abundance of mcrA and a positive hydrogen breath test and between the 
abundance of the hydrogenogenic gene FeFe-hydA and the hydrogenotrophic gene mcrA were 
significant, likely due to the syntrophic nature of organisms which create these respective 
metabolites. Similar to the phylogenetic assessment of the microbiome,4 the abundance of gene 
targets in stool and colonic mucosa were not correlated, which reinforces the importance of 
obtaining both fecal and colonic mucosal samples. Dietary carbohydrate intake was associated 
with the abundance of FeFe-hydA in feces, presumably because fermentable carbohydrates are a 
major substrate for microbial hydrogen production.40  
Limitations of this study include target gene activity depends on factors other than their 
abundance, such as substrate availability, environment, and the evolution of the organism.41 
While microbial communities are ubiquitous throughout the colon, there may be regional 
differences.6 A type II error may have limited our ability to identify significant relationships 
between the abundance of genes and the composition of specific microbiota as also between the 
abundance of FeFe hydA and breath hydrogen excretion. The relationship between the 
abundance of mrcA and 16S rRNA genes of methane producing microbes (i.e., Archaea) was not 
evaluated. 
In conclusion, similar to our prior phylogenetic assessment of microbiota, the functional 
genes associated with H2 production and utilization in the colonic mucosa were more abundant in 
constipated patients than healthy people, independent of colonic transit. While the abundance of 
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hydrogenogenic and hydrogenotrophic genes was correlated, the abundance of these genes was 
not associated with the breath levels of their respective gases after lactulose ingestion. Breath 
methane was not related with constipation or colonic transit. A larger study integrating 
phylogenetic, transcriptomic, functional genomic, and metagenomics techniques with 
physiologic parameters is necessary to more fully resolve how microbes generating and 
disposing of H2 impact colonic function. 
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FIGURES AND TABLES 
Table B1. Summary of Patient Characteristics * 
Variable Healthy (n=25) Constipated (n=25) P value 
Age, y 39±10 48±15  .02 
BMI, kg/m2 26±4 25±4 .13 
Total caloric intake, kcal 1597±402 1265±350 .005 
Carbohydrate, g 188±54 155±62 .054 
Protein, g 75±19 60±26 .002 
Fat, g 60±26 46±15 .03 
Fiber, g 17±13 12±4 .01 
Carbohydrate (% of total calories) 47±9 49±12 .24 
Protein (% of total calories) 20±6 20±7 .88 
Fat (% of total calories) 33±6 32±6 .85 
Breath methane (AUC, ppm*min) 1488±2895 4100±6656 .20 
Breath hydrogen (AUC, ppm*min) 7154±4716 6483±5824 .44 












Small intestinal transit (Colonic 
filling [%] at 6 hours) 
45±27 48±26 .74 
Colonic transit, GC24 2.6±1.1 1.6±0.8 .0006 
Colonic transit, GC48 3.9±0.9 2.8±1.0 .001 
Abbreviations: AUC, area under the curve; BMI, body mass index; GC24, geometric center of 
colonic transit at 24 hours; GC48, geometric center of colonic transit at 48 hours 
* All data presented as mean (SD)   
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Table B2. Association Between Mucosal Gene Abundance and Overall Mucosal Microbiota 
Composition *  
Gene Unweighted Unifrac Weighted Unifrac Bray-Curtis 
dissimilarity 
Mucosal    
FeFe-hydA .002 .02 .07 
dsrA .002 .004 .08 
mcrA .03 .19 .007 
Fecal    
FeFe-hydA .21 .54 .30 
dsrA .37 .16 .28 
mcrA .79 .66 .49 













FeFe-hydA Phyla    
 Actinobacteria -0.22 .006 .02 
 Bacteroidetes * 0.23 .05 .08 
 Proteobacteria -0.58 .002 .01 
 Family    
 Actinobacteria;Propionibacteriaceae -0.35 .006 .09 
 Bacteroidetes;Odoribacteraceae † -0.06 .03 .24 
 Bacteroidetes;Sphingobacteriaceae 0.46 .02 .19 
 Proteobacteria;Comamonadaceae † -0.52 .001 .03 
 Genus    
 Actinobacteria;Propionibacterium -0.35 .003 .06 
 Bacteroidetes;Odoribacter † -0.19 .02 .19 
 Proteobacteria;Comamonas † -0.25 .02 .19 
 Proteobacteria;Delftia † -0.45 .002 .06 
dsrA Phyla    
 Bacteroidetes * 0.33 .04 .09 
 Proteobacteria -0.50 .02 .08 
 Family    
 Bacteroidetes;Barnesiellaceae 0.04 .03 .28 
 Proteobacteria;Bradyrhizobiaceae -0.28 .04 .28 
 Proteobacteria;Comamonadaceae † -0.43 .02 .26 
 Proteobacteria;Rhizobiaceae -0.48 .02 .26 
 Genus    
 Bacteroidetes;Odoribacter † -0.30 .02 .14 
 Bacteroidetes;Sphingobacterium 0.28 .008 .14 
 Firmicutes;Ruminococcus -0.22 .03 .23 
 Proteobacteria;Agrobacterium † -0.48 .01 .14 
 Proteobacteria;Bradyrhizobium -0.28 .05 .28 
 Proteobacteria;Delftia † -0.48 .009 .14 
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Table B.3. (cont.)    
mcrA Phylum    
 Actinobacteria -0.25 .04 .11 
 Proteobacteria -0.36 .02 .08 
 Family    
 Bacteroidetes;Odoribacteraceae † -0.14 .01 .17 
 Bacteroidetes;Paraprevotellaceae -0.39 .02 .18 
 Proteobacteria;Comamonadaceae † -0.44 .03 .23 
 Proteobacteria;Pseudomonadaceae 0.30 .04 .25 
 Proteobacteria;Rhizobiaceae -0.48 .004 .12 
 Genus    
 Actinobacteria;Propionibacterium -0.36 .04 .27 
 Bacteroidetes;Odoribacter † -0.28 .003 .06 
 Firmicutes;Butyrivibrio -0.05 .05 .30 
 Proteobacteria;Agrobacterium † -0.48 .003 .06 
 Proteobacteria;Delftia † -0.43 .008 .10 
 Proteobacteria;Pseudomonas * 0.30 .04 .27 
Abbreviations: FDR, false discovery rate 























Figure B2. Differences in mucosal gene abundance in health and constipation.  
P values are adjusted for colonic transit. **P<0.005, ***P<0.001; FeFehydA, FeFe hydrogenase; 















Figure B3. Correlations among abundance of genes in colonic mucosa 
Values represent Spearman correlation coefficients. **P<.005, †P<.001; FeFehydA, FeFe 
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ROLE OF MICROBIAL HYDROGEN METABOLISMIN CHRONIC CONSTIPATION 
AND CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME 
ABSTRACT 
An investigation was performed to quantify colonic hydrogenogenic (hydrogen-producing) and 
hydrogenotrophic (hydrogen-consuming) microbiota in patients with chronic constipation or 
constipation predominant irritable bowel syndrome compared to healthy controls. Mucosal 
biopsies were collected during flexible sigmoidoscopy or routine screening colonoscopy from 17 
constipated and 17 normal subjects, along with clinical and demographic data. On a subset of 
subjects, breath gas and transit time measurements and Bristol Stool Scale scores were collected, 
and quantitation of hydrogenogenic and hydrogenotrophic functional genes were performed 
(FeFE-hydrogenase, pan-dsrA, and methyl coenzyme-M reductase). Correlations were performed 
between breath gas concentration and functional gene targets abundance (N=8) (Figure C.1). 
Initial analysis demonstrated presence of hydrogenogenic and hydrogenotrophic functional genes 
in patients, the abundance of which correlated positively with breath gas concentrations. 
Quantification of hydrogenases involved in the production of hydrogen and electron bifurcation 
have been performed, and samples are being prepared for metegenomic analysis to describe 
dominate methods of hydrogen cycling in the human gut which can be compared with breath 
values collected during initial stage of the study. This investigation is motivated by a genomic 
and metagenomics survey published by PI Gaskins and coworkers, which observed that 
hydrogen metabolism is more diverse and widespread in the human colon than originally 
appreciated. One key observation was the strong suggestion that the majority of hydrogen 
reoxidation in the human gut is through electron-bifurcation coupled to ferredoxin respiration. If 
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proven correct, this would result in a significant paradigm shift in the understanding of microbial 
hydrogenotrophy, which could have widespread scientific and clinical implications. However, 
the survey only assessed the genetic determinants of hydrogen metabolism using published 
genomes and metagenomes from stool. Confirmation of these results with additional samples is 
imperative, and use of mucosal biopsies are likely to reveal more about the diversity and 



















Figure C.1. Breath hydrogen concentration is positively correlated with hydrogenogenic and hydrogenotrophic gene targets in 
colonic mucosa of constipated subjects. Quantitative PCR targeting hydrogenogenic FeFe hydrogenase and hydrogenotrophic 
methyl coenzyme M reductase and dissimilatory sulfite reductase was performed in eight constipated subjects. Breath H2 
concentration after lactulose intake was measured over three hours. All functional gene targets positively correlated with H2 breath 
















































































HIGH FAT FEEDING INCREASES SUFIDOGENIC MICROBIAL  
ABUNDANCE IN C57BL/6 MICE 
ABSTRACT 
The hypothesis that a high fat (HF) diet rich in saturated fat stiumulates sulfidogenic bacteria 
was investigated. Forty C57BL/6J mice were fed a low fat (10% energy from fat) or a HF lard-
based (60% energy from fat) diet for 6 or 20 weeks. Mucosa samples were collected from the 
ileum, cecum, and colon and used to target the specific bacterial genera B. wadsworthia, 
Desulfovibrio spp., Desulfobulbous spp., Desulfobacter spp., and Desulfotomaculum spp. The B. 
wadsworthia–specific dissimilatory sulfite reductase (dsrA-BW), which encodes an enzyme that 
catalyzes a step in the reduction of inorganic sulfate to H2S, was targeted to measure the 
abundance of this member of the Desulfovibrionaceae family. Mice fed the HF diet had greater 
(P <0.05) abundance of 3 types of sulfidogenic bacteria, primarily in colonic mucosa, compared 
with LF-fed mice at week 20 (Figure D.1). A follow-up study was conducted which investigated 
whether a butter-fat based HF diet also stimulates sulfidogenic bacterial growth, and whether 
consumption of grapes attenuates this effect. C57BL/6J mice (N=10 per group) were fed one of 
five treatment diets for 10 weeks as follows: low fat (10% energy from fat), HF (34% energy 
from fat) plus 3% powdered grapes, HF plus 3% sugar, HF plus 5% powdered grapes, and HF 
plus 5% sugar. Intestinal mucosa and digesta were collected from the duodenum, jejunum, 
cecum, and proximal and distal colon. In addition to the same 16S rDNA and functional gene 
targets used in the previous study, the bacterium Akkermansia muciniphila and four functional 
genes utilized by F. nucleatum in the fermentation of cysteine were quantified via qPCR. 
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Abundance of Desulfobacter spp. and dsrA-BW was lower in ileal mucosa of mice consuming a 





























Figure D.1. Abundance of sulfidogenic bacteria in ileal, cecal, and distal colon mucosa in 
C57BL/6J mice fed either LF (10% of energy) or HF (60% of energy) diets for 6 or 20 wk. 
Abundance of 16S ribosomal RNA and functional gene targets in ileum (A), cecum (B), and 
distal colon mucosa (C). Values are means 6 SEMs (n = 10 per treatment). Means without a 
common lowercase letter differ, P , 0.05 (least-squares means Student’s t test). DBB, 
Desulfobulbus species; DFM, Desulfotomaculum species; DSB, Desulfobacter species; dsrA-
BW, Bilophila wadsworthia– specific dissimilatory sulfite reductase; DSV, Desulfovibrio 
species; HF, high-fat; LF, low-fat. 
_____________________________________________________________________________ 
1 Reprinted with permission from Wan Shen, Patricia G. Wolf, Franck Carbonero, Wei Zhong, Tanya Reid, H. Rex 
Gaskins, Michael K. McIntosh. Intestinal and systemic inflammatory responses are positively associated with 
sulfidogenic bacteria abundance in high-fat-fed male C57BL/6J mice. J Nutr 2014 Aug;144(8):1181-7. © (2014). 




Figure D.2. Abundance of B. wadsworthia-specific functional gene target dsrA and 
Desulfobacter spp. (DSB) in ileal mucosa of C57BL/6J mice fed either LF or HF diets with 
or without 3% or 5% powdered grapes for 10 weeks. Means ± S.E.M. (n = 9–10) without a 
common lowercase letter differ (P= 0.05) using one-way ANOVA and Student's t test. 3S, HF 
diet containing 3% sugar; 3G, HF diet containing 3% grapes; 5S, HF diet containing 5% sugar; 








1 Reprinted with permission from Jessie Baldwin, Brian Collins, Patricia G. Wolf, Kristina Martinez, Wan Shen, 
Chia-Chi Chuang, Wei Zhong, Paula Cooney, Chase Cockrell, Eugene Chang, H. Rex Gaskins, Michael K. 
McIntosh. Table grape consumption reduces adiposity and markers of hepatic lipogenesis and alters gut microbiota 




SULFIDOGENIC BACTERIA ABUNDANCE IN COLONIC MUCOSA IS POSITIVELY 
CORRELATED WITH MILK AND ANIMAL FAT INTAKE AND NEGATIVELY 
CORRELATED WITH MONO AND POLYUNSATURATED FATTY ACIDS 
ABSTRACT  
Correlations between mucosal sulfidogenic bacteria and diet were examined using sigmoid 
biopsies and the NIH Dietary History Questionnaire collected from 9 healthy subjects over 4 
time points (0, 3, 6, and 9 months) (Figure E.1). Bacterial genera, namely Akkermansia 
muciniphilia, Bilophila wadsworthia, Desulfovibrio spp. (DSV), Desulfobulbus spp. (DBB), 
Desulfobacter spp. (DSB), and Desulfotomaculum spp. (DFM) were quantified by 16S rRNA 
gene-specific qPCR. Functional genes for pan-dissimilatory sulfite reductase (dsrA) and B. 
wadsworthia specific dsrA (dsrA-BW) were measured along with three genes utilized for 
cysteine fermentation by Fusobacterium nucleatum: L-cysteine desulfhydrase (Lcd), L-
methionine-γ-lyase (FN1419), and cystathionine-β-synthase (FN1055). Significant positive 
correlations were observed between high saturated fat intake and increased abundance of DSB, 
dsrA-BW, and A. muciniphilia; specifically those present in milk fat, palm, and coconut oils. 
Similarly, DSB abundance was increased with total dairy intake, (r = 0.48 p = 0.003). In 
addition, DSV was positively associated with red meat (r = 0.36 p = 0.04) and cholesterol (r = 
0.30 p = 0.02) intakes. Conversely, DSB was negatively associated with intake of mono and 
polyunsaturated fatty acids, particularly linoleic (r = -0.46 p = 0.0059), erucic (r = -0.52 p = 
0.002), eicosenoic (r = -0.56 p = 0.0006), and docosahexaenoic (r = -0.45 p = 0.007) acids. 
Collectively, these observations demonstrate mucosal sulfidogenic bacteria abundance is 
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positively correlated with high milk and animal fat intake and negatively correlated with mono 



























Figure E.1. Abundance of sulfidogenic qPCR targets from sigmoid biopsies collected from 9 




Figure E.2. Observed correlations between sulfidogenic target abundance and diet in 9 healthy subjects using Pearson’s 
correlation coefficient. FN1419, L-methionine-γ-lyase; FN1055, cystathionine-β-synthase; Lcd, L-cysteine desulfhydrase; dsrA, pan-
dissimilatory sulfite reductase; dsrA-BW, B. wadsworthia specific dsrA; Bwads, B. wadsworthia 16S rDNA; AKM1, A. muciniphila 
16S rDNA; DSV, Desulfovibrio spp. 16S rDNA; DSB, Desulfobacter spp. 16S rDNA; DBB, Desulfobulbus spp. 16S rDNA. p<.05*, 




COMPARISON OF SULFIDOGENIC BACTERIA IN MUCOSA AND STOOL OF 
NATIVE AFRICANS AND AFRICAN AMERICANS 
ABSTRACT 
African Americans who consume a high animal fat and protein diet are at high risk of CRC, 
while the lowfat and animal protein consuming NA population have a very low CRC occurrence. 
To observe native and dietary differences between populations, stool and mucosal samples were 
obtained from 20 AA and 12 NA individuals before and after diet exchange. Bacterial genera, 
namely Desulfovibrio spp. (DSV), Desulfobulbus spp. (DBB), Desulfobacter spp. (DSB), and 
Desulfotomaculum spp. (DFM) were quantified by 16S rRNA gene-specific qPCR. Primers 
targeting functional genes including methyl coenzyme M reductase II (mrtA), Bilophila 
wadsworthia specific dissimilatory sulfite reductase A (dsrA-BW), both FeFe (FeFe-hydA) and 
Fe-only (Fe- hydA) hydrogenase were used. In addition, primers targeting genes in 
Fusobacterium nucleatum for cysteine fermentation were used including 2 homologues of L-
cysteine desulfhydrase (Lcd and Cdl), L-methionine-γ-lyase (FN1419), and cystathionine-β-
synthase (FN1055). AA had significantly higher weight (p=0.0001), height (p<0.0001), and 
BMIs (p=0.02) than NA individuals. In mucosa, NA had a significantly higher abundance of 
DSV (p=0.004), dsrA-BW (p=0.007), and Cdl (p=0.01), while AA had a higher abundance of 
Lcd (p<0.0001). Individuals eating a western diet had a significantly higher abundance of dsrA-
BW (p=0.02), and a significantly lower abundance of Lcd (p<0.0001) in mucosa. In stool, AA 
had significantly higher amounts of Cdl (p=0.01) and FeFe-hydA (p=0.004) and individuals 
eating a NA diet had significantly higher amounts of DBB (p=0.05), DSV (p=0.01), and FN1055 
(p=0.004). African Americans consuming a NA diet had a significantly greater abundance of 
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DSV (p=0.03), Cdl (p=0.009), and FN1055 (p=0.07), and a significantly lower abundance of Fe-
hydA (p=0.02) in stool. Native Africans consuming a western diet had a significantly lower 
abundance of DBB (p=0.01) and Lcd (p=0.03) (Figure F.1). Significant differences were not 
observed in NA or AA mucosa upon diet exchange. Collectively, these observations demonstrate 
that changes in diet have different effects on the mucosa and stool of an individual, that a 
fermentable diet may increase the abundance of hydrogen utilizers like Desulfovibrio spp. and 






















Figure F.1. Abundance of bacterial genera and functional gene targets in Native African 
and African American subjects before and after diet exchange. Abundance of 
Desulfobulbous spp. and Desulfovibrio spp., as well as the functional genes L-cysteine 
desulfhydrase (Cdl), L-cysteine desulfhydrase (Lcd), cystathionine-β-synthase (FN1055), and 





SULFIDOGENIC BACTERIA ARE MORE ABUNDANT IN WOMEN WITH A 
HISTORY OF BREAST CANCER 
ABSTRACT 
Hydrogen sulfide is a proinflammatory and genotoxic agent that is released as a consequence of 
microbial sulfur metabolism. Compelling evidence suggests that the diversity and composition of 
the human gut microbiome may promote inflammation and have wide-spread effects on the host. 
For this reason, using functional and 16S gene targets for Desulfovibrio spp. (DSV), 
Desulfobulbus spp. (DBB), Desulfobacter spp. (DSB), Desulfotomaculum spp. (DFM), and the 
functional genes B. wadsworthia specific dsrA and F. nucleatum L-cysteine desulfhdrase the 
abundance of sulfidogenic bacteria was quantified from stool of 200 subjects between the age of 
30-80 with history or risk of breast cancer versus healthy controls. Analysis revealed increased 
abundance of sulfidogenic DSV, DBB, and B. wadsworthia in woman with a history of breast 
cancer compared to healthy controls. Women with a family history of breast cancer had a greater 
abundance of DSV, DBB, and DFM species. Taken together, these data reveal that sulfidogenic 









Figure G.1. Abundance of bacterial genera and functional gene targets in women with a 
history of breast cancer vs. healthy controls. Abundance of Desulfobulbous spp., Desulfovibrio 
spp., Desulfobacter spp., Desulfotomaculum spp., as well as the functional genes F. nucleatum L-
cysteine desulfhydrase (Cdl) and B. wadsworthia dsrA in women with or without a history or 
family history of breast cancer. Means ± S.E.M. without a common lowercase letter differ (P= 
0.05) using one-way ANOVA. 
